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Antimicrobial peptides (AMPs) play a key role in the innate immune response. They can 
be ubiquitously found in a wide range of eukaryotes including mammals, amphibians, 
insects, plants, and protozoa. In lower organisms, AMPs function merely as antibiotics by 
permeabilizing cell membranes and lysing invading microbes. However, during evolution 
these peptides have become multifunctional molecules acting in the complex networks of 
higher organisms with additional properties such as having a mitogenic activity, 
antitumor activity or playing a role in adaptive immune responses. Hence, the AMPs are 
interesting targets to analyze transcriptional regulatory networks as their involvement in 
diverse pathways suggests. Understanding transcription regulation of any class of gene is 
a mammoth task, which can be approached from many angles. The author has focused on 
promoter region analysis of AMP genes, specifically to find transcription factor binding 
site motifs. The questions that were asked in the beginning of the thesis were, what are 
the promoter elements that regulate transcription of different AMP genes? Are they 
common across different AMP genes or specific to each AMP gene or AMP gene group? 
Are the promoter elements conserved across different species of an AMP gene group? 
Can promoter element modules be created out of these promoter elements? Can new 
AMP genes be found using the non-homology, promoter analysis based approach? This 
thesis has attempted to answer these questions by using examples of several AMP gene 
families. To be able to address the questions raised for this thesis, the author employed an 
array of computational biology techniques (sequence analysis based), supported by 
statistical evidence in a stepwise manner. The thesis begins with the creation of an 
antimicrobial peptide database (Chapter 3) that proved to be a good resource for the 
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research done for this thesis. Some prominent AMP families were analyzed in depth at 
peptide level and Hidden Markov Model (HMM) method was employed as a prediction 
tool to elucidate plausible important functional residues of some AMP families (Chapter 
4). The author further delved into the gene level of AMPs and used the antimicrobial 
peptide database as a starting point to narrow down the families to work on for 
transcription regulation. The author has also collaborated with RIKEN Institute, Japan, 
for this research and used FANTOM full-length cDNA repository from RIKEN that was 
unpublished data resource at the time this research began. 
Ab-initio motif finding method was used to find novel promoter elements (PEs*). 
The author was able to find common and different PEs between different species for 
AMP families (Chapter 5). The common, conserved PEs were used to develop specific 
models of promoters of co-regulated genes or genes having similar function (Chapter 6). 
These models were then used to search across the human promoter data for potentially 
new genes that have high possibility of being co-expressed as the target AMP gene group 
(Chapter 7). The search across the promoter regions of the human genome was done with 
the idea that the outcome will be a set of genes and/or new AMP genes themselves. Thus, 
this approach facilitates unfolding the relationship of AMP genes with other genes of the 
same pathway and helps us understand parts and functions of the underlying gene 
networks. This indirectly enriches the knowledge about the responses that cells generate 
while reacting to pathogen invasion and potentially can help in designing better 
antimicrobial drugs.  
*PE is abbreviation for Promoter Element, which has been used interchangebly with TFBS in this thesis 
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Part I Chapter 1: Introduction 
 
























1.1 Background on AMPs 
 
Antimicrobial peptides (AMPs) are integral components of innate immunity in many 
organisms. They may be broadly classified into two classes, those that are directly anti-
microbial, and those that are derived by proteolytic cleavage of a precursor. (Pazgier et 
al., 2006, Li et al., 2006, Shinnar et al., 2003 , Ibrahim et al., 2005 , von Horsten et al., 
2002).  
Mammals produce many different antimicrobial peptides that are active against a 
broad spectrum of pathogens, including Gram-positive and Gram-negative bacteria, 
rickettsia, protozoans, fungi and some viruses (Hancock and Diamond, 2000)  
Many AMPs are also involved in functions not directly associated with the innate 
immune response. For example, under normal physiological conditions, hepcidin is an 
important regulator of hepatic iron homeostasis, but at least in zebra fish it also acts as 
AMP (Shike et al., 2004). Another AMP, the neutrophil granule derived peptide cap37, 
which binds to Gram-negative bacterial endotoxins, also acts as signaling molecule 
causing the up-regulation of protein kinase C activity (Kamysz et al., 2003). Individual 
AMPs may have distinct functions in different locations (for example, at mucosal 
surfaces or in phagocytes), and must be regulated so as to be available when the pathogen 
challenge is presented. This instigates an interesting research problem, which is, to 
understand underlying transcriptional players for different families of AMP genes and 





1.2 Research issues investigated in this thesis 
 
AMPs are of commercial and academic interest due to their unique sequence 
properties and ability to attack an array of pathogens. Realizing the importance of these 
groups of genes, gene discovery efforts have been undertaken by many groups. For 
example, efforts were directed to the computational discovery of beta defensin producing 
genes (Scheetz et al., 2002,  Schutte et al., 2002). The method used is based on a 
similarity approach associated with HMM search and BLAST search of EST sequences 
mapped to confirm the transcription of these genes. However, this approach has some 
inherent limitations as both BLAST and HMMER analyses could not identify all known 
beta defensin genes, even not all used in the training of HMMER (Schutte et al., 2002). 
This was due to the fact that AMPs are highly diverse peptide sequences even within the 
same family and species (Maxwell et al., 2003, Tennessen, 2005). Hence, similarity can 
be very low in which case it is difficult to decide if putative hits obtained with low 
similarity can be considered being new AMPs. 
The discovery of new AMP coding genes (AMPcgs) can be considered a special 
case of the general gene discovery problem. The existing experimental and computational 
methods (Xiang and Chen, 2000, Iida and Nishimura, 2002, Maggio and Ramnarayan, 
2001, Zhang, 2002) are not specifically tuned to this gene class, which reduces chances 
for targeted search for AMP genes. For example, the common approach that can be used 
to search for new AMP members is homology search by tools like BLAST against known 
and ‘artificial’ (DNA translated) peptide sequences (Xiao et al., 2004, Zaballos et al., 
2004). While this approach is widely used, it suffers a serious problem related to the level 
of similarity through which one can infer that the predicted peptide belongs to the target 
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group. A new methodology for computational gene discovery has been proposed and 
used recently for some specific classes of genes (Frech et al., 1997, Wasserman and 
Fickett, 1998) based on the concept of modelling of the gene’s promoter region. This 
approach seems reasonable to use for the purpose of AMP gene discovery as literature 
reviews suggest that the promoter regions of the highly diverse AMPs are fairly 
conserved (Ganz, 2003). This can suitably complement homology based gene 
identification. This approach also facilitates in unfolding of possible new association of 
genes with other genes (in terms of co-regulation) of the same pathway and unearthing 
parts and functions of the underlying gene networks which earlier have not been reported 
(Cohen et al., 2006, Dohr et al., 2005).  
In this study, the major aim has been to use computational approaches to find the 
underlying PEs i.e. the transcription factor binding sites (TFBSs) and their organization 
across different AMP families. This is a challenging computational problem because of 
the difficulty finding true TFBSs in promoter regions .The TFBSs in promoter regions are 
very short motifs and their sequence variability has not been very well understood. 
Secondly, the promoter regions of genes can be several hundred to thousand base pairs 
long and the TFBSs can lie anywhere across the region. Finding true positive TFBSs has 
been the aim of many groups working on algorithms to predict the TFBS motifs (Hertz 
and Stormo, 1999,  Frith et al., 2004, Bailey and Elkan, 1995). The TFBS motifs, which 
are cis-elements and are present nearby each other in the promoter region, can be grouped 
into modules. Some of these modules* have been observed to be conserved across 
different classes of genes or across different species for the same genes. This 
phenomenon is particularly seen in genes of belonging to a particular classes and having 
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similar functions that co-express together under specific conditions (Werner et al., 2003, 
Werner, 2003, Werner, 2002). Thus, genes under the same conditions have similar TFBS 
patterns contained in their promoter regions. These TFBS patterns can be used to develop 
specific models of promoters of co-regulated genes and these models can be used to 
search across genome for potential new genes that also have high chance of being co-
expressed as the target gene group (Werner, 2001). Genes predicted on the basis of 
derived promoter models of the target AMP gene group are expected to be genes that 
could be part of the same pathway in which an AMP participates directly or indirectly 
(Niyonsaba et al., 2003, Wang et al., 2003, Moon et al., 2002). and some could be AMP 
genes. 
Using promoter region analysis to find new AMP genes and co-regulated genes is 
a first of its kind approach in the field of antimicrobial peptides. The results of this 
analysis can guide the way for experimental validation of the predicted set of genes. This 
thesis attempts to add knowledge to the understanding of transcriptional regulation of 
AMPs based on computational methods. 
In order to achieve this primary objective, the secondary objectives of this thesis 
include (a) building a comprehensive repository of AMPs and (b) integrating analysis 
tool for sequence based classification. These objectives lay the foundations that would 
facilitate future wider systematic studies of the various AMP families in addition to the 




1.3 Objectives of this thesis  
 
Large-scale analysis of antimicrobial peptide genes at promoter level provides a global 
view on their transcriptional regulation level. This analysis in turn can support 
experimental studies by assisting in planning critical experiments and, when properly 
used, it can significantly improve the efficacy of experimental studies to understand 
transcriptional regulation. This research area is important for increasing our insight and 
knowledge about the little known area of transcriptional regulation of AMPs. In general, 
AMPs display an array of diverse functions and new information about their 
transcriptional regulation can help us understand their role and position in innate 
immunity, adaptive immunity and other related pathways in a better way. This would in 
turn have long-term implications in their role as potential drug candidates.  
The first step towards executing a systematic data mining strategy to deduce novel 
insights into huge amount of biological data is to provide an adequate data management 
pipeline. Thus, consolidating the scattered data on antimicrobial peptides into a 
centralized database is a prerequisite for a systematic large-scale analysis. Information 
gained from such analysis is useful for developing new analytical tools for study of novel 
antimicrobial sequences. 
Therefore, the specific objectives of this thesis were to: 
1. Build a database of antimicrobial peptides with integrated query, extraction and 
sequence analysis tools, (Chapter 3, 4) 
2. Extract and analyze the promoter dataset of AMP genes and find the key regulatory 
elements that are playing a role, (Chapter 5) 
3. Develop promoter models of AMP genes for several AMP families, (Chapter 6) and 
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4. Use promoter models to search across human promoter data for (Chapter 7) 
a) detection of new co-regulated genes, and 
b) deciphering parts of gene networks of which AMP genes are members.  
 
1.4 Contribution of this thesis 
 
AMP-coding genes and their products have been extensively analyzed with regard to 
evolution (Crovella et al., 2005  Patil et al., 2004, Xiao et al., 2004, Rodriguez de la 
Vega and Possani, 2005). Functional studies focusing on biochemical and immunological 
characterization have been performed on individual members (Krause et al., 2003 Kragol 
et al., 2001, Risso, 2000, Selsted et al., 1993). However, until now there has not been any 
comprehensive characterization of promoter regions among all mammalian AMPs. This 
study is unique in scale and methodology. The author has employed a combination of 
computational methods and proper statistical testing and, 1) identified in promoter 
regions of 77 genes representing 22 AMP families known and novel transcription factor 
binding motifs, 2) their combinations and conserved modules, and 3) linked them 
according to biological functions in context of the AMPs. 
The author’s original contributions to the field of antimicrobial peptides include: 
1) Organizing a large and unique data set of ~1788 entries of antimicrobial peptides 
from public databases and literature and creating a web-accessible, publicly 
available database (http://research.i2r.a-star.edu.sg/Templar/DB/ANTIMIC). 
This database of antimicrobial peptides is the most comprehensive resource 
(eukaryotic and prokaryotic) for researchers to identify antimicrobial peptides and 
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analyze their sequence which otherwise would involve multiple querying of other 
databases. Integration of Hidden Markov Model (HMM) based tool and using it to 
find the potentially important residues of functional importance in certain AMP 
families.  
2) Identifying common and specific putative regulatory elements (TFBS motifs) 
within the AMPcg’s promoter regions. These findings have been supported by 
literature evidence wherever possible.  
3) Developing promoter models of several AMP gene groups. To the best of the 
author’s knowledge and based on the literature search, there have been no 
attempts to model promoters of AMPcgs. 
4) Identifying likely co-regulated AMPcgs using AMP promoter models based on a 
scan across promoter regions of the human genome and determining parts of 
potential transcription regulatory networks in which some of the AMP genes are 
possibly involved. 
5) Providing a functional analysis of the genes so identified and their relation to 




1.5 A summary of the thesis 
This thesis consists of three parts. Part I provides an introduction to the thesis, in terms of 
the importance of antimicrobial peptide research, objectives of the thesis and 
contributions of the thesis. Chapter 2 gives an overview of the field of antimicrobial 
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peptides and how bioinformatics is facilitating the understanding of AMPs at peptide and 
gene level (Chapter 1).  
Part II describes the implementation of specialized data warehouse of 
antimicrobial peptides – ANTIMIC integrated with bioinformatics tools (Chapter 3). In-
depth usage and sequence analysis done of AMP families using ANTIMIC Profile tool 
that is integrated in the ANTIMIC database is discussed in Chapter 4.  
Part III presents the original findings of the study that includes comparative 
genomic sequence analysis to find TFBSs by ab-initio motif searching approach using 
Dragon Motif Builder tool in several groups of AMPs (Chapter 5). The findings have led 
to some important observations about the families of TFs that may potentially regulate 
AMPcgs.TFBS modules were generated from the promoter analysis of some AMP groups 
and this provided insights into the concept of conserved TFBS framework in regulation 
of well-studied and novel AMP groups in Chapter 6. Chapter 7 presents the results of the 
scan done using the TFBS modules generated in Chapter 6 across human promoter 
dataset. 
Part IV (Chapters 8 and 9) discusses and draws conclusions from the 
bioinformatics-based approach to large-scale analysis of antimicrobial peptides. It also 
discusses future directions respectively. 
The work presented in this thesis has been published in the following journals, 
1) Brahmachary, M., Krishnan, S.P., Koh, J.L., Khan, A.M., Seah, S.H., Tan, T.W., 
Brusic, V. and Bajic, VB. ANTIMIC: a database of antimicrobial sequences. 




2) Brahmachary, M., Schönbach, C., Yang, L., Huang, E., Tan, S.L., Chowdhary, R., 
Krishnan, S.P.T., Lin, C.-Y., Hume, D.A., Kai, C., Kawai, J., Carninci, P., 
Hayashizaki, Y. and Bajic, V.B.. Computational promoter analysis of mouse, rat and 




a) A Hybrid Algorithm for Motif Discovery from DNA Sequences (Edward Wijaya, 
Kanagasabai Rajaraman, Manisha Brahmachary, Vladimir B. Bajic). Poster 
presented at Asia Pacific Bioinformatics Conference (APBC 2004) held in 
Singapore. 
 
b) Poster on ANTIMIC database for European Conference of Computational 
Biology (ECCB 2003, September) held in Paris. 
 
c) Poster on Ab-initio identification of Promoter Elements in Antimicrobial Peptide-
coding Genes in 17th International Conference on Genome Informatics, at 
















Part I: Chapter 2: Overview of AMPs  
 
The seat of knowledge is in the head, of wisdom, 


















2.1 Properties of antimicrobial peptides  
 
Antimicrobial peptides are ancient weapons of the innate immune system. They are 
categorized under the first line of defense system of complex higher organisms and 
probably the only defense system in simpler organisms like bacteria. They are widely 
present in the animal and plant kingdom. Hence, there are numerous families of these 
AMPs and new ones are been discovered regularly. They are an effective weapon against 
an array of pathogens. The antimicrobial peptides intelligently target the microbial 
cellular membrane and exploit the inherent difference between microbial cell membrane 
and multicellular plants and animals. They are mostly cationic peptides though there are 
examples of anionic peptides also which kill pathogens typically by permeabilizing their 
cell membrane. Interestingly, most pathogens have not been able to develop resistance 
against them. (Zasloff, 2002). 
These cationic AMPs usually have <100 amino acid residues, with at least two 
positive charges due to lysine and arginine residues and around 50% hydrophobic amino 
acids (Hancock and Diamond, 2000). There are more than 50 families of AMPs and more 
than 800 AMPs (Kamysz, 2005). Most AMPs are derived from larger precursors that 
include a signal sequence. They go through post-translational modifications that include 
proteolytic processing, and in some cases glycosylation (Bulet et al., 1993), carboxy-
terminal amidation and amino-acid isomerization, and halogenation (Zasloff, 2002). 
Many of these peptides are gene-encoded and synthesized by ribosomes. However, some 
peptides are derived as cleaved portions from larger proteins, such as buforin II from 
histone 2A (Park et al., 1996) and lactoferricin from lactoferrin (Bellamy et al., 1992). 
These peptides are known to be so diverse that the same peptide sequence is rarely 
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recovered from two different species of animal, even those closely related (Maxwell et 
al., 2003). Exceptions include peptides cleaved from highly conserved proteins, such as 
buforin II (Zasloff, 2002). However, within the antimicrobial peptides from a single 
species, and between certain classes of different peptides from diverse species, significant 
conservation of amino-acid sequences can be recognized in the pre-proregion of the 
precursor molecules (Simmaco et al., 1998). This suggests that the pre-proregion is 
probably conserved, as they are involved in secretion and intracellular trafficking of the 
peptide. The highly diverse nature of antimicrobial peptides arises from the need of each 
organism to adapt and survive in different microbial environments. Hence, even single 
mutations can dramatically alter the biological activity of these peptides (Boman, 2000).  
2.2 Mechanism of action of AMPs 
Antimicrobial peptides act by targeting the membranes of microbes that have a 
fundamental difference with multicellular animals. In bacterial membrane, the outermost 
leaflet of the membrane bilayer, which is the exposed surface, is heavily populated by 
lipids with negatively charged phospholipids head groups. In contrast, the outer leaflet of 
the membranes of plants and animals is composed principally of lipids with no net charge 
(Matsuzaki, 1999). Most of the lipids with negatively charged head groups are segregated 
into inner leaflet, facing the cytoplasm. Shai (1999), Matsuzaki (1999) and Huang (2000) 
proposed a model for AMP-bacterial membrane interaction (Shai, 1999 , Matsuzaki, 
1999, Yang L. et al., 2000). According to the model, the cationic peptides interact 
electrostatically with the negatively charged membrane. They adopt amphipathic 
structure where the positively charged residues are lined up on one side and the non-polar 
residues arranged on the other side of the peptide to be able to accommodate the specific 
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conditions at the membrane-water interface. This is followed by displacement of lipids, 
alteration of membrane structure and in certain cases entry of the peptide into the interior 
of the target cell. Three models have been proposed to describe the molecular events 
taking place during the peptide-induced leakage of the target cell. Figure 2.1 is a 
graphical representation of these models which have been discussed in detail in the 
following section. 
Figure 2.1: Mode of action of AMPs 
 
a) cationic antimicrobial peptide interact with anionic membrane surface  and 
form amphpathic structure. b) pore formation models; the AMPs  can integrate 
into the membrane in three ways barrel stave model, carpet model, aggregate 
model. Figure has been adopted from  (Koczulla and Bals, 2003) 
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2.2.1 Barrel stave model 
According to the barrel stave model after initial electrostatic binding to the outer leaflet 
of the bacterial membrane, alpha helical amphipathic peptides group together into barrel-
like clusters that line amphipathic trans-membrane pores. The non-polar side chains face 
the hydrophobic fatty acid tails at the inside of the phospholipids bilayer and the 
hydrophilic side-chains are pointed inward into the water-filled pore. Progressive 
recruitment of additional peptide monomers leads to a steadily increasing pore size. 
Leakage of intracellular components through these pores subsequently leads to cell death 
(van 't Hof et al., 2001).   
2.2.2 Carpet model 
The carpet model proposes that the AMP clusters cover the surface of the membrane like 
a carpet. The membrane then collapses at the point of saturation of the concentration of 
the AMPs. In a short period of time, wormholes are formed all over the membrane 
leading to an abrupt lysis of the microbial cell. The lipid layer bends back on itself like 
the inside of a torus. The lateral expansions in the polar head group region of the bilayer 
are filled up by individual peptide molecules (Shai, 2002). This model has been the 





2.2.3 Aggregate Channel model 
Another model known as the aggregate channel model proposes that after binding to the 
phospholipids head groups, the peptides insert into the membrane and then cluster into 
unstructured aggregates that span the membrane. These aggregates are proposed to have 
water molecules associated with them providing channels for leakage of ions and 
possibly larger molecules through the membrane. This model essentially differs from the 
other two in the way that only short-lived trans-membrane clusters of an undefined nature 
are formed, which allow the peptides to cross the membrane without causing significant 
membrane depolarization. Once inside, the peptides proceed to their intracellular targets 
to exert their killing activities. Another mechanism that has been suggested on AMP-
bacterial membrane interactions focuses on self-promoted uptake of AMP (van 't Hof et 
al., 2001). The cationic peptides bind to the negatively charged LPS present on the 
surface of Gram-negative bacteria. In the process of binding to LPS, they displace cations 
like Ca2+ and Mg2+ that are necessary for cell surface stability. This causes disruption in 
the surface of membrane, and eventually with formation of pores, larger molecules enter 
the cell. This self promoted uptake pathway works not only in Gram-negative bacteria but 
also in Gram-positive bacteria (Nykanen et al., 1998 ). 
The ability of AMPs to bind non-specifically to negatively charged membranes and 
induce pore formation makes them capable of being able to attack a variety of microbes 
(Gram-positive, Gram-negative bacteria, fungi, virus, and protozoa). However, recently it 
has been discovered that AMPs also bind specifically to target molecules on the surface 
of pathogenic membranes to carry out their lytic activities. Nisin binds with high affinity 
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to Lipid II, the fatty acyl proteoglycan anchor in the bacterial membrane, from which it 
subsequently diffuses into the surrounding membrane (Brotz et al., 1998). Some plant 
defensins also use a similar strategy (Thevissen et al., 2000).   
After the AMPs bind to the cell surface of the pathogens, many of them do not 
kill the pathogen merely by permeabilizing the cell membrane. Several of the AMPs have 
intracellular targets that they bind to and inhibit, thus causing the death of the pathogen. 
Drosophila AMP, attacin blocks transcription of the omp gene in E.coli (Carlsson et al., 
1991). Bactenecins (Bac5, Bac7) inhibit protein and RNA synthesis of E.coli and 
Klebsiella pneumoniae by inhibiting the respiration pathway in addition to 
permeabilizing their membrane (Skerlavaj et al., 1990 ). PR-39 has been shown to kill 
E.coli by inhibiting its DNA and protein synthesis (Boman et al., 1993). Neutrophil 
antimicrobial peptide 2 (eNAP-2) from horse, target and inactivate microbial serine 
proteases like subtilisin A and proteinase K (Couto et al., 1993). 
2.3 Therapeutic applications of AMPs  
The short peptide length and versatility of AMPs in targeting a variety of pathogens has 
generated lot of interest in labs and pharmaceutical industries to create these peptides 
synthetically and also create hybrids of these peptides to increase efficacy of their 
functional range (Ferre et al., 2006, Saugar et al., 2006 , Hongbiao et al., 2005). AMPs 
also seem to be the potential answer to pathogens that have cleverly grown resistant to 
conventional antibiotics. Most pharmaceutical endeavors have been to develop topical 
applied agents from AMPs, as the long-term toxicology of these AMPs is not fully 
understood to facilitate development of safe oral drugs. One such example is magainin 
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analogue Pexiganan (Ge et al., 1999). Another hurdle is that many of these AMPs show 
effective pathogen killing in vitro, but in vivo efficient killing requires high concentration 
of AMPs that can cause host cell toxicity. Table 2.1 lists the AMPs that have been 
commercialized. 
Many other applications of AMPs as anti-infective agents have been 
demonstrated. AMPs have shown potential for being ‘chemical condoms’ to inhibit the 
spread of sexually transmitted diseases from pathogens like Neisseria, Chlamydia, human 
immunodeficiency virus (HIV), Herpes simplex virus (HSV) (Yasin et al., 2000). AMPs 
in tandem with the conventional antibiotics have shown to increase potency of antibiotics 
in vivo by facilitating access of antibiotics into the bacterial cell (Darveau et al., 1991, 
Giacometti et al., 2000). LL37 has been tested in animal model to alleviate pulmonary 
bacterial infection associated with cystic fibrosis (Bals et al., 1999). Medical devices 
such as intravenous catheters are laced with magainin peptides  
that are bound to them by covalent bonds and this facilitates inhibition of microbial 
colonization and growth on their surfaces (Haynie et al., 1995). AMPs are being used as 
imaging probes for bacterial and fungal infections due to their specific affinity for 
microbial membranes (Welling et al., 2000 ).  
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Table 2.1: Commercial Development of AMPs 
This table has been adopted from (Zasloff, 2002) and modified after (Gordon et al., 2005) 
 
 
Peptide  Source AMP Activity Target disease Company Stage 
Pexiganan (Msi-78) Magainin 2 Bacteria 
Infected Diabetic Food 
Ulcers  Magainin (Genaera)  
Completed Phase III; 
not approved by FDA, 
pending additional 
studies 




like Bacteria Acne Micrologix Phase II, finished 
Iseganan  (Ib-367) Protegrin Bacteria, Fungi Mucositis  Intrabiotics Pharmaceuticals
Phase II, oral - topical 
use, failed 
P-113  Histatins Bacteria, Fungi Oral Candidiasis, Mucositis Demegen  Phase II 
Heliomycin   Bacteria Antibacterial  Entomed Preclinical 
Human 
Lactoferricin   Fungi   Am Pharma  Preclinical 
Xmp.629  Bpi Bacteria 
Antimicrobial Activity 
Against P. Acnes  Xoma Phase III 
Neuprex (Rbpi21) Bpi Bacteria 
Reduce Inflammatory 
Complications Associated 
With Pediatric Open Heart 




2.4 Regulation of AMP genes 
 
Since AMPs can be both gene encoded peptides and cleaved products, it is likely that 
their induction and expression fall under numerous different regulatory mechanisms 
which are yet to be deciphered (Koczulla and Bals, 2003). Some parts of the regulatory 
mechanisms have been studied in AMPs like beta defensin, alpha defensins in human, 
mouse and bovine species (Wehkamp et al., 2004, Witthoft et al., 2005, Sherman et al., 
2006, O'Neil, 2003, Fang et al., 2003, Musikacharoen et al., 2001, Fehlbaum et al., 2000, 
Yamamoto et al., 2004). While expression of alpha defensins are generally constitutive 
(Chen et al., 2006), beta defensin expression in general is induced by different stimuli 
(Chen et al., 2006) like microbial signals, developmental signals, cytokines, 
neuroendocrine signals in tissue specific manner. For example hBD-2 expression gets up 
regulated by infections and inflammatory stimuli (Taguchi and Imai, 2006, Voss et al., 
2006, Rivas-Santiago et al., 2005, Kao et al., 2004). Factors like interleukins (IL-1alpha, 
IL-1beta), tumor necrosis factor-alpha, microorganisms (Gram-positive and Gram-
negative bacteria, Candida albicans) and LPS are some of the stimulatory agents for 
expression of beta defensins (Singh et al., 1998, O'Neil et al., 1999, Bals et al., 1999). 
NF-kB binding site has been found in promoter regions of beta defensins (Diamond et al., 
2000). Intracellular signaling probably includes NF-kB, NFIL-6, and JAK/STAT 
pathways (Kao et al., 2004, Jang et al., 2004). One of the mechanisms of induction of 
antimicrobial peptides has been deciphered in Drosophila (Imler and Bulet, 2005,  Naitza 
and Ligoxygakis, 2004) and an analogous mechanism exists in humans (Williams, 2001). 




the signaling cascade that cause induction of some AMP genes (Danilova, 2006). 
Different signaling cascades are triggered by diverse pathogens in Drosophila. This yields 
different sets of peptides. For example, the Toll receptor pathway is activated in response 
to fungi or Gram-positive bacteria while the immune deficiency gene pathway is 
activated in response to Gram-negative bacteria (Lemaitre et al., 1997, Michel et al., 
2001, De Gregorio et al., 2002). However, a lot more needs to be known in terms of the 
regulatory mechanisms of AMPs.  
To understand the regulatory mechanism of AMPs or any other genes, the 
identification of regulatory elements is the first step. Computational biology can facilitate 
identification of these regulatory elements faster than experimental identification. Over 
the years, the growing amount of genomic sequences of different species has facilitated 
validation and fine-tuning of the computational protocols for transcriptional regulation 
analysis. The aim is to identify the right transcription factor binding sites in regulatory 
regions like promoters. Promoters are identified computationally through mapping TSS 
(Transcription Start Sites) of genes and extracting the upstream regions. Once this data is 
in hand, it is then possible to search for cis-regulatory elements computationally by 
screening genomic sequences for the presence of TFBS motifs that have already been 
identified. TFBSs are usually short (5–25 bp), degenerate sequence motifs that occur very 
frequently in the genome, hence a position weight matrix (PWM) is often used to 
quantitatively represent the binding specificity of these factors. More advanced 
algorithms also facilitate search for pairs or multiple TFBSs in a combination that could 
be biologically relevant. To reduce the number of false positives, comparative genomics 




TFBSs. Chapters 5, 6 and 7 discuss in details the various current approaches and 
algorithms that are been used to achieve the above stated objectives. 
The systematic integration of diverse data types (e.g., individual TFBS hits 
generated by PWM or IUPAC strings, expression data, sequence data from multiple 
organisms etc.) together with the development of progressively more sophisticated 
computational algorithms for promoter prediction, regulatory element identification, and 
TF coordination modeling, as well as the accumulation of experimental databases of 
genes and TFs (such as TRANSFAC, TRANSCompel, etc.), will synergistically yield 
new information and reduce data output to a manageable scale for further experimental 
validation, thus providing an integrated platform for deciphering the transcriptional 
regulatory networks.  
Figure 2.2 summarizes the general strategy that is implemented computationally 
in the research of transcription regulatory domain. The starting point is identification of 
promoter regions using either mRNA/EST mapping or in silico promoter prediction 
(Bajic et al., 2002, Sonnenburg et al., 2006). Co-regulated genes are then derived from 
expression profiling analysis to refine the promoter dataset to be analyzed. The promoters 
are subjected to TFBS or composite elements analysis. A predictive regulatory module 
can be further derived through statistical model building. The module or original TFBS 
can be used to find other genes regulated in a similar pattern. Comparative genomics 
(phylogenetic footprinting) can be used both target gene identification and TFBS 
identification. Expression profiling can also be used to validate the in silico target gene 
prediction. The ultimate test for validity of predictions made by computational methods is 




 In the thesis, a slightly different strategy has been employed, although the essence 
of the general strategy is retained as shown in Figure 2.2. The author has first derived the 
TFBS modules from computational analysis of AMPcg promoter regions and scanned a 
larger promoter dataset to find other co-regulated genes. Thus, this study also shows 
extraction of putative co-regulated genes using computational approach. The co-regulated 
gene set is then compared to co-expression data derived from expression profiles as a 





















Figure 2.2: Flowchart of computational analysis for transcriptional regulatory   
 based research 





















Part II: Chapter 3: ANTIMIC database 
 



















New AMP peptides are being discovered continuously from different organisms 
experimentally and there is a vast amount of data on natural AMPs but it is not available 
through one central resource. Bioinformatics facilitates an effective way to store and 
analyze large volumes of complex biological data through creation of databases. This 
chapter focuses on resources containing antimicrobial peptide data, the creation of the 
ANTIMIC database by the author and bioinformatics applications for analysis of 





3.2.1 Significance of bioinformatics in antimicrobial peptide research 
 
AMPs are important components of the innate immune system of many species. These 
peptides are found in eukaryotes, including mammals, amphibians, insects and plants, as 
well as in prokaryotes (Simmaco et al., 1998, Kylsten et al., 1990, Dangl and Jones, 
2001, Luders et al., 2003). Other than having pathogen-lytic properties, these peptides 
have other activities like antitumor activity, (Kamysz et al., 2003) mitogen activity, or 
they may act as signaling molecules (Kamysz et al., 2003). Their short length, fast and 
efficient action against microbes and low toxicity to mammals, have made them potential 
candidates as peptide drugs (Koczulla and Bals, 2003). In many cases, they are effective 
against pathogens, which are resistant to conventional antibiotics (Pereira, 2006). They 
can serve as natural templates for the design of novel antimicrobial drugs (Gordon et al., 
2005, Koczulla and Bals, 2003). 
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Resourceful use of the two approaches (experimental and bioinformatics) can facilitate 
great strides in understanding the properties and effect of AMPs in biological context. 
The main goal is the extraction of new knowledge from large-scale analysis of AMP data. 
The bioinformatics approach provides means for systematic study of a large number of 
AMPs, and facilitates experimental design and selection of key experiments.  
 
3.2.2 Sources for antimicrobial peptide data and related information  
 
 
Antimicrobial peptide related data and information can be found across various resources. 
The data include nucleotide and amino acid sequences, post-translational modifications, 
secondary structures and 3D structures deposited in public databases such as GenBank 
(Benson et al., 2005), Swiss-Prot (Bairoch et al., 2004) and PDB (Deshpande et al., 
2005). Structure-function information, and mutation studies data, is available in the 
literature. The advantages and disadvantages of these databases for the creation of a 
database of antimicrobial peptide will be reviewed in the next sections. The issues of data 
collection, cleaning and annotation when consolidating the scattered data have also been 
described.   
3.2.2.1 GenBank and GenPept databases 
 
Antimicrobial peptide data are extracted from GenPept protein database of GenBank 
(Benson et al., 2004) which contains publicly available translated nucleotide sequences 
found in GenBank. GenBank stores data that are direct submissions from labs and batch 
submissions from large-scale sequencing projects to help maintain accuracy, relevance 
and comprehensiveness of the database. However, records in these databases contain only 
  
28 
basic information such as the AMP sequence, its name, taxonomy of the source organism, 
and when available, a list of basic sequence features and references. Also, there are many 
instances of entries of partial peptide sequences being present though a different entry 
contains the whole peptide sequence of the same gene. Hence, a certain amount of 
redundancy remains in the Genbank database. The records need to be enriched with 
structural and functional information that is available in literature.  
3.2.2.2 Swiss-Prot and TrEMBL databases 
 
 
Swiss-Prot and TrEMBL (Bairoch et al., 2004) databases were also used as resources for 
extraction of data for creation of ANTIMIC database. These databases have a 
comprehensive collection of annotated protein sequences. They contain structural and 
functional information about peptide sequences that may include disulfide connectivity, 
information on secondary structure and protein family classification, among others. The 
information in the records expedites subsequent annotation when new structure-function 
information is available.  
3.2.2.3 Protein Data Bank (PDB) 
 
 
Analyzing antimicrobial 3D structures are important because function is related to its 
structural folding. Inclusion of 3D structural information to antimicrobial sequence 
analysis facilitates identification of residues that are important for structure and function. 







3.2.5 Issues on data collection, cleaning, annotation  
 
Different databases have different formats and variations in fieldnames that describe the 
same information. This poses problems when data needs to be extracted in an automated 
manner from these sources. 
For example, an AMP primary sequence is described in the ‘translation’ field of a 
GenBank record but in Swiss-Prot, it is described in the ‘sequence’ field. Standardization 
of data representation across different databases will definitely enable a smoother 
extraction process and cross-referencing of fields across different databases. For example, 
a standard field such as ‘translation’ can be used to describe AMP primary sequence 
regardless of data sources. The uniform data representation is critical because consistency 
is required for efficiency of subsequent analyses.  
When consolidating records from different databases, the same data may be 
duplicated in another database, resulting in data redundancy. Data cleaning involves 
removing these redundant records to improve on data quality. Data cleaning also involves 
detecting discrepancies in data information, highlighting, and subsequently correcting the 
conflicts.  
Records in the public databases typically contain basic information. Data 
annotation, also known as data enrichment or enhancement, is the process of furnishing 
critical commentary or explanatory notes. Data annotation enriches the data for 
extrapolation of meaningful insights from multi-source bits of information. Correlating 
the relevant information from multiple sources is critical for increasing the overall 
knowledge and understanding of a specific subject in the data warehouse (Karasavvas et 
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al., 2004). It is important to differentiate experimentally determined function from those 
that have been predicted computationally (Karp et al., 2001) because the latter require 
subsequent validation. This would allow researchers to verify and decrease the 
propagation of incorrect predicted function during data annotation.  
 
3.2.4 Data warehouses of antimicrobial peptides 
 
To the author’s knowledge, four antimicrobial databases exclusive of the author’s 
database (ANTIMIC) are currently available as major resources for the study of 
antimicrobial peptides. These meta-databases (databases for storing metadata (data that 
describes data) for a specific purpose) contain entries collected from different sources. 
An attempt has been made in Italy to consolidate information about AMPs and 
store it in a database called AMSdb (http://www.bbcm.univ.trieste.it/~tossi/search.htm). 
This database contains annotated AMP sequence data and enables a keyword search for 
categories such as ID, date, family, category, activity, organism source, and generic 
keywords. The AMSdb database consists of 804 entries (as of 05 August 2003) of 
eukaryotic origin only. This database does not provide any tools for the analysis of data. 
Another database (http://public-1.cryst.bbk.ac.uk/peptaibol/home.shtml), 
Peptaibol database, is a highly specialized one that contains over 300 entries of antibiotic 
peptides known as Peptaibols (Chugh and Wallace, 2001), that originate from fungal 
organisms like Trichoderma and Emericellopsis. This database enables users to search for 
information about Peptaibols by name, or Peptaibol group. It also allows for searching of 
entries using motifs specific for Peptaibols (that are known to have non-standard amino 
acid residues in them). The database stores Peptaibol entries with PDB entries and 
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enables users to view the structure from the database. The authors of this database have 
classified the Peptaibols into subfamilies based on the alignments of these sequences with 
common sequence features thought to be important for channel formation (Chugh and 
Wallace, 2001). 
The APD (the Antimicrobial Peptide Database) is another data resource for 
AMPs. It contains annotated information for 559 peptides (498 antibacterial, 155 
antifungal, 28 antiviral and 18 antitumor, some peptides are member of multiple groups). 
It has an interactive interface for peptide query, prediction and design. It also provides 
statistical data for a select group of or all the peptides in the database. Peptide information 
can be searched using keywords such as peptide name, ID, length, net charge, 
hydrophobic percentage, key residue, unique sequence motif, structure and activity. APD 
facilitates studying the structure–function relationship of antimicrobial peptides. The 
database can be accessed via a web-based browser at the URL: 
http://aps.unmc.edu/AP/main.html (Wang and Wang, 2004). 
 SAPD (Synthetic Antibiotic Peptides Database) 
(http://oma.terkko.helsinki.fi.8080/~SAPD) contains information about peptide 
antibiotics that have been that have been synthesized based on naturally occurring 
structures of antimicrobial peptides. This database caters to researchers who want 
information about the various structure manipulation experiments that have been done on 
AMPs. It contains only 22 entries of synthetic peptides with detailed information. 
 Compared to these databases, ANTMIC contains the most number of AMPs 
that cover sequences from both eukaryotes and prokaryotes. It has sequence analysis 
tools integrated with the database that are unique to this database. These tools are  
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sequence similarity search tool such as BLAST, a peptide structure viewer tool to view 
the 3-D peptide structure and analytical tools like the Antimic profile module, facilitate 
analysis and classification of AMPs. The details of these tools have been discussed in the 
following sections. 
 
Table 2.2: Comparison of the various antimicrobial peptide databases  
 














































APD eukaryotic peptide sequences 






synthesized based on 
naturally occurring 
structures of  AMPs
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3.2.5 Bioinformatics tools 
 
 
The next step after creating a comprehensive collection of data and storing it in databases 
is the use of computational tools for analysis to extract biologically meaningful 
information. General bioinformatics tools commonly used in sequence analyses of 
antimicrobial peptide data include but are not limited to BLAST (Altschul et al., 1997) 
and Clustal W (Thompson et al., 1997). The BLAST search tool finds regions of local 
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similarity between query sequences and database sequences by calculating the statistical 
significance of matches. Uses of BLAST include inferring functional and evolutionary 
relationships between sequences as well as helping to identify members of gene families. 
Clustal W is a general purpose multiple sequence alignment program for nucleotide or 
protein sequences. It involves the optimal alignment of the greatest number of identical or 
similar residues into columns across many nucleotide or protein sequences. Patterns of 
aligned sequences can be used in the analysis of function, structure and phylogeny 




















3.3 Materials and methods  
 




The ANTIMIC database contains an extensive collection of antimicrobial sequences from 
many families. The database has been created on an in-house data-warehousing platform 
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(BioWare, sdmc.i2r.a-star.edu.sg/Templar) that enables building of specialized 
searchable biological databases. BioWare comprises three program modules: BioWare 
Retreive Module retrieves raw data from diverse sources on the internet; BioWare-Prep 
Module processes retrieved data, and Templar Module integrates this information into a 
central repository. The processing includes generation of a report summary for removal 
of redundant entries, renumbering of entries, and other sub-modules like a module for 
generation of multiple alignments and a module for viewing cysteine bridge patterns to 
help the database creator to manage the information more efficiently. 
 
4.3.4 Data collection for the ANTIMIC database 
 
 
The data has been extracted from public databases. Specific keyword search terms like 
“alpha defensin” and generic keyword terms like “antibacterial”, “antifungal”, etc. were 
used within the BioWare Retrieve Module to search the NCBI’s GenBank and Swiss-Prot 
databases. 
 
3.3.2 Data filtering 
 
 
This preliminary data set was checked for duplicates and redundancies, with help of 
BioWare and manual curation. Entries that may have been the earlier versions of another 
entry were removed. This was facilitated by the BioWare-Prep Module that generates a 
sequence comparison report summary based on pair wise alignment of entries in the data 
set. Entries, that had 100% sequence identity, were reported as duplicates. Duplicates 
having the same name and taxon (organism source) were compared. The entry judged to 
contain the most complete information was kept while the others were not considered. 
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Duplicates originating from different source species were kept as separate entries. 
Sequences that shared fragment or partial identity, where one sequence was an identical 
fragment of another, were checked for their uniqueness by referring to both literature and 
the cross-references field from the public databases. Most of these entries were earlier 
versions of other entries in the data set and hence were deleted. All deleted entries were 
added to the ANTIMIC file of rejected entries (FRE), which is used to avoid future 
retrieval of the same entry during database updates. This resultant data set will be 
referred to in this text as the preliminary cleaned data set.  
Next, each of the entries were checked manually to ensure that they are the AMP 
entries and not irrelevant entries, examples including “Integrin” or “Reticulon 4 receptor 
precursor” which may have been picked up by the keyword search. Records eliminated at 
this step were recorded in the FRE. The final cleaned data set was used as the input to the 
Templar Module, and the online version of the ANTIMIC database was generated 
(http://research.i2r.a-star.edu.sg/Templar/DB/ANTIMIC/).  
The antimicrobial sequences were formatted into a blastable database and integrated to 
the ANTIMIC database. 
 
3.3.3 Antimicrobial structural data incorporation 
 
The ANTIMIC database has a structure viewer module that contains the PDB structures 
of antimicrobial sequences. The structure viewer was populated by searching the PDB 
database for 3-D structures of antimicrobial sequences present in the ANTIMIC database. 
PDB accession numbers present in the annotation of entries in the ANTIMIC database 






3.3.4 Creating the ANTIMIC profile tool for antimicrobial classification 
 
A web-based antimicrobial peptide analysis tool named as ANTIMIC profile tool was 
created with the aim to facilitate tentative classification of query sequences into different 
antimicrobial families. It has three modules based on the HMMER software package 
(http://hmmer.janelia.org/), (Eddy, 1995). The ANTIMIC profile tool uses predefined 
antimicrobial-specific library of profiles, although users can generate profiles out of their 
specific sequences. The profile library has been created out of mature peptide regions of 
AMPs of different families. The mature peptide region from each of the AMP sequences 
of a family were extracted based on the annotation provided for the AMP sequence in 
Swiss-Prot or GenBank. The mature domains were then subjected to multiple sequence 
alignment using Clustal W (Thompson et al., 1994). The Clustal W output was further 
processed with hmmbuild (part of HMMER package) to create an HMM profile. This 
profile was stored as one of profiles of antimicrobial-specific library e.g. mellitin.hmm, 
protegrin.hmm etc. 
The ‘Query profile’ module of ANTIMIC tool was built by first constructing an 
antimicrobial HMM database. The HMM database was built by concatenation of single 
HMM profile files created from different AMP family sequences. The files were 
concatenated using the –A “append” option of hmmbuild program. Then the 
hmmcalibrate program was run to determine appropriate statistical significance 
parameters for a HMM prior to doing database searches.  
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After the HMM profile database was built, known antimicrobial query sequences 
were used to test the specificity of the HMM profiles in the database. Query sequences 
that do not have known antimicrobial function were also used as a negative test set (see 
chapter 4) to check the specificity of ‘Query profile’ program. 
The Query db module is based on the hmmsearch program of HMMER package. For the 
“Query db” module, the nr dataset from Genbank was downloaded in fasta format and the 
ANTIMIC database peptide sequences were downloaded in fasta format and these 
datasets were built into two different databases to be queried against by the HMM 
profiles created. Details of the various HMMER command options can be found in the 
HMMER userguide. Figure 3.1 summarizes the strategy to build the ANTIMIC database. 
 
3.4 ANTIMIC database features 
 
 
The ANTIMIC database is the most comprehensive source of natural AMPs to date that 
has been manually curated. The database currently has 1788 number of entries (last 
updated on October 2002) extracted from GenBank and Swiss-Prot. The entries come 
from both eukaryotic and prokaryotic organisms. The creation of the database is a 
systematic collection of AMP sequences and the first step in the computational approach 
to understand the transcriptional regulation of AMPs. Hence, the intention to create the 
database was to aid molecular analysis of AMPs. In addition to comprehensive peptide 
information and AMP specifics, ANTIMIC database has integrated data extraction tools, 
sequence similarity search tools, BLAST, peptide structure viewer tool, and analytical 
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tools like the ANTIMIC profile module, all of which facilitate analysis and classification 
of AMPs. Figure 3.2  gives the statistics of the data stored in ANTIMIC database.  
Figure 3.3 shows the distribution of  ANTIMIC data based on structures of various AMP 
groups. As discussed earlier AMPs have highly variable primary sequences,  and they 
show some degree of conservation at structure level. Thus AMPs have been also 
classified based on their common structures (van 't Hof et al., 2001, Vizioli and Salzet, 
2002). A striking conservation is observed of AMPs that have disulfide bridges. For eg. 
defensins have been grouped as alpha, beta, theta based of their disulfide architectures 
(Chen et al., 2006). 
 
3.4.1 Database Organization 
 
 
Each ANTIMIC entry includes a concise description of the sequence, the scientific name 
and taxonomy of the source organism, bibliographic references, and a table of features 
listing areas of biological significance, coding regions, peptide regions, sites of mutations 
or modifications and the protein translation. 
The annotation of each entry in the database contains the following fields (Figure 
3.4): A unique accession number ‘DBACC’ that defines each record in the ANTIMIC 
database. The format is (D) (six digit number), where D denotes an entry of AMP and the 
six-digit number is a unique descriptor of the entry. Next, the field ‘Date’ identifies the 
date when the entry was made. The field ‘Locus Name’, ‘Sequence length’, and 
‘GenBank Division’ contain information on the locus, length of the sequence, and the 
division group to which the sequence belongs in GenBank. In some entries ‘GenBank 
Division’ is also known as ‘Molecular type’. The date when the entry was updated by 
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public database is shown in the field ‘GenBank Modification Date’ or, in some entries, as 
‘Release Date’. The ‘Name’ field contains the name of AMP used in literature, and if 
available, their common names. The field ‘Accession’ provides hyperlinks to the 
corresponding entries of the relevant external databases, GenBank and Swiss-Prot. The 
organism source of AMPs can be found in the ‘Source’ field and its taxonomy is shown 
in the ‘Species’ field. The ‘Reference’ field contains the literature references, with the 
author names and titles. Relevant comments or observations can be found in the 
‘Comment’ field. Structural features of AMPs, such as residues forming the disulfide 
bridges, helices or strands, are described in the field ‘Features’. Putative structural 
information derived by similarity to known structures is indicated as ‘By Similarty’. 
Many entries have the field ‘Link’ that links that entry other databases EMBL, Pfam, and 
ProDom etc. The field ‘Translation’ provides the amino acid sequences of an AMP entry. 
If the PDB structure is available, the field ‘Structure’ contains internal hyperlinks to the 
PDB structure stored in ANTIMIC database for relevant records. 
 
3.4.2 Integrated Tools 
 
 
The ANTIMIC database contains several integrated tools to help in the data extraction 
and analysis of AMP sequences. The data extraction and sequence viewing tools include:  
- Keyword search, 
- BLAST search, and  
- Structure viewer. 
The Keyword search feature allows users to search the database using keywords. 
The BLAST (Altschul et al., 1990) search enables users to perform sequence similarity 
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search against the antimicrobial sequences stored in the database. The structure viewer 
allows for the 3-D structures of individual AMPs to be viewed.  
The analysis-based tools consist of the ANTIMIC profile tool. This tool has 
multiple modules. The modules allow for building of new profiles, querying new 
sequences against the build profiles or against the predefined profile library, as well as 
against either ANTIMIC or nr databases. A detailed analysis done using ANTIMIC 
profile tool is discussed in Chapter 4. 
Users can access ANTIMIC entries by using either a simple keyword search such 
as species name, type of antimicrobial activity, Swiss-Prot or GenBank accession 
numbers, etc., or they can perform complex searches for more specific results by using 
more than one keyword with the support of Boolean operators. For example, a simple 
search would be to use a keyword like “Protegrin” to retrieve entries of this family. A 
complex search would be “mellitin and wasp” which will return mellitin family related 
entries that are specific to the wasp species. Therefore, any term that is present in the 
annotation of the entries can be used in combination with others to retrieve specific 
results. The results are displayed in a tabular form as a list. The list displays accession 
numbers, species from which AMP originates, and the antimicrobial sequence name. The 
accession number is hyperlinked within the database to the full data record. 
The database has integrated the BLAST program (Altschul et al., 1990 ) that 
consists of a set of similarity search programs for protein or DNA sequences. The 
BLAST feature allows users to perform sequence comparison using the BLAST 
algorithm. A query sequence of amino acid can be compared against all sequences in the 
ANTIMIC database. Users can choose to return the results either in standard BLAST 
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output or color-coded multiple sequence alignment generated by MView program 
(Brown et al., 1998). MView highlights the positions of conserved and homologous 
amino acids in the multiple sequence alignment returned by BLAST.  
For the antimicrobial sequences that have an entry in the PDB the corresponding 
peptide structures can be seen through the structure feature using the Chime (Horton, 
1999) or Swiss PDB viewer (Guex and Peitsch, 1997). The PDB files can also be 
downloaded. The latest version of Chime 2.6 SP4 is functional with Netscape Navigator 
(version 4.x) (Figure 3.5). 
3.5 Future work 
 
A database for antimicrobial peptides can prove to be very useful for scientists in 
academics and commercial organizations. For the ANTIMIC database to be consistently 
useful to the researchers, data enrichment with more data information on AMPs and 
regular updating is important. The ANTIMIC database can be further enriched by adding 
gene information, promoter sequences, gene information, transcript information, gene 
structure, orthologs and paralogs and gene ontology of known AMPs that have been 
extracted in the process of understanding AMP regulation. The peptide information can 
also be enriched in many ways. Some suggestions are peptide cleavage information, 
amino acid post translation modification of the peptides, known mechanism of action for 
AMPs and minimal inhibitory concentration (MIC) that can be appended to the existing 
AMP entries.  
New AMPs are being discovered regularly and hence the ANTIMIC database needs 
to be updated regularly. A semi-automated process with the help of BioWare is proposed 
to make regular updates possible. Keywords (AMP gene names, family names) of new 
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AMPs can be collected. BioWare can be used to search for annotation of these AMPs 
using the keywords and retain only the new entries. Secondly, the ANTIMIC profile tool 
can be facilitated to extract new AMP sequences based on profile searches. 
3.6 Conclusion 
 
ANTIMIC is a specialized database that has been built with the aim of making a 
comprehensive repository of natural AMPs complemented by data extraction and analysis 
tools to help further analysis of AMPs. One of the integrated tools, the ANTIMIC profile 
module, enables users to assign a new putative antimicrobial sequence to a family and 
functional domain. It also enables the capture of new peptide homologs from other public 
databases. Chapter 4 gives a detailed view of the utility of the ANTIMIC tool to datamine 




Figure 3.2: Number of AMP entries in ANTIMIC database in terms of different  
  species  




Figure 3.3: Number of AMP entries in ANTIMIC database in terms of different 
sequence properties 
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Full data record of AMP named 1PG1 from the protegrin family. Information about 
cysteine bridges is shown in color for simpler viewing. 
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Figure 3.5 Structure viewer image 
 
Structure viewer image shows the PDB structures of AMPs. The structures can be viewed with 
the Chime program that is compatible with Netscape Navigator. The figure shows the structure 



















Part II: Chapter 4: HMM based sequence analysis of AMPs 
 
Every artist was first an amateur 


























In this chapter the author demonstrates the usage of the ANTIMIC profile tool that is 
integrated with the ANTIMIC database (Chapter 3). ANTIMIC profile tool can help to 
identify the plausible important residues for AMP peptides that are involved in their 
antimicrobial function. This tool can also facilitate in assigning new putative AMP 
sequences to AMP families based on HMM profile matches. It also facilitates search for 
new AMP sequences based on the profiles of different AMP families. 
4.2 Background 
 
4.3.4 Classification of AMPs based on sequence properties 
 
Attempts have been made to classify the huge and diverse collection of AMPs based on 
biochemical and structural features. The largest number of AMPs are cationic molecules. 
Based on structural features, cationic peptides are divided into three classes (Table 4.1). 
The first class consists of linear peptides forming alpha-helical structures. Examples under 
this class comes from cecropins originating from insects which are a family of 3-4kDa 
linear amphipathic peptides, magainins whose source is from frogs, and cleaved product of 
histone molecules (buforin II). The second class consists of cysteine-rich open ended 
peptides containing one or more disulfide bridges. Defensins, which originate from 
different mammalian species fall under this category. Defensins themselves are arranged in 
families based on structural differences. The third class comprises peptides rich in specific 
amino acids such as proline, glycine or histidine. AMPs like drosocin, metchnikowins from 
Drosophila are proline rich peptides. Attacins and diptericins are glycine rich peptides 




There is a novel group of AMPs isolated from mammalian epithelia, which are 
anionic in nature (Table 4.2). The first class comprises of phosphorylated compounds like 
peptide B, enkelytin that are cleavage products of neuropeptide precursors like 
proenkephalin-A. The other group of anionic peptides are aspartic acid rich peptides like 
dermicidin. At present their mode of action is not clearly deciphered.  
There are also aromatic dipeptides that are AMPs. These are low molecular weight 
antibacterial compounds. Examples of these are N-beta-analyl-5-S-glutathionyl-3,4-
dihydroxyphenylalanine identified in Sarcophaga peregrina.Another class of anionic 
peptides are derived from oxygen binding proteins like lactoferrin from human and 
hemocyanin derived peptide from shrimp. Bactericidal activity of anionic peptides, 



















Table 4.1: Classification of cationic AMPs.  
  Reference (PMID)*: Pubmed Unique ID 
 
Structure and representative 





ID Reference (PMID)* 
Linear alpha-helix peptides      
Cecropins Insects, pig Bacteria, fungi, virus, Carpet  11807545, 10426426, 10333735 
Clavanin, styelin Tunicates Bacteria   10333735 
Magainin, dermaseptin Amphibians Bacteria, protozoa Torroidal pore 
2MAG 
(magainin) 11807545, 10333735 
Buforins Amphibians Bacteria, fungi Binds nucleic acids  11807545, 8573171 , 9514864  
Andropin Insects Bacteria   1899226 
Myeloid antibacterial peptide 27 
(mature peptide) Bovine Bacteria, fungi   8910461 
Antibacterial peptide BMAP-34 
(mature peptide) Bovine ?   9409740 
Linear peptides rich in certain 
amino acids      
Pro-rich:      





Pyrrhocoricin, Hemipteran Bacteria, fungi   10426426 
Metchnikowin      
Bactenecin 5 (mature peptide 
region) Sheep Gram-negative bacteria   10417180  
Abaecin honey bee 
Gram-negative,Gram-
positive bacteria   7961803  
Gly-rich:      
Diptericins, attacins Dipterans Bacteria   10426426 
His-rich:      
Histatin Human Bacteria, fungi 
Inhibits enzymatic 
activity  11807545, 10333735 





Tyr-rich:      




protein synthesis 1G8C 11807545, 10333735 
Single disulfide bridge      
Thanatin Hemipteran Bacteria, fungi  8TFV 11807545, 10426426, 10333738  
Cyclic dodecapeptide precursor 
(Cathelicidins) Bovine Bacteria   8706679 
Brevinins Frog Bacteria   11807545, 10333735 
Brain natriouretic peptides Human Bacteria, Fungi   11410403 
Two disulfide bridges      
Tachyplesin II 
Horseshoe 
crab Bacteria, fungi, virus Binds nucleic acids  11807545, 10333735, 10333738  
Androctonin Scorpion Bacteria, fungi  1CZ6 11807545, 10333738  
Lactoferricin Human Bacteria  1lfc 1599934 
Protegrins Pig Bacteria, fungi Torroidal pore 1lxe,1kwy  
Three disulfide bridges      
Alpha defensins Mammals Bacteria, fungi 
Inhibit protein 
synthesis (human 
alpha defensins)  11807545, 10333735 





T;1E4R; 1bnb  11807545, 10333735 
Defensins Insects Bacteria, fungi, protozoa   10426426, 10333738 
Penaeidins Shrimp Bacteria, fungi   10333738, 11598107  
Saposin c-like pore forming 
peptides 
Entamooeba 
dispar Bacteria   10518795 
More than three disulfide 
bridges      
Tachycitin 
Horseshoe 




Drosomycin Fruit fly Fungi  1MYN; 10333738 
Gambicin Mosquito Bacteria, fungi, protozoa   11606751  
Heliomicin Lepidopteran Bacteria, fungi  1I2U;  11580275  




Table 4.2: Classification of non-cationic AMPs.  
 This table has been modified from Vizioli and Salzet, 2002) 
 
 
Structure and representative peptides Organism Antimicrobial activity 
Reference 
(PMID)* 
I. Anionic peptides       
a. Neuropeptide derived:       
Enkelytin Bovine, human, Bacteria 
11192590, 
11377277 
Peptide B Bovine, human, Bacteria 
11192590, 
11377277 
  Leech, mussel     
b. Aspartic acid rich:       
H-GDDDDDD-OH Ovine Bacteria 8552650 
Dermcidin Human Bacteria 11694882 
Glu-rich       
Maximins 3/H5  Toad Gram-positive bacteria 11835991 
II. Aromatic dipeptides    
N-β-alanyl-5-S-glutathionyl- 
3,4-dihydroxyphenylalanine Flesh fly Bacteria, fungi 8662858 
p-Hydroxycinnamaldehyde Saw fly Bacteria, fungi 9923603 
Peptides derived from oxygen-binding 
III. Proteins   
Hemocyanin derived Shrimp Bacteria 11598107 
Hemoglobin derived Tick Bacteria 10464258 




 4.2.2  Computational classification methods 
In recent years, many computational approaches and tools have evolved to classify 
peptides in various ways. Hidden Markov Model (HMM) is one such approach besides 
Support vector Machine (SVM), Artificial Neural Networks (ANN), Decision trees and 
so on (Jia et al., 2006). HMM performs better than other machine learning methods in 
classifying proteins in family and superfamilies (Can et al., 2004). HMM is used to 
provide statistical representation of real biological processes. One example is 
classification and characterization of protein families (Bateman et al., 1999). HMM 
generates optimum multiple sequence alignment for a given protein family that can be 
used as a method for classification of protein sequences. HMMs can be considered as a 
scoring system that is based on probabilistic models of linear sequences.  
HMM profiles are able to capture the sequence properties for the set of peptide 
sequences. The profile generated can then be used to search for other sequences in a 
database that match this profile or a new sequence can be queried against the profile to 
see whether it matches the profile. This is possible as HMM inherently has probabilities 
assigned to each position of the alignment. In a typical HMM profile, the probability 
parameters are converted to additive log-odds scores before aligning and scoring a query 
sequence (Barrett et al., 1997). Therefore, if the probability of the match state emitting 
residue y is py, and the expected background frequency of residue z in the sequence 
database is fz, the score of residue z at this match state is log py/fz. The scoring takes into 
account gap alignments also which is different from gap alignments in other sequence 
alignment tools like BLAST. In HMM profile, for an insertion of length x, there is a state 




moving from match state to insert state, (x-1) state transitions for each subsequent insert 
state that cost log tII, and a state transition for leaving the insert state that costs log tIM 
(Eddy, 1998). 
 
4.2.3 ANTIMIC Profile tool 
 
The ANTIMIC profile tool integrated with the ANTIMIC database is based on 
HMMER (Eddy, 1998) (a program which uses Hidden Markov Models for motif 
description). The ANTIMIC profile tool is aimed at facilitating tentative classification of 
query sequences into different antimicrobial families. It uses predefined antimicrobial-
specific library of profiles, and also allows users to generate profiles out of their specific 
sequences. The profile library has been created out of mature peptide regions of AMPs of 
different families as discussed below. The ANTIMIC profile tool suggests positions, 
which represent the signature for the selected family and potentially may be crucial for 
antimicrobial activity, as well as those, which are ‘non-critical’ in the functional domain 
of a family of sequences. The profiles used by this module can serve as templates for 
suggesting to which family of antimicrobial sequence a query sequence may belong. The 
use of profiles enables capturing of homologs from public databases, which have a high 
likelihood of belonging to a particular family. 
The ANTIMIC profile tool has multiple modules . It consists of a profile-building 
module known as ‘Build profiles’ that enables the creation of profiles out of the 
sequences submitted by the user. The input sequences in this module can be in any format 




(http://iubio.bio.indiana.edu/soft/molbio/readseq/). The module generates a Clustal W 
alignment of the sequences, which is used to generate the profile. The user can view the 
Clustal W alignment in the web browser. The result page gives the user the option to 
view the profile that has been generated or use the profile for querying. If the option of 
use profile is selected the user is directed to the ‘Query profile’ module. Using this 
module the user can input query sequences for query against the profile. The ‘Query 
profile’ module stores the profiles built by the user with an ID tag and stores a permanent 
profile library “antimicrobial.hmm”. The antimicrobial.hmm consists of HMM profiles of 
several families of AMPs. The families currently included are melittin, magainin, 
bacteriocin, cecropin, and protegrin. HMM profiles of individual families are also 
provided separately.  
The ‘Query profile’ module helps a user to predict to which family a query 
sequence most likely belongs to (based on primary sequence properties) and whether it is 
likely to share the same mode of action as the matched family of sequences. The results 
contain three sections: a ranked list of the best scoring HMMs; a list of the best scoring 
domains in order of their occurrence in the sequence; and alignments for the highest 
scoring domains. The matches are shown with scores (bits) and E-values. The bits score 
indicates how well the sequences match an HMM profile. E-value, which is calculated 
from bits score, shows the number of false positives that is expected to be seen at or 
above this bit score. Therefore, an E-value of 0.1 indicates that there is only a 10% space 
chance that the hit is a false or has come up by chance. Hence, a low E-value is best. The 




residues) for both the query sequence and the consensus pattern for a family are shown in 
capital letters.  
The second module is known as ‘Query db’. Query db allows users to search for 
sequences in the GenBank ‘nr’ and ANTIMIC databases, which match specific profiles. 
These AMP profiles are predefined (for five AMP families) and could be used either as 
single profiles or as a library. Additionally, users may employ their own generated 
profiles.  
4.3 HMM profiles of some AMP families 
 
This section highlights a detailed analysis of HMM profiles generated for two AMP 
families (melittin, and beta-defensin) by ANTIMIC profile modules and its use in 
differentiating different query sequences.  
 
4.3.4 Melittin profile analysis 
 
Melittin are found in bees and are linear peptides without any disulfide bridges. They 
possess a highly asymmetric polar/non-polar amino acid distribution with six polar amino 
acids clustering at the c-terminal end (Maget-Dana, 1999). The peptides usually have a 
charge of +5 at pH 7 and a polar/non-polar amino acid ratio of 0.86 (Maget-Dana, 1999). 
Melittin is known to have a strong lytic activity towards red blood cells which is due to 
its amino acid residue tryptophan that plays a significant role in causing this hemolytic 
property (Blondelle et al., 1993). 
Six melittin sequences were taken and their mature peptide region extracted 
(Table 4.3). Using build profile module the sequences were aligned in a multiple 




different sources were collected to test against the melittin HMM profile. This test dataset 
consisted of six analogs of melittin, which were different from the wild type melittin 
sequence by a few residues. All of these analogs had a substitution of an amino acid 
residue at different positions with tryptophan (W) residue (Blondelle et al., 1993). 
Studies have shown that Trp residue plays a critical role in binding peptides to cholesterol 
present in biological membranes through the indole moiety (de Kruijff, 1990). It also 
plays role in hemolytic activity of thiol-activated sequences (de Kruijff, 1990). Hence, 
these analogs have been synthesized to understand the effect of a second Trp residue on 
melittin’s hemolytic activity (Blondelle et al., 1993). Two cecropin-melittin hybrid 
sequences were included which have a part of cecropin AMP sequence and a part of 
melittin AMP sequence. These hybrid sequences have been created in experimental labs 
studying the effect of hybridizing two different AMP sequences to get a more efficacious 
AMP sequence (Wade et al., 1992, Juvvadi et al., 1999). Protegrin AMP sequence from 
pig (PG3_PIG P32196) was included in the dataset. Non-AMP sequence Acyl-CoA 
dehydrogenase family member 8 (ACAD8_HUMAN) was introduced in the dataset. 
Finally, two melittin sequences were put in the dataset. One melittin sequence consisted 
of only the mature peptide region while the other was the complete peptide sequence, 
proprepeptide (Table 4.4). 
The results of the query are shown in (Appendix 1, Supplementary Figure 4.1). 
The wild type, melittin mature peptide sequence and the melittin proprepeptide sequence 
both had the same E-value and the lowest E-value scores as expected. Hence, they were 
the closest sequences to the melittin profile. Protegrin and Acyl-CoA dehydrogenase 




profile. Both these sequences showed high E-value scores, which indicated their distance 
from the melittin profile. Acyl- CoA dehydrogenase had slightly lower score than 
protegrin as it was a longer sequence length and thus had more number of random 
matches. 
Next were the six melittin analogs all of which had nearly similar E-value scores. 
Mut5_L6 and mut13_L13 both had the same E-value scores, which was the lowest score 
in the group of melittin analogs. These two analogs have a substitution of Leu-> 
Tryptophan at position 6 and 13 respectively. Experimental evidence shows that a 
substitution of any of these two leucines with Trp leads to a decrease in hemolytic 
activity. The mut13_P14 is different from other analogs due to a Proline (P->W) 
(Tryptophan) substitution. This substitution leads to a small increase in hemolytic activity 
(Blondelle et al., 1993). Not surprisingly, this sequence had a slightly greater E-value 
than the rest of the analogs. The analogs were followed by the cecropin-melitin hybrid 
sequence (CecropinA(1-8)-Mel(1-18)). This was closer to the melittin profile as it had a 
greater part of melittin sequence in its sequence length. CA (1-7)M(2-9) on the other 
hand had a shorter melittin sequence contributing to the hybrid formation and hence did 
not show a favorable E-value score.  
This result shows that HMM based scoring system can be used to segregate 
sequences having different properties into groups based on differences in E-values. 
Analysis of the E-values of different test sequences shows that the melittin profile 
generated by HMM is able to differentiate between members of the melittin family and 
non-members. It can also differentiate sequences where residues are substituted at critical 




used to create specific profiles out of analogs or mutated sequences to test against new 
query sequences for checking profile similarity. The next example demonstrates this 
point. 
 
4.3.4 Melittin analog profile analysis 
 
Another analysis that was done using HMM was to classify analogs of a particular family 
of AMP and create profiles out of it to observe the critical residues that cause certain 
properties of the AMP to increase or decrease. Melittin analogs were collected from 
literature (Blondelle et al., 1993) that show change in the hemolytic activity of melittin. 
Two different profiles were generated from analogs. One profile was created out of three 
analog sequences that had substitution of leucine residues with tryptophan at position 9, 
position 13 and position 16 of the wild type melittin residue. These sequences were 
observed to show decreased hemolytic activity in assays (Blondelle et al., 1993). A 
second profile was created out of seven analog sequences with tryptophan substitutions at 
positions 1, 7, 11, 12, 15, 23, 21. These sequences showed significant increase in the 
hemolytic activity of melittin.  
Next, these profiles were tested against a set of sequences for their specificity to 
see if they could differentiate between a sequence that has increased hemolytic activity and 
one that has decreased hemolytic activity. A set of four sequences was chosen to test 
against the profiles. Two were analogs with substitution of lysine-23 with tryptophan and 
leucine-16 with tryptophan. Lysine-23 substituted analog shows increased hemolytic 
activity while leucine-16 has decreased hemolytic activity (Blondelle et al., 1993). 
Mel_apicc mature peptide sequence representing the wild type melittin sequence was the 




substituted with tryptophan at position 2. This sequence did not show any significant 
increase or decrease in activity compared to the wild type melittin sequence. 
Querying against the “increase hemolytic activity” profile showed that the wild 
type melittin sequence (mel_apicc) and K-23 (increased hemolytic activity) analog had 
the lowest E-values*. Leucine-16 that represents the analog with decreased hemolytic 
activity had a higher E-value than K-23. I-2 analog that showed no change in hemolytic 
activity and had a slightly higher E-value than L-16. Thus, the profile was able to 
differentiate the analog with increased activity from the one with decreased activity. 
It was observed that querying against the “decrease hemolytic activity” profile using the 
same test set, leucine-16 (L-16) and wild type melittin sequence had lower E-values than 
K-23 and I-2. Thus, L-16 was closer to this profile, an obvious outcome and K-23 was 
more distant to this profile as compared to L-16. 
Since the analogs have single substitutions in their sequences, the E-values to 
differentiate the two different categories of melittin analogs were not on a very wide scale 
difference. However, a significant difference in the E-values was observed that enabled 
ranking them on the basis of closeness to the profile. The test set sequences and the 
results of the analog profiles are in (Table 4.5, and Appendix 1, Supplementary Figure 
4.2). 

















4.3.4 Beta-defensin profile analysis 
 
The melittin profile is an example of model dataset that is fairly conserved and 
homogenous in its sequences. Therefore, another AMP family was taken where the 
peptide sequences are not so well conserved among themselves, though they have been 
classified under the same beta-defensin family. The beta-defensin profile was made of 13 
different beta-defensin mature peptide sequences from human, mouse, and different 
monkey species (Table 4.3). The test dataset contained five sequences, which consisted 
of two beta defensin from different monkey species and one beta defensin from goat. 
Acyl-CoA dehydrogenase family member 8 (non-AMP) and protegrin (Table 4.4). 
Supplementary Figure 4.3 shows the results of the querying against the beta-defensin 
profile. Beta-defensin from BD01_CERPR (Preuss’ monkey) and BD01_PONPY 
(Orangutan) had the most favorable E-values (low E-value). Beta-defensin from goat had 
a different E-value indicating that it was not very close to the primate and rodent beta-
defensin sequences. The goat beta defensin sequence has residue substitutions in many 
conserved positions. The cysteine residue positions are conserved. However, its E-value 
is much lower compared to non beta-defensin sequence protegrin and non-AMP sequence 
(Acyl-CoA dehydrogenase family member 8) and is comparable to the other two monkey 
beta-defensin sequences. Protegrin and Acyl-CoA dehydrogenase family member 8 had 
very high E-value scores indicating they did not belong to this AMP profile. 
 
4.3.4 Querydb results 
 
Querydb enables to extract sequences from public databases that have similar sequence 




been integrated to the ANTIMIC profile module. The nr dataset contains 137,010 peptide 
sequences. 
The melittin profile was searched against the nr database with a default E-value 
cutoff of 10 to test its specificity and sensitivity. The search returned three hits 
(Appendix 1, Supplementary Figure 4.4). The first two hits (gi|69550, gi|229444) with 
low E-value scores belonged to the melittin family. The third hit (gi|16121500) was a 
tyrosine-specific transport protein from the bacteria Yersinia pestis CO92 which does not 
belong to the melittin family. It perhaps appeared since some conserved residues of 
melittin domain matched the residues of the tyrosine-specific transport protein. This 
profile has a high sensitivity and fair specificity index and a good correlation coefficient 
(Table 4.6). 
The beta-defensin profile was searched against nr dataset with an E-value cutoff 
of 10. Search returned 12 hits (Supplementary Figure 4.5). The top most hit was beta-
defensin 1 from human which was also one of the sequences of the dataset used in 
creating the beta-defensin HMM profile. Majority of the hits were beta-defensins from 
different mammalian species (human, bovine, mouse, horse). Though the profile was 
generated using a number of primate species sequences, the primate sequences did not 
come up as hits since the nr dataset used for querying lacked monkey beta-defensins. The 
only sequence that was a false hit was, gi|230338 which is a trypsin peptide complex with 
Bowman-birk inhibitor. The sensitivity, specificity and correlation coefficient for beta-
defensin profile indicates that it has average sensitivity, high specificity and a fairly good 
correlation coefficient. Table 4.6 gives the sensitivity, specificity and correlation 




database. The overall quality of the profile search against the nr database has been 
calculated in terms of sensitivity, specificity and correlation coefficient with the 
following formula: 
Sensitivity (Sn) = TP/ (TP+FN) TP =True Positive; FN=: False negative; FP=: false 
positive 
Specificity (Sp) = TP/ (TP+ FP) 
Correlation coefficient (CC) = (TP*TN)- (FN*FP)/√(TP+FN)(TN+FP)(TP+FP)(TN+FN) 
 
 
4.4 Discussion  
 
HMM has been used as the method for creating peptide profiles of different AMP 
profiles. The author has taken examples of different families of AMPs and has attempted 
to show that using HMM profiles one can predict the salient functional residues and a 
possible change in the strength of the property, even with single mutations at some 
residues. This has been shown through the melittin analog properties example. This 
example can be extrapolated to design in-silico mutant peptides, which have a desired 
property provided apriori knowledge about a family of sequences exists. It has also been 
possible to differentiate between sequences that are evolutionary divergent though they 
belong to the same AMP family. This has been shown with the beta-defensin profile 
analysis.  
As a part of future work, HMM profiles can be created for the AMP families that 
have not been covered by this study. Comparison of HMM with other machine learning 




tested on AMP families to compare performance of HMM with other methods. These 
methods can also be combined with HMM to see if a better classification method can be 
determined.   
 
4.5 Conclusion 
This study was to investigate the classes of AMP peptides and see if current 
classifications fit, and attempt to propose a computational method of classification that 
could be used across all AMPs based on the sequence properties. The HMM profiles 
were also set up find new AMPs. However, as previously reported and also observed, the 
variation and diversity of the AMP sequences even within the same family and species 
(Maxwell et al., 2003) makes is difficult to identify or predict new AMPs. Thus, a new 
approach is proposed that has been used recently for some specific classes of genes 
(Frech et al., 1997,  Wasserman and Fickett, 1998) based on the model of the gene’s 
promoter region. This approach seems reasonable to use for the purpose of AMP gene 
discovery as literature reviews suggest that the promoter regions of the highly diverse 
AMPs are fairly conserved (Ganz, 2003). This approach can be suitably complemented 
with homology based gene identification methods to increase the possibilities of 
extracting new AMPs from whole genomes. Chapter 5 and onwards shows 








Table 4.3: Sequences from melittin and beta-defensin AMP family used to create HMM profiles 
 
melittin peptide_name Species sequence (mature_peptide) 
 MEL_APICC Apis cerana cerana  GIGAVLKVLTTGLPALISWIKRKRQQ  
 MEL_APICE Apis Cerana GIGAVLKVLTTGLPALISWIKRKRQQ 
 MEL_APIDO Apis dorsata GIGAILKVLSTGLPALISWIKRKRQE 
 MEL_APIFL Apis florae GIGAILKVLATGLPTLISWIKNKRKQ 
 MEL_VESMC Vespula maculifrons  GIGAVLKVLTTGLPALISWIKRKRQQ 
 MEL_APIME Apis mellifera  GIGAVLKVLATGLPALISWIKRKRQQ  
beta-defensin    
 BD01_MOUSE Mus musculus DQYKCLQHGGFCLRSSCPSNTKLQGTCKPDKPNCCKS 
 BD01_HUMAN Homo sapiens (Human)    DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK 
 BD01_PRECR Presbytis cristata (Silvered langur)  DHYNCVRSGGQCLYSACPIYTKIQGTCYHGKAKCCK 
 BD01_PREME Presbytis melalophos (Banded langur) DHYNCVRSGGQCLYSACPIYTKIQGTCYHGKAKCCK 
 BD01_PREOB Presbytis obscurus (Dusky langur) DHYNCVRSGGQCLYSACPIYTKIQGTCYHGKAKCCK 
 BD01_HYLLA Hylobates lar (Common gibbon) SDHYNCVRSGGQCLYSACPIYTKIQGTCYQGKAKCCK 
 BD01_GORGO Gorilla gorilla gorilla DHYNCVSSGGQCLYSACPIFTKIQGTCYGGKAKCCK 
 BD01_MACFA Macaca fascicularis (Crab eating macaque) DHYNCVRSGGQCLYSACPIYTRIQGTCYHGKAKCCK 
 BD01_MACMU Macaca mulatta (Rhesus macaque)    DHYNCVRSGGQCLYSACPIYTRIQGTCYHGKAKCCK 
 BD01_CERAE Cercopithecus aethiops (Green monkey) DHYNCVRSGGQCLYSACPIYTKIQGTCYHGKAKCCK 
 BD01_CERER Cercopithecus erythrogaster (Red-bellied monkey) HYICVRSGGQCLYSACPIYTKIQGTCYHGKAKCCK 
 BD01_PAPAN Papio anubis (Olive baboon)    DHYNCVRSGGQCLYSACPIYTRIQGTCYHGKAKCCK 
 BD01_CERPR Cercopithecus preussi (Preuss's monkey) DHYNCVRSGGQCLYSACPIYTKIQGTCYHGKAKCCK 
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Table 4.4: Sequences queried against melittin and beta-defensin profiles 
 
Name Sequence 
melittin test sequences  
mel_apicc (mature_peptide) (mellitin1) wildtype gigavlkvlttglpaliswikrkrqqg 
mut5_l6 (mutant mellitin) gigavwkvlttglpaliswikrkrqq 
mut13_l13 (mutant mellitin) gigavlkvlttgwpaliswikrkrqq 
mut1_g1 (mutant mellitin) wigavlkvlttglpaliswikrkrqq 
mut6_l7 (mutant mellitin) gigavlwvlttglpaliswikrkrqq 
mut10_t11 (mutant mellitin) gigavlkvltwglpaliswikrkrqq 
mut13_p14 (mutant mellitin) gigavlkvlttglwaliswikrkrqq 
cecropina(1-8)-melittin(1-18) ( mellitin hybrid) kwklpkkigigavlkvlttglpalis 
ca(1-7)m(2-9) kwklfkkigavlkvl 







mel_apicc(complete peptide) (melittin_complete) mkflvnvalvfmvvyisfiyaapepepapeaeaeadaeadpeagigavlkvlttglpaliswikrkrqqg 




































Table 4.6: Sensitivity, Specificity, Correlation coefficient calculation 
AMP 
profile TP FN FP TN Sn Sp CC 
melittin 2 0 1 137008 1 0.66 0.99
beta-
defensin 11 9 1 136990 0.55 0.91 0.71
 
TP: true positive; FN: false negative; FP: false positive; TN: true negative; 
























Part III:Chapter 5:  Ab-initio search for TFBS motifs 
 
Nothing great was ever achieved without enthusiasm. 
























From the previous chapter (Chapter 4), analysis of AMP sequences within a single family 
like defensins showed that there is considerable amount of variation in sequences even 
within the same family. This attributes to their ability to have a broad spectrum of 
antimicrobial activity (Pereira, 2006). Due to their inherent variability in sequence, AMPs 
demonstrate low levels of similarities for homology to be inferred (Patil et al., 2004, 
Maxwell et al., 2003, Hughes, 1999) thus, one alternative is to look at the regulatory 
regions of these AMPcgs to see if they are more homologous in terms of the regulatory 
elements. 
 The author examined the regulatory regions of AMP genes in the effort to 
investigate the presence of conserved motifs upstream of the highly diverse AMPs 
gathered in the ANTIMIC database described in Chapter 3. In particular, transcription 
factor binding site (TFBS) motifs were closely investigated. One of the main features of 
commonality amongst the highly diverse AMPs, and across AMP families, is their 
involvement in some kind of defense or defense related responses. It is therefore possible 
in principle that common regulatory mechanisms are involved in triggering their 
expression in response to an external threat. Their expression may be regulated by 
common transcription factors (TFs) that regulate the expression at the transcriptional 
level. Hence, the aim in this chapter was to uncover TFs or TF groups that are common to 
AMP genes, whose presence could be put into biologically relevant contexts for 




methods show common features across various AMP gene families and some appeared to 
be specific to certain AMP families. 
Studies have been done using computational and experimental approaches to find 
conserved TFBS motifs across the same AMP gene within various species. For example, 
lactoferrin is a serum tranferring protein that is involved in the transport of ions (Fe3+) 
and in human and bovine is known to have antimicrobial activity (Bellamy et al., 1992, 
Bellamy et al., 1993). An analysis done on the promoter region of this gene from multiple 
species (human, mouse, bovine and porcine species) showed that they had some 
conserved regulatory elements. A non-canonical TATA box (GATAAA) with an adjacent 
Sp1 site was present in all the promoter regions. All the promoters had similar basic 
arrangement and a GC-rich sequence. Moreover, in two species, human and mouse, 
multiple steroid hormonal response elements specific only to these two species were 
found (Teng, 2002). However, there has been no attempt so far to find common motifs 
across different AMP genes across different species. This study demonstrates the first 
attempt to find common and taxon-specific motifs in a large scale manner across the 
AMP families based on the databases described in Chapter 3. 
This study has been the first in attempting to find common and specific motifs in 









5.2.1 Basic introduction of transcription, the key process involved in gene 
regulation 
Transcription is a complex process of decoding information present in DNA into mRNA 
molecules. This process depends on the collective action of transcription factors along 
with the core RNA polymerase II transcriptional machinery, and a variety of co-
regulators that bridge the DNA binding factors to the transcriptional machinery. In 
addition a number of chromatin remodeling factors that mobilize nucleosomes, and an 
array of enzymes that catalyze the covalent modification like acetylation, decacetylation, 
phosphorylation, metyhylation etc of histones and other proteins are also required 
(Kadonaga, 2004)  
Initiation of transcription requires the enzyme RNA polymerase and transcription 
factors. Transcription factors initiate transcription, but are not themselves part of RNA 
polymerase. The focus will be on RNA polymerase II and its promoter region as it is 
responsible for mRNA transcription. Polymerase II is not capable of initiating 
transcription on its own, without the co-factors. This is to check against unscheduled 
transcription, which can be disastrous for a cell.  
There are two major steps in the initiation of transcription. The first step is 
binding of different transcription factors (TFs) to upstream promoter and enhancer 
sequences to form a multi-protein complex. In the second step, this complex directly or 
indirectly recruits a polymerase II complexed with some general transcription factors 
(GTFs) to the core promoter. Subsequently, transcription is initiated by this initiation 




Transcriptional initiation is activated by two types of cofactors. They are 
transcriptional accessory factors (TAFs) and GTFs like TFIID, TFIIE, TFIIH, and TFIIF. 
The TAFs form the TFIID complex. TFIID binds to TATA box via TATA box binding 
protein (TBP). TFIID is involved in the transcription of most pol II promoters. TFIIE and 
TFIIH are two GTFs that are necessary for pol II to clear the promoter for elongation. 
TFIIF is required for bringing pol II into closer contact with the promoter region during 
the initiation process. In addition to these GTFs, there are several other transcriptional 
activators and repressor proteins (TFs) involved in transcriptional regulation. Only 
specific subsets of these factors bind directly with TAFs or form a ternary complex with 
TAF. Once the complete complex including TFs, TAFs, GTFs and pol II is assembled on 
the promoter, this is called the initiation complex, which is now competent to initiate 
RNA synthesis. 
5.2.2  Defining a eukaryotic promoter 
 
A eukaryotic promoter is defined as the region containing binding sites for transcription 
factors. RNA polymerase itself binds around the start point of transcription initiation on 
the gene, but does not directly contact the extended upstream region of the promoter. The 
difference between eukaryotic and prokaryotic promoter is that initiation at eukaryotic 
promoter involves a large number of factors that bind to a different cis-acting element. 
Bacterial promoters are largely defined in terms of the binding site for RNA polymerase 
in the immediate vicinity of the start point. The promoter region for RNA polymerase II 
is usually upstream of the start point of a gene beginning from the start of the first exon. 
Each promoter consists of characteristic sets of short conserved sequences that are 




region of >200bp. Some of the elements and the factors that recognize them are common; 
they are found in a variety of promoters and are used constitutively. Others are specific, 
they identify particular class of genes and their use is regulated. The elements occur in 
different combinations in individual promoters. All RNA polymerase II promoters have 
sequence elements close to the start point that are bound by the basal apparatus and that 
establish the site of initiation. Sequences positioned further upstream determine whether 
the promoter is expressed in all cell types or is specifically regulated. Promoters that are 
constitutively expressed have upstream sequence elements that are recognized by 
ubiquitous activators. Promoters that are expressed only in certain times or places have 
sequence elements that require activators that are available only at certain times or places. 
Structurally, promoters contain the transcription start site (TSS) and contain a part of the 
first exon of a gene. 
A RNA polymerase II eukaryotic promoter contains different types of promoter 
elements in its structure. They are core promoters, proximal promoters, distal promoters, 
enhancer, silencers, boundary /insulators. (Butler and Kadonaga, 2002) 
Core promoters are usually within -35 to +35 region of promoter and contain the 
transcription start site (TSS). They constitute the general transcription factor binding sites 
involved in initiation of transcription like TATA box, Inr (initiator), BRE (TFIIB 
recognition element),DPE (downstream core promoter element). Each of these motifs 
have a specific function in the process of transcriptional regulation. It is important to note 
that each of these core promoter elements is found in some but not all core promoters. 
For example, TATA box is not found in all core promoters. In addition to the core 




include the proximal promoter, enhancers, silencers, and boundary/insulator elements. 
These elements contain recognition sites for a variety of sequence-specific DNA-binding 
factors that are involved in transcriptional regulation. The proximal promoter is the 
region in the immediate vicinity of the minimum promoter site (roughly from −250 to 
+250 nt). The minimum promoter is the region that is capable of initiating basal 
transcription and may include a few more sites located close to the TATA box or the 
TSS. The proximal promoter contains the functionally important regulatory controls and 
is present near the TSS. The distal part of promoter is also the most variable one with 
respect to composition as well as length. It can consist of binding sites for any of the 
transcription factors.  
Enhancers and silencers can be located many kilo base pairs from the 
transcription start site and act either to activate or to repress transcription. 
Boundary/insulator elements appear to prevent the spreading of the activating effects of 
enhancers or the repressive effects of silencers or heterochromatin (Butler and Kadonaga, 
2002). Figure 5.1 shows a graphical representation of the various promoter regions on 
the genome. 
 














Figure 5.1: Schematic diagram of the different regions of a polymerase II promoter  
The shaded boxes, semicircle and triangle indicate the TF binding sites.DSE: Distal 








Many computational methods for predicting promoters have been developed over the last 
few years. In general, the algorithms can be divided into two groups. First, is the signal-
based approach, which relies on the recognition of relatively conserved signals and 
conserved spacing among patterns such as the TATA box, CCAAT box. Second, there is 
the content-based approach, which distinguishes promoter sequences from non-promoter 
sequences based on content differences such as triplet base-pair preferences around the 
TSS, hexamer frequencies in conservative 100-bp upstream regions, etc. using linear 
discriminant function (TSSG, TSSW) (Werner, 1999) or quadratic discriminant analysis 
(CorePromoter) (Werner, 1999). These programs have been able to predict about 13%–
54% of the promoters, correctly; each program also predicted a number of false positive 
promoters. To find the proximal promoter, the approach is to find the TSS. 
 However specification of the TSS can be difficult. It is also known that a growing 




sites. Many algorithms that do promoter prediction are based on EPD (Eukaryotic 
Promoter Database). This database contains experimentally elucidated promoter regions 
for many eukaryotic species. Detection of exact location of TSSs is not a trivial problem 
and is often confronted with issues of false predictions. Algorithms that detected TSSs 
were based on the identification of TATA box sequences, which are often located ~30bp 
upstream of a TSS. However, TATA binding motif is found very frequently in the 
upstream region as much as in every 250 bp in long genome sequences, reflecting the 
promiscuous binding characteristics of the TATA-like sequences and thus this does not 
prove to be an effective approach. Newer algorithms have shifted the emphasis to the 
prediction of promoters that contain one or more TSS(s). This approach is biochemically 
more justified as many genes have multiple TSS(s). 
In human genome, the sequence property that is used to predict promoter region is 
based on differences in methylation of CpG dinucleotides. There are regions in the 
genome sequences >200 base pairs that have high G+C content, and are known as CpG 
islands. CpGs are methylated on cytosine as a phenomenon for regulation of gene 
activity. However, in regulatory sequences, like promoter region CpGs remain 
unmethylated unlike other regions where the CpG methylation can be up to 80%. 
(Wasserman and Sandelin, 2004) Methylated cytosines are mutated to adenosines at a 
high rate, resulting in a 20% reduction of CpG frequency in sequences without a 
regulatory function as compared with the statistically predicted CpG concentration. This 
imbalance in CG dinucleotide has been exploited in bioinformatics for detecting 
promoter sequences. Numerous methods have been developed that directly or indirectly 




based on frequency of CpG dinucleotides perform remarkably well at correctly predicting 
regions that are proximal to or that contain the sites of transcription initiation. Two 
commonly known methods – Eponine and FirstEF use divergent approaches. FirstEF 
finds regions in genes with higher concentration of CG dinucleotides than the local C and 
G concentrations would suggest. It subtly improves performance by restricting 
predictions to those regions that contain or are followed by a predicted 3’- splice site, 
thereby indicating the presence of a first exon. Eponine uses a neural network model that 
analyses the over-and under-represention of longer oligonucleotide sequences. As 
Eponine’s strand prediction is based on the identification of a TSS, which is an unreliable 
step, predictions of promoter orientation are not reliable. There is also the phenomenon of 
the presence of bidirectional promoters, which limits the ability of the current 
bioinformatics methods to accurately predict promoter orientation.  
It would be worthwhile to point to two recent programs for finding promoter 
regions- Dragon Promoter Finder (DPF) (Bajic et al., 2002) and Dragon Gene Start 
Finder (DGSF) (Bajic and Seah, 2003). DPF does a content analysis of the region around 
the predicted. It uses aritificial neural network (ANN). DGSF also uses ANN along with 
CpG islands and DPF output (Bajic et al., 2004). In a recent study on the whole human 
genome, DGSF appeared to be the most accurate promoter prediction program, while 
DPF was one with the second highest sensitivity. 
Not all transcription initiation sites are proximal to CpG islands and that the 
association between CpG dinucleotides and promoters is not present in all organisms. As 
only ~60% of human promoters are situated proximally to CpG islands, hence alternative 




of promoter regions that lack CpG islands requires the use of transcript data. Recurrent 
alignment of the 5’edges of ESTs and /or full-length cDNAs can be indicative of 
promoter locations. Two programs that are based on mapping the 5’ most position (5’ 
untranslated mRNA sequence) of full-length cDNA to genome are – PromoSer 
(http://biowulf.bu.edu/zlab/PromoSer/) and FIE2 (http://research.i2r.a-
star.edu.sg/FIE2.0/). PromoSer identifies the TSS of a gene, by mapping all available 
mRNA and EST sequence data onto the genome and then tracks the overlapping 
alignments (denoted as a cluster) to determine the furthest possible extension to these 
sequences and hence determines the TSS. In many cases, PromoSer data set is enriched 
with full-length mRNA sequences produced by cap-trapping and oligo-capping methods, 
that facilitates higher confidence in the predictions. Table 5.1(a, b) list the promoter 





Table 5.1a: Promoter databases 
 
 
Promoter databases   
Source URL Address Method of extraction (Data quality) 
Genomatix 




1.known,curated (collected from EPD, DBTSS, GenBank) ; 
2.predicted  
DBTSS http://dbtss.hgc.jp/ 
oligo-capped cDNAs (experimentally confirmed full length cDNA) 
mapped to genome,alternate TSS accountable 
BU (PromoSer) http://biowulf.bu.edu/zlab/PromoSer/ 
map mRNA+EST-genome (full length mRNA data from refseq, 
oligo-captrapping in some cases. Alternative TSS sites accountable  
UCSC http://genome.ucsc.edu/ 
This includes only cases where the transcription start is annotated 
separately from the coding region start. Sequences 5000 bases 
upstream of annotated transcription start of RefSeq genes. 
EPD http://www.epd.isb-sib.ch/ experimental 
Ensembl http://www.ensembl.org/index.html 
pulls out upstream region based on EMBL mRNA records.   
No guarantee that the upstream regions are promoter regions and the 
TSS is right. 
Mpromdb 
http://bioinformatics.med.ohio-





sp Experimental (full length cDNA) 
Riken (Only TSS 








Table 5.1b: Promoter prediction tools 
 
Promoter prediction programs URL Address 
Eponine http://www.sanger.ac.uk/Software/analysis/eponine 
FirstEF http://rulai.cshl.edu/tools/FirstEF 





Dragon Promoter Finder http://research.i2r.a-star.edu.sg/promoter/promoter1_5/DPF.htm 







FIE2 (5’ end Information Extraction v2) is another web based program that identifies and 
extracts nucleotide sequence region around the start of genes (promoter region) and their 
translation initiation site (TIS). It uses information provided by the National Center for 
Biotechnology Information’s (NCBI’s) LocusLink. FIE2 identifies the 5’-most end of a gene on 
its respective chromosome based on alignment of a selected set of mRNAs representative of the 
gene. The accuracy of the information extracted is therefore limited by the accuracy and 
completeness of the sequence annotation with regard to the completeness of the cDNA 
sequences till the 5’ untranslated region and sequence alignment provided by Locus Link. In 
addition, multiple TIS positions are also occasionally presented, for example, as a result of 
multiple alignments of transcript variants.  
The latest technique that brings us closer to accurate promoter prediction is CAGE tag 
transcripts. CAGE (Cap analysis of gene expression) is a cap-cloning technique that has been 
extended with a SAGE-like procedure to cleave the initial 5’ 20 nucleotides of full-length 
cDNAs. These oligomers are then ligated into long polymers and sequenced. Generation of these 
CAGE tags from transcripts that are derived from diverse tissues promises not only to facilitate 
improved promoter prediction, but also to provide insights into tissue-specificity. 
 
5.2.4 Detection of transcription factor binding sites 
 
DNA sequences that are a part of the promoter region do not give direct information about 
regulation. Promoters do not have fixed stretches of sequence homology, which are responsible 
for promoter function. The elements influencing transcriptional regulation that binds to promoter 
regions do so in short stretches of the region. These regions or motifs are known as transcription 




gapless. These sites are interspersed with non-conserved sequences. The regulatory regions 
(promoters) that contain regulatory sites are very long (varying from several hundred to more 
than 1000 nucleotides). The actual regulatory DNA sites corresponding to a motif are called the 
instances of that motif. Every instance of a motif normally has the same length, but they may 
have slightly different sequence compositions. This variability of regulatory sites makes 
biological sense. Better gene expression control can be achieved by having regulatory sites with 
different intrinsic affinities for regulatory proteins. TFBSs do not show any significant specific 
pattern with respect to location and orientation within the promoter sequences. Identification of 
TFBSs computationally poses a problem since they are very short signals and have sequence 
variability that is not very well understood (Tompa et al., 2005). 
There are mainly two different computational approaches to detect TFBSs namely 
finding motifs with known TFBS Position Weight Matrices (PWMs) and secondly ab-initio 
motif search. The first approach is finding TFBSs on a sequence using matrix or other models of 
known TFBS. The binding sites are determined by experimental methods like deletion mapping 
and then mutagenesis of the regulatory sequences (TFBSs). A single TF can bind multiple target 
sequences having significant variation; hence, multiple sites are required to construct a model. 
The multiple binding sites are aligned. The sequence variability of the collection of binding sites 
strongly affects the downstream models for predicting additional sites. A consensus sequence is 
generated from the alignments of the multiple binding sites. To accurately reflect the 
characteristics at each position, a matrix that contains the number of observed nucleotides at each 





The frequency matrix is converted to a position weight matrix (PWM) in which normalized 
frequency values are converted to log-scale. PWM are also known as PSSM (position-specific 
scoring matrices). Since TFBSs are short, degenerate sequence motifs that can occur very 
frequently across a whole genome, the PWM provides a summary of the binding specificity of 
these TFs and hence is a representation of their binding specificity. Using the PWM, a DNA 
sequence can be scanned for known TF binding-site elements. Several programs have been 
developed to perform searches based on PWM and IUPAC: SIGNAL SCAN, MATRIX 
SEARCH, MatInspector, ConsInspector, TFSearch, etc. PWM based search is considered 
sensitive, however there are a few drawbacks of using PWM. Using PWM approach will yield 
only a small fraction of the predicted binding sites, which are functionally significant.  
Current matrix models are based on the assumption that a nucleotide at one position has 
no effect on the likelihood of a nucleotide being observed at an adjoining position. For a few 
cases in which large data collections have been generated to richly define binding, advanced 
models that incorporate higher-order interactions between positions have proved more effective  
(Wasserman and Sandelin, 2004).  
Another assumption is that TFs have strict spatial requirements in their binding sites that 
preclude variable spacing (Wasserman and Sandelin, 2004).  For some TFs, such as subset of the 
nuclear receptor family, variable spacing is allowed, rendering standard PWMs inappropriate for 
TFBS prediction. 
Another limitation of the matrix model based TFBS prediction is the construction of 





The recent advancement of microarray technology and the availability of a large number 
of complete genome sequences have resulted in a new approach to finding TFBSs. Genes are 
classified under different clusters based on their expression patterns. Genes in the same cluster 
are assumed to be co-regulated. However, it should be noted that co-expressed genes which are 
not co-regulated may not necessarily share same promoter features (Werner et al., 2003 ).  
          Computational approaches like ab-initio TFBS detection method can be used to discover 
regulatory elements. In ab-initio or de-novo approach, for a given set of co-regulated genes or 
genes belonging to same family, programs detect over-represented motifs in the regulatory 
regions. Some of the programs that use this approach are listed in Table 5.2. A prior knowledge 
of TFBSs is not needed in this approach and hence it is more relevant for searching new and 
highly conserved motifs within promoter regions as well as getting already known TFBSs (van 
Helden, 2003). Dragon Motif Builder, the program used in this thesis will be discussed in detail 





Table 5.2: Programs for de novo prediction TFBS motifs.  
 








Gibbs Sampling algorithm that returns a series of motifs as weight 
matrices that are over-represented in the input set http://atlas.med.harvard.edu/ 10698627 
ANN-Spec 
Models of the DNA-binding specificity of atranscription factor 




Model motifs using weight matrices, searching for the matrix with 




Gibbs sampling-based algorithm that automatically optimizes the 
alignment width and evaluates the statistical significance of its 
output. http://zlab.bu.edu/glam 14704356 
Improbizer 
Uses expectation maximization to determine weight matrices of 




Optimizes the E-value of a statistic related to the information 
content of the motif http://meme.sdsc.edu/ 7584439 
MITRA 





Matrix-based , motif-finding algorithm that extends Gibbs sampling 




Detects overrepresented oligonucleotides with oligo-analysis and 
spaced motifs with dyad-analysis http://rsat.scmbb.ulb.ac.be/rsat 10734201 
SeSiMCMC 
Modification of Gibbs sampler algorithm that models the motif as a 
weight matrix, optionally with the symmmetry of a palindrome or of 




Consensus-based method that enumerates exhaustively all the oligos 
up to a maximum length and collects their ocuurences (with 











Dragon Motif Builder (DMB) (E Huang et al., 2005) is based on the Expectation 
Maximization (EM) algorithm. The Expectation maximization (EM) algorithm estimates 
the maximum likelihood of parameters in probabilistic models, where the model depends 
on unobserved (latent) variables. EM alternates between performing an expectation (E) 
step, which computes the expected value of the latent variables, and a maximization (M) 
step, which computes the maximum likelihood estimates of the parameters given the data 
and setting the latent variables to their expectation. 
In DMB, EM is used to estimate the probability density of the most popular 
patterns within a set of DNA sequences. The optimal motifs are predicted with pattern 
matching score function and the population of the motifs among the sequences. The EM 
algorithm iteratively augments the motif data by guessing the values of the optimal score 
and population with the sequence, and then re-estimates the parameters by assuming the 
“best” value for the motif group. In order to model the probability density of the data 
effectively, most likelihood function was implemented to choose the initial value that has 
highest converged likelihood value. The threshold coefficient for information content has 

























5.3 Materials and methods 
 
The strategy used to find the motifs in AMP promoter regions is schematically depicted 
in Figure 5.2. Most of the AMP sequences were extracted from the ANTIMIC database 
(Brahmachary et al., 2004) (http://www.research.i2r.org.sg/Templar/DB/ANTIMIC/) that 
contains the largest number of non-redundant AMPs (1,439) and GenBank.  TBLASTN 
(Altschul et al., 1990 ) with BLOSUM45 matrix was used to search 102,801 flcDNAs of 
the FANTOM collection (Carninci et al., 2005 ) (FANTOM1+2 (60,770) plus 
FANTOM3 (42,031)) against AMP protein sequences of ANTIMIC. Since TBLASTN 
translates the query sequence into six possible open-reading frames, cDNAs with short 
CDS below the protein-coding annotation threshold can be captured. From the translated 
flcDNA sequence out of 183 mouse candidates with sequence identities to known AMPs 
equal or greater than 60% over length of 100 residues or with E-value of 0.01 or less, five 
were identified as false positives by checking their stable gene name and gene ontology 
annotations. Less stringent threshold settings (i.e. 50% or 55%) applied to a test set of 
cathelicidins, alpha and beta defenins led to too many false positives (data not shown) 











Figure 5.3: Workflow of promoter sequence set preparation and analysis 
 
  
AMP peptide sequences were collected from ANTIMIC and Genbank databases and 
searched with TBLASTN against FANTOM3 cDNA sequences applying a cut-off of 
equal or greater than 60% identity. The promoter regions [-1000, +200 nt] of mouse 
AMPcg, human and rat orthologs were extracted and submitted to Dragon Motif Builder 
(DMB) for ab initio motif searching. The resulting consensus motifs were passed to 





5.3.2 Extraction of promoter regions 
 
The mouse flcDNA were annotated with their official gene names and symbols, 
associated representative cDNAs, chromosomal localization information, TUID 
(transcriptional unit ID) and CAGE TSS (transcription start site information based on 
CAGE tags) (Carninci et al., 2005). Human and rat orthologs were determined for the 
AMP-coding mouse flcDNAs, using the Entrez Gene (Maglott et al., 2005) and 
HomoloGene (Wheeler et al., 2005). In addition, each of these ortholog groups was 
manually checked for synteny. The promoter regions of the orthologs in human and rat 
were extracted using PromoSer (http://biowulf.bu.edu/zlab/PromoSer) (Halees et al., 
2003) and FIE2 (http://research.i2r.a-star.edu.sg/promoter/FIE2_1) (Chong et al., 2003, 
Halees et al., 2003) programs, as well as H-Invitational database (Fujii et al., 2004). All 
three resources provide estimated TSS locations based on mapping EST and flcDNA data 
to genomic sequences. The promoter regions extracted for mouse, human and rat covered 
(-1000, +200) relative to the estimated transcription start site (TSS) location. In the case 
of multiple TSS locations in human and rat sequences the most 5’ one was extracted. The 
TSS location of mouse sequences was determined by using the start position of the first 
exon of the FANTOM cDNA-genome mapping data 
(http://fantom31p.gsc.riken.jp/cage/download/mm5/cage.rep_tag.2004-11-
16.chr_all_gff.tar.gz). Mouse promoter sequences (-1000, +200) were then extracted by 
mapping the TSS location to the mouse genome data from UCSC 
(http://hgdownload.cse.ucsc.edu/goldenPath/mm5/chromosomes/). The final dataset 
contained 77 promoters from mouse, rat and human. Only seven mouse sequences had 




was estimated for all sequences based on the 5’end of the flcDNA data. For histone2a 
genes a region of (-200, +100) relative to the TSS was extracted because these genes 
appear to have bidirectional promoters within 200 nt of the TSS.  
 
5.3.2 Motif search  
 
 
The promoter sequences were submitted to the Dragon Motif Builder (DMB) program (E 
Huang et al., 2005) (http://research.i2r.a-star.edu.sg/DRAGON/Motif_Search/) for ab-
initio motif finding. The EM threshold was set to 0.85 for all families that lacked 
experimentally confirmed TFBSs in their promoters. One should note that there is no rule 
about what is the optimal threshold. In fact, the optimal threshold is likely to be different 
for different promoter sets. Thus, a somewhat arbitrary threshold of 0.85 was used 
because it resulted in relatively specific matrix families. Since the algorithm is heuristic, 
different thresholds usually produce different results. In the cases when there have been 
known functional TFBSs, for the AMpcg family, two different thresholds (0.85, 0.75) 
were used and the one selected was the one that fitted better to the experimentally 
confirmed TFBSs, as this would very roughly approximate selection of a more optimal 
threshold in these cases. The program was set to search for 20 motif families, with motifs 
of length 10 to 15 nt within each of the 22 AMPcg families. In total 440 motif families 
were identified. In the case of the histone2a family a shorter motif length of 8-12 nt was 
chosen because the promoter length of histone2a family was shorter than for the other 
families. After DMB identified the sequence motifs, Patch program (mismatch =0; motif 
length =6; species =all) was used (Wingender et al., 2000) of TRANSFAC professional 




these families. Promoter models were created from motifs that were conserved among the 
all promoter sequences of an AMPcg family.  
 To find motif families that are common across many AMPcg families, all 440 
motifs were combined and searched for the most commonly found sub-motif families in 
them. For this the DMB program was used for searching for motifs of 6-8 bp length. The 
reduction of motif length did not cause over-prediction of motifs since the search was 
restricted to sequences of the previously identified motifs of length 10-15 bp. Potential 
motif-binding TFs were identified by the Patch program as already described. 
For the penk family, three programs DMB, MEME (http://meme.sdsc.edu) 
(Bailey and Elkan, 1994) and Improbiser (http://www.soe.ucsc.edu/~kent/improbizer) 
were used to search for motifs of 10-15 nt length, based on EM algorithm. Improbiser can 
identify a maximum of six motif families. For MEME and DMB 20 motif families were 
identified and the top six families based on e-value, were selected. This threshold setting 
allowed us to obtain comparable results from three different programs. The motifs were 
then compared with TRANSFAC database entries to obtain TFs that can potentially bind 
to these motifs. Figure 5.3 shows the workflow of ab-inito based motif finding. 
 
5.3.3 Phylogenetic analysis 
 
Multiple sequence alignments and phylogentic analyses of alpha-defensin sequence were 
done using Clustal W (Thompson et al., 1994) and MEGA3.0 (Kumar et al., 2004). 
Alpha-defensin sequences covering (-1000, +200) region relative to TSS were extracted 
using the Ensembl (Birney et al., 2004) gene data export function. UPGMA (unweighted 




constructed with Mega3.0 (Kumar et al., 2004) using Kimura 2-parameter methods with 
1000 bootstrap replications. 
 
5.3.4 Statistical significance of potential NHR-binding motifs 
  
All families were sorted according to the number of motifs that may bind NHR. Then, the 
author split AMPcg families into two groups, A and B. In group B the family that had the 
least number of such motifs was included. The remaining families were placed in group 
A. P-value was calculated for the enrichment in motifs that may bind NHR. The p-value 
is determined using the hypergeometric distribution and the right-side Fisher’s exact test 
and was corrected by the Bonferroni method for the 440 tests (this is the number of motif 
families identified; 20 motif families for each of the 22 AMPcg families). The author 
then excluded from group A the AMPcg family with the next least number of target 
motifs and added that family to group B. The P-value calculation was repeated. This 
process of eliminating AMPcg families from group A is repeated until A contained the 
last of the 22 AMPcg families. Based on the 21 p-values calculated this way 
(Supplementary Table 5.7), the one with the smallest value was determined, 2.81167E-
06 (Bonferroni corrected value = 0.001237134). This determines the group of 11 AMPcg 














5.4 Results and discussion 
 
5.4.1 Novel AMP transcripts 
 
The FANTOM3 data set comprising more than 100,000 flcDNAs has recently been 
released (Carninci et al., 2005). Macrophages, cells of the innate immune system, were a 
major source of additional new flcDNAs in this set. ANTIMIC-derived AMP sequences 
were mapped to the FANTOM3 cDNA set to search by sequence similarity (TBLASTN) 
for candidate cDNAs encoding new members of AMP families. Of 183 mouse candidates 
with sequence identities to known AMPs equal or greater than 60% over length of 100 
residues or with E-value of 0.01 or less, five were identified as false positives by 
checking their stable gene name and gene ontology annotations. Thus, 178 AMPcg 
sequences belonging to 29 families were identified. One hundred and three new mouse 
transcripts belonging to the AMP families alpha-defensin, alpha2casein, apoa2, beta-
defensin, spag11, bpi, calgranulin, cathelicidin, cathepsinG, dbi, slpi, enhancer of 
rudimentary homolog, granulin, hepcidin, histone2a, IFN-inducible antiviral protein Mx, 
lactoferrin, lysozyme, mbp, melanotropin alpha, ovotransferrin, proenkeph alin 1, sap2, 
secretogranin, skiv2l, spyy, vasostatin, vip and zap, were found in the FANTOM3 
(without FANTOM1+2) sequence subset. All new members were sequenced from cDNA 
libraries of immune cells (i.e. macrophages), adipocytes and testis, among others, 
indicating that the transcriptome of inducible genes involved in innate immunity is still 
incomplete.  
The definition of true orthologies across species is difficult in multigene families 
associated with innate immunity, wherein gene duplication is a common feature of 




family noted that there are three members of the myeloid-associated family (S100A8, A9 
and A12) in humans, but only two (S100A8 and A9) in mice (Ravasi et al., 2004). 
Correspondingly, it was found that the mouse AMP casein delta (csnd), defensin-related 
sequence cryptidin peptide (Defcr-rs1), mast cell protease family (mcpt2, mcpt4, mcpt8), 
and histone2a (Hist2h2aa2), did not have corresponding family members in human 
(Supplementary Table 5.2). On the other hand, the Rnase A family member Rnase 7 
was found in human, but was absent in mouse. Within the beta-defensin and alpha-
defensin family members, cDNA sequences confirm mouse-specific expansion reported 
in previous genome-based studies (Schutte et al., 2002 and Scheetz et al., 2002). 
The analysis was restricted to the three mammalian species as the approach was 
aimed at finding differences and similarities in mammalian orthologs of mouse data from 
the FANTOM3 project. Orthologs of mouse genes in invertebrates and cold-blooded 
vertebrates are too distant for such promoter analysis. Another problem is the absence of 
very accurate promoter data sets for these species, which are necessary for this type of 
analyses. This resulted in consideration of only a subset of bona fide orthologous mouse, 
human and rat promoter sequences representing only 22 out of 29 AMP families. . For 
these 22 AMP families, 31 promoter regions from mouse with the corresponding 30 and 
15 promoter orthologs from human and rat, respectively, were extracted (Supplementary 
Table 5.1). Mouse cryptidins were included in the alpha-defensin family because they 
represent a subfamily of alpha-defensins (Eckmann, 2005). The analyzed families and the 




5.4.2 Promoters and ab-initio motif discovery 
 
 
Having assembled a set of candidate AMPcgs, the aim was to identify sets of potential 
transcriptional control elements common to all or some of these genes. For many of these 
genes, the precise TSSs have been identified through the high throughput CAGE 
technology, since macrophages were extensively polled with this method (Carninci et al., 
2005). However, for this thesis, (-1000 to +200) promoter region relative to the longest 
cDNA was chosen. The most common current approach to identification of motif 
complements amongst co-regulated genes is to search using predetermined position-
weight matrices for known TFBSs as available from TRANSFAC, JASPAR and other 
sources. This approach presumes that binding is not influenced by context. The author 
has used the ab-inito approach for finding TFBS motifs. . There are several ab-initio 
motif discovery programs available (Tompa et al., 2005). No program shows a distinct 
advantage over others on all data types. However, the author compared the performances 
of DMB (E Huang et al., 2005), an in-house developed program with two other 
programs, MEME (Bailey and Elkan, 1995) and Improbiser 
(http://www.soe.ucsc.edu/~kent/improbizer/improbizer.html). All three programs use ab-
inito motif discovery algorithms based on Expectation Maximization. Promoter 
sequences of the proenkephalin (penk) AMP group (4922504O09, HIX0007519.2, 
NM_017139) were used, which has been studied empirically in transfection assays. Penk 
promoters are known to possess a TATA box and respond to cyclic AMP, glucocorticoids 
and protein kinase C (AP1) agonists (Kobierski et al., 1999 , Garcia-Garcia et al., 1998 , 
Fu et al., 1997). Since Improbiser can identify only six motifs, the top six motifs 




DMB- reported three motifs (TATA, AP-2, AP-1) that may bind TFs known to control 
the penk promoter (Fu et al., 1997 , Le et al., 2003). MEME reported one motif (TATA) 
and Improbiser two (NF-Y, TATA) motifs. As DMB and MEME can identify arbitrary 
number of motifs, top 20 motifs generated by DMB and MEME were considered. Seven 
DMB-derived motifs coincided with known TFBSs (TATA, NF-kappaB, AP-2, AP-1 
NFI/CTF, NF-Y, MZF1, MIG1, MBP-1) (Fu et al., 1997, Le et al., 2003) known to 
control the penk promoter. MEME yielded only three known penk promoter motifs 
(TATA, NFI/CTF, AP-1). Considering the differences in performance and the longer 
computation time of MEME, DMB was the preferred program for the entire analysis.  
 
5.4.3 Phylogenetic analysis of defensins 
 
 
Alpha-defensins are specific to mammals. Phylogenetic analyses of alpha-defensin 
protein-coding sequences was done to provide support for gene duplication events and 
rapid evolution under positive selection pressure (Patil et al., 2004). Gene duplication 
events have probably led to both species-specific and functionally diverse subsets of 
alpha-defensins, which should be also detectable in the upstream regulatory regions. The 
author was interested to see how promoter content reflects phylogenetic similarity. Nine 
alpha-defensin promoters of mouse, rat, chimpanzee and human were analyzed in terms 
of phylogenetic, functional and motif relationships. The UPGMA tree (Figure 5.4) shows 
two clusters. With the exception of rat Defcr4, the tree topology coincides with the 
previously reported (Patil et al., 2004) enteric (i.e. intestine) and myeloid/neutrophil cell 
expression of rat, mouse and human alpha-defensins. Enteric-expressed defensins are 




myeloid and neutrophil-specific defensins help macrophages and neutrophils to kill 
internalized bacteria. Human DEFA3, DEFA4, chimpanzee DEFA4 and rat Defa 
represent the myeloid-specific alpha-defensins. Mouse Defcr20, Defcr2, rat Defcr4, 
human and chimpanzee defa5 belong to the enteric-expressed group of alpha-defensins. 
Comparison of myeloid-expressed rat Defa with enteric-expressed mouse defcr2 
promoter regions showed that the common arrangement 20-7-4 of three promoter motifs 
was conserved in rodents (Figure 5.4). The annotation means that in the promoter region 
from 5’ to 3’ the order of motifs identified is: ‘motif20 – motif7 – motif4’. These three 
motifs potentially may bind: motif20 (AR PXR-1: RXR-alpha), motif7 (POU1F1a, 
POU2F1), motif4 (RAR-alpha1, RXR-alpha) (Table 5.3). This arrangement of motifs 
appears to be unique to mouse Defcr2 and rat Defa and thus, suggests association with 
the specific myeloid or enteric expression.  
A comparison of myeloid–specific human and chimpanzee sequences 
(Hosa_DEFA4, Patr_DEFA4, Hosa_DEFA3) and enteric sequences (Hosa_DEFA5 and 
Patr_DEFA5) showed that they share arrangement of four motifs (20-10-11-19). For 
myeloid-specific primate sequences Hosa_DEFA4, Patr_DEFA4, Hosa_DEFA3 a 
common arrangement of eight motifs (20-10-1-13-1-19-9-18-14) was found across the 
promoters. When myeloid-specific rat sequence Rano_DEF1 was included, only a 
common arrangement of three motifs (17-1-18) was found, that was specific to all 
myeloid sequences in the data set. Enteric primate sequences (Mumu_Defcr20, 
Mumu_Defcr2, Rano_Defcr4, Hosa_DEFA5, Patr_DEFA5) have an arrangement of three 
motifs (17-10-7) in common. Motif 17 (GMASTTCTKT) was found common between 




is a putative binding site for IRF-1, IRF-3, NF-AT1, NF-AT2, NF-AT3, NF-AT4. In the 
case of rodent sequences (Rano_DEF1, Rano_DEFCR4) motifs 20, 7 and 16, associated 
with putative binding sites for YY1, STAT5A, IRF-1, IRF-3, NF-AT1, NF-AT2, NF-
AT3, NF-AT4 were common between the two sequences (Figure 5.4, Table 5.3, 
Supplementary Figure 5.1). The upstream regulatory regions of mouse cryptidin alpha-
defensins contained eight common motifs with similar positioning.  
The extremely low sequence homology of beta-defensin promoters of orthologs 
and paralogs among cow, mouse, rat, chimpanzee and human, together with different 
exon-intron structures suggests multiple events of functional changes or acquisition of 
new functions as a result of positive diversifying selection during evolution (Maxwell et 
al., 2003, Morrison et al., 2003, Semple et al., 2003. Additional analysis with 
RepeatMasker (http://www.repeatmasker.org) also revealed various retro-transposons in 
the upstream regions of rat and mouse beta-defensins that are absent in primates. 
Probably the most striking example of functional specialization in the primate lineage is 
SPAG11. SPAG11 is derived from the ancestral fusion of two beta-defensins. Expression 
of SPAG11 AMPs appear to be androgen-dependent and restricted to the male urogenital 




















The boxes represent the motifs found by ab-initio searching. The numbers (i.e. 13) in the boxes 
refer to different motifs. The grey line connecting the boxes denotes a promoter region of 1,200 
bp length. The broken arrow indicates the TSS. The species abbreviations are Rano: Rattus 



















Table 5.3 Common motifs found between groups of enteric and myeloid-specific alpha-defensin sequences  
 
The species abbreviations are Rano: Rattus norvegicus, Mumu: Mus musculus; Patr: Pan troglodytes; Hosa: Homo sapiens. 





Motif Putative TFBS Gene name 
20 AGAARCTCAGS AR, PXR-1:RXR-alpha  
Hosa_defa4 (myeloid), Patr_defa4 (myeloid), Hosa_defa3 
(myeloid), Patr_defa5 (enteric) 
10 CATAMTACCTGA AP-1, c-Jun   
Hosa_defa4 (myeloid), Patr_defa4 (myeloid),  
Hosa_defa3 (myeloid),  Patr_defa5(enteric) 
11 KAGYTTTTWTCC GATA-1, NF-AT1,NF-AT2,GATA-6,GATA-3,NF-AT3,NF-AT4  
Hosa_defa4(myeloid), Patr_defa4 (myeloid), 
Hosa_defa3(myeloid), Patr_defa5(enteric) 
19 AGTAAAGCCA Unknown 
Hosa_defa4(myeloid), Patr_defa4 (myeloid), 
Hosa_defa3(myeloid), Patr_defa5(enteric) 
    
20 AGAARCTCAGS YY1 STAT5A  Rano_DEF1 (myeloid), Rano_DEFCR4 (enteric) 
17 GMASTTCTKT IRF-1 IRF-3 NF-AT1 NF-AT2 NF-AT3 NF-AT4 Rano_DEF1 (myeloid), Rano_DEFCR4 (enteric) 
6 GAAAAAAGAAT Unknown Rano_DEF1 (myeloid), Rano_DEFCR4 (enteric) 
    
20 AGAARCTCAGS AR PXR-1:RXR-alpha Rano_DEF1 (myeloid), Mumu_Defcr2 (enteric) 
7 AAAMATYCAT POU1F1a, POU2F1  Rano_DEF1 (myeloid), Mumu_Defcr2 (enteric) 
4 GAAGGACCAGC RAR-alpha1, RXR-alpha Rano_DEF1 (myeloid), Mumu_Defcr2 (enteric) 
    
17 GMASTTCTKT GR AR Mumu_Defcr20 (enteric), Mumu_Defcr2 (enteric) 
3 ATTCTCHTGGACA RXR-beta T3R-alpha1 T3R-beta1 USF1b USF1 GR Mumu_Defcr20 (enteric), Mumu_Defcr2 (enteric) 
9 CTCTTGCCTG C/EBPalpha  Mumu_Defcr20 (enteric), Mumu_Defcr2 (enteric) 
13 GGAATCAAGT Unknown Mumu_Defcr20 (enteric), Mumu_Defcr2 (enteric) 
10 CATAMTACCTGA AP-1 c-Jun Mumu_Defcr20 (enteric), Mumu_Defcr2 (enteric) 
5 CCTGCTCCCTGBT AR T3R-alpha RXR-alpha VDR Mumu_Defcr20 (enteric), Mumu_Defcr2 (enteric) 
8 TGTCCTGGTCC Mumu_Defcr20 (enteric), Mumu_Defcr2 (enteric) 
Mumu_Defcr20 (enteric), Mumu_Defcr2 (enteric) 
 
GR PR-alpha PR-beta PR B RAR-alpha1 RXR-beta RAR-gamma  
T3R-alpha T3R-beta1 T3R-beta2 HNF-4alpha RAR-alpha RAR-alpha:RXR-
gamma ,RAR-beta RAR-beta:RXR-alpha AR NFI/CTF RXR-alpha VDR 
ERR1 Mumu_Defcr20 (enteric), Mumu_Defcr2 (enteric) 




5.4.4 Frequently occurring TF binding motifs conserved across many AMPcg 
families 
 
The transcriptional regulation of AMPcg families varies from family to family because of 
the different AMP characteristics and their tissue cell-specific expression. Thus, it would 
not be expected that different AMPcg families share considerable similarities in their 
promoters. It is thus challenging to explore if such similarities exist and whether a TF can 
be involved in the control of more than one AMPcg family. In this section, the author 
looked for possible common motifs that are shared across several AMPcg families (see 
Methods). By analyzing only those motif groups that were found to be shared by at least 
six AMPcg families, eight motif groups out of total of 94 motif instances were found 
from 31 mouse, 30 human and 15 rat AMP promoter sequences (Table 5.4). This 
suggests that, a core set of TFs exist that participate in transcription activation of many 
examined AMPcg families in all three examined species. 
 Species-specific differences were observed in the combination of motifs and 
positions relative to the TSS. Each of the motif families is represented by the consensus 
motif obtained from all motif instances in that family. The consensus motif AGGAAA is 
known to be recognized by TFs PEA3, c-Ets1, E74A, PU.1, LyF-1, c-Ets-2, ISGF-3, NF-
AT1, NF-AT2, NF-AT4 and DEAF-1. Consensus motifs ACAGCA and ATGGAG are 
specific for GR and Nkx2-1, respectively. Consensus motif CCCGCCCC corresponds to 
binding site for TFs Sp1/Sp3. TGGCATT recognizes TF NF-1. CCAGGG, ACCTGG 
and TCTTTC did not match to any known TFBS contained in the TRANSFAC database. 
These three consensus motifs could represent potentially novel cis-elements.  
 Comparison of the TFs associated with the predicted motifs showed that  four 




such as, GR for motif ACAGCA. This motif was conserved among 32 genes of ten 
different AMP families in mouse, rat and human. PEA3, c-Ets1, PU.1, LyF-1, c-Ets-2, 
NF-AT1, NF-AT2 and NF-AT4-specific motif AGGAAA was observed in 34 genes 
belonging to 11 AMPcg families. Sp1 and Sp3-specifc motif CCCGCCCC appeared in 
15 genes derived from six AMPcg families. NF-1 motif TGGCATT was present in 36 
genes of nine AMP families. All these motifs were found in human, mouse and rat AMP 
genes (see Table 5.4). Consensus motif CCAGGG was observed in 24 genes of eight 
AMPcg families. ACCTGG was present in 28 genes of seven AMPcg families. TCTTTC 
motif occurred in 26 genes of nine AMPcg families. 
 Four motifs appeared to be species- or lineage-specific. For example, AGGAAA 
motif was found only in three rodent genes of the lysozyme family. CCAGGG was 
absent in genes of the human Spag11 family. TGGCATT motif was absent in human 
genes of the Apoa2 and Spyy families. CCCGCCCC was not found in mouse genes of the 
Apoa2 family (Table 5.4). However, one should note that this observation has been made 
for the region of (-1000, +200) bp of the promoters. Similar species-specific differences 
were reported for the promoter of mouse and human Toll-like receptor 3 and its 
expression pattern (Heinz et al., 2003). It is possible that these AMP genes are regulated 
by different promoter regions in mouse and human. Due to lack of sufficient data on 
microbial context, signaling pathways and TF binding-data on AMPs, it remains to be 
seen whether these disparities reflect an exposure to a different microbe environment or a 
physiological differences. Thus, it can be concluded that in spite of differences in 
functions of AMPcg families and differences in their tissue cell-specific expression, their 




these common motifs function as binding sites for unknown or undiscovered TFs. These 
motifs also represent interesting experimental targets, at least for the assessment of 
binding of TFs suggested through the computational analysis. 
Among the most frequently occurring motifs in promoters of AMPcgs the 
analysis identified three PEs (CCAGGG, ACCTGG and TCTTTC) that are not known to 





Table 5.4: Motifs that are highly enriched among different AMP families. 
 
Pattern: The consensus of motif sequence found in the AMP sequences; TF name: 
Transcription Factor name associated with the motif; Total AMP: The number of 
AMP families that contain the motif; AMP family: The AMP families which 
contain the motif; Seq IDs: The mRNA ids of AMPcgs whose promoter sequences 
are analyzed; Mm: mouse, Hs: human, Rn: rat (if the motif is found in a species it is 
denoted by “+” else it is denoted by “-”). 
 
No. Pattern TF name Total AMP AMP Family Seq IDs Mm Hs Rn 
1 ACAGCA GR 10 Alpha defensin 
2010016B13, 2010016F14, 
NM_021010, NM_001926, 
NM_001925, NM_005217 + + -
    Apoa2 
I530003A11,HIT000032344.2, 
NM_013112 + + + 
    BPI 9230105K17,BC040955 + + - 
    Calgranulin 
F430201H11, NM_002965, 
NM_053587 + + + 
    Hepcidin NM_052971,2210420P15 + + - 
    Histone 2A 
9030420B16, NM_003512, 
1190022L06, NM_021052 + + - 
    Melanotropin alpha 
5730403F20, NM_000939, 
NM_139326 + + + 
    Secretogranin 
5730420J08,HIX0015625.2, 
NM_012526 + + + 
    Vasostatin 
G630083O06,HIX0011909.2,NM
_021655 + + + 
    ZAP 
F420004O17,HIX0007129.3,NM









NF-AT4, 11 Alpha defensin 
2010016B13, 2010016F14, 
NM_021010, NM_001926, 





    BPI 9230105K17,BC040955 + + - 
    Calgranulin 
F430201H11, NM_002965, 
NM_053587 + + + 
    Cathelicidin 
F930015N03,NM_004345,AF484
553 + + + 
    Hepcidin 2210420P15,NM_052971 + + - 
    Histone 2A 
9030420B16,NM_003512,11900
22L06,NM_021052 + + - 
    Lysozyme 
9530003J23,I420013M05, 
NM_012771 + - + 
    MBP 
2510004C07,HIX0009634.2,NM
_031619 + + + 
    Proenkaphalin 
4922504O09,HIX0007519.2,NM
_017139 + + + 
    Secretogranin 
5730420J08,HIX0015625.2, 
NM_012526 + + + 
    VIP 9130007F05,HIX0006306.2 + + - 
3 CCAGGG unknown 8 Alpha defensin 
2010016B13,2010016F14, 
NM_021010,NM_001925 + + - 
    Spag11 9230111C08,NM_145087 + - + 
    BPI 9230105K17,BC040955 + + - 
    DBI 6720460E16,NM_020548 + + - 
    Granulin 
0610012H06,BC000324, 
NM_017113 + + + 
    Lysozyme 
9530003J23,I420013M05, 
AF099029,NM_012771 + + + 
    Melanotropin alpha 
5730403F20,NM_000939,NM_1
39326 + + + 
    SPYY 
0710005A05,C820007C10, 










9230103N16, 4930563B01 + + + 
    BPI 9230105K17,BC040955 + + - 
    Calgranulin 
F430201H11, NM_002965, 
NM_053587 + + + 
    Cathelicidin 
F930015N03,NM_004345,AF484
553 + + + 
    Granulin 
0610012H06,BC000324, 
NM_017113 + + + 
    Lactoferrin 9830118D19,NM_002343 + + - 
    ZAP 
F420004O17,HIX0007129.3,NM
_173045 + + + 
5 ATGGAG Nkx2-1 10 Alpha defensin 
2010016B13,2010016F14, 
NM_001926,NM_001925,NM_0
05217 + + - 
    Calgranulin 
F430201H11, NM_002965, 
NM_053587 + + + 
    Cathelicidin 
F930015N03,NM_004345,AF484
553 + + + 
    DBI 6720460E16,NM_020548 + + - 
    Slpi 
2310075E18,HIT000038907.2,N
M_053372 + + + 
    Hepcidin 2210420P15,NM_052971 + + - 
    Lactoferrin 9830118D19,NM_002343 + + - 
    MBP 
2510004C07,HIX0009634.2,NM
_031619 + + + 
    VIP 9130007F05,HIX0006306.2 + + - 
    Vasostatin 
G630083O06,HIX0011909.2,NM
_021655 + + + 
6 TCTTTC unknown 9 Alpha defensin 
2010016B13,2010016F14, 
NM_001925,NM_005217 + + - 
    BPI 9230105K17,BC040955 + + - 
    Calgranulin 
F430201H11, NM_002965, 




    Slpi 
2310075E18,HIT000038907.2,N
M_053372 + + + 
    Hepcidin 2210420P15,NM_052971 + + - 
    MBP 
2510004C07,HIX0009634.2,NM
_031619 + + + 
    Melanotropin alpha 
5730403F20,NM_000939,NM_1
39326 + + + 
    SPYY 
0710005A05,HIX0006525.2,NM
_012614 + + + 
    ZAP 
F420004O17,HIX0007129.3,NM
_173045 + + + 
7 CCCGCCCC Sp1, Sp3 6 Alpha defensin 
2010016B13,2010016F14, 
NM_021010,NM_001926 + + - 
    Apoa2 HIT000032344.2,NM_013112 - + + 






5.4.5 Distribution of known TF binding motifs in AMPcg families 
 
Prior to discussing results of specific AMPcg families the predicted motifs were 
compared with the experimentally verified motifs documented in previous reports. The 
predicted motifs comprise binding sites for various immune-response related TFs (e.g. 
NF-kappaB) and nuclear hormone receptors (i.e. RXR alpha). The ab-initio determined 
motifs potentially bind 41 (59%) out of 70 experimentally confirmed TFs that participate 
in the control of these AMPcg families. Among members of the lactoferrin family, all 
experimentally reported TFs (SP1, C/EBP) were found. Six AMP families (zap, apoa2, 
calgranulin, granulin, spyy, bin1b/spag11) lacked published experimental information on 
associated TFs. DMB-predicted motifs for these families include 57 motifs conserved 
among mouse and human. Supplementary Table 5.3 shows a comparison between the 
motifs that were found by ab-initio approach versus those reported to be experimentally 
found for each of the AMPcg families. The list of experimentally detected TFs that is 
presented here is not exhaustive, but it well supports the ab-initio motif finding method. 
For each AMP family, motifs were found that did not match any of the known 
TRANSFAC-contained motifs and were reported as “unknown motifs”. Other set of 
motifs matched to known TFBS but were previously not reported to control AMPcgs. 
These new AMPcg-associated candidates are shown in Supplementary Table 5.4. 
 In this section, all the predicted TFs that potentially bind motifs identified for 
different AMPcg families have been categorized into ten tissue specific categories and 
two general categories of cell-cycle specific TFs and nuclear hormone receptors (NHRs). 
This work was done in collaboration with VB Bajic. Table 5.5 and Supplementary 




motifs were compared to TRANSFAC-contained motifs to determine their 
correspondence with the known TFBSs. Twelve different categories of TFs were 
considered. These are adipocyte-related, NHR, cell cycle-related, immune cell-specific, 
liver cell-specific, lung cell-specific, muscle cell-specific, nervous system-related, 
pancreatic beta cell-specific, pituitary gland-specific, eye-specific, and bone- (and teeth-) 
specific TFs. The categories were chosen based on supporting knowledge of links, for 
example between the immune system and a particular category. For example, microglia 
cells which are brain macrophages (Moran et al., 2004) would represent a link between 
the nervous system and immune system. The association of TFs with different TF groups 
is based on the TRANSFAC database collections and literature survey.  
 To determine the dominant TF categories that are potentially involved in control 
of AMPcg families, motifs that TFs could bind to were analyzed, as well as the 
distribution of the TFs across the 22 AMPcg families. For each of the AMPcg family 
only the top two-ranked TF categories were considered. The ranking was based on the 
proportion of motifs that potentially bind TFs of specific category in any AMPcg family. 
Cases were considered when TF-binding motifs associated with a particular TF category 
occurred in 25%, 30%, 35% or 40% of all motifs observed in an AMPcg family. Three 
TF categories (liver-specific, neuron system-specific, NHR) appeared to be either the first 
or second ranked in three out of four considered cases, and these TF categories, also 
represent the top ranked ones, overall. The results are summarized in Table 5.5. The 
appearance of NHRs in these top ranked TF groups is unexpected. If we require that at 
least 35% (7 out of 20) of the identified motifs for each of the AMPcg families can bind 




AMPcg families. The next one is the group of liver-specific TFs (10 families), followed 
by adipocyte-specific TFs (8 families) and immune cell-specific TFs (5 families).  
 Further, the group of AMPcg families were determined that are most enriched in 
motifs that potentially bind NHRs. This group is determined as explained in Methods and 
contains 11 AMPcg families. Each of the families contains at least 35% (7 out of 20) of 
motifs that potentially bind NHRs. These 11 families are alpha-defensin, lactoferrin, 
hepcidin, bin1b, zap, dbi, cathelicidin, proenkaphalin, mbp, slpi, bpi. The statistical 
significance of the enrichment of NHR related motifs in this group is based on the 
Bonferroni corrected p-value obtained from the right-sided Fisher’s exact test (corrected 
p-value = 1.237e-003) (for the null hypothesis that there is no enrichment of NHR in the 
considered 11 families as compared to all 22 AMPcg families). The correction factor was 
440 that equals to the number of identified motifs in all 22 families. The parameters for 
p-value were: k = 92 (number of motifs that potentially bind NHRs in the group of 
families), n = 220 (number of motifs identified in 11 families), K = 139 (total number of 
motifs in all 22 families that potentially bind NHRs), N = 440 (total number of all 
identified motifs in all 22 families). The small p-value suggests that the enrichment of 
motifs that potentially bind NHRs is statistically highly significant for the considered 11 
AMPcg families out of 22 analyzed families.  
 Based on distribution of absolute number of TFBSs in different categories it was 
observed that Spag11, an epididymis-specific defensin, which is also important in 
inducing sperm maturation (Zhou et al., 2004) appears to be distinctly regulated 




data shows that spag11-specific motifs are over-represented, compared to motifs of the 
beta-defensin family (Table 5.5).  
 On the other hand, if looking at the rank position of a particular TF group in 
individual AMPcg families (number of motifs that could bind TFs from a particular 
category), six TF categories emerge as dominant categories. These are, in order, liver-
specific, neuron system-specific, adipocyte-specific, NHR, immune-cell specific and 
lung-specific TFs. The ranking of TFs suggests that the functions of AMPs extend far 
beyond antimicrobial actions as mediators in energy metabolism and neuroendocrine 
regulations. The finding is reminiscent to multi-functionality of cytokines (i.e. IL6, TNF-
alpha, MIF etc.) in adipocytes, liver and immune cells during metabolic challenges and 
stress (Mohamed-Ali et al., 1998, Yudkin et al., 2000 and Sakaue et al., 1999). The 
results are presented in (Supplementary Table 5.5)  
 As a further support to the above finding, comparison with another dataset was 
performed to ascertain the claim that the TF groups that have been found to influence 
AMP gene groups are not non-specific for AMPs. To test this, motif search was carried 
out in similar manner on a set of 78 promoter sequences from non-immune, house 
keeping genes, considered as a negative data set. To determine if the usage of different 
categories of TFs is the same in AMP-genes and house keeping genes, a non-parametric 
ranksum test was performed (Conover, 1998 ). The ranksum test allows evaluation of 
actual population distributions rather than means of populations, which would be the 
typical test used to compare AMP families versus housekeeping genes.  
 Individual rank sum test was carried out for each of the six significant TF 




AMP families with the housekeeping gene set. The ranksum test gave a p-value is 
5.1872e-004 and the corrected p-value for 6 tests was 0.0031, indicating that the null 
hypothesis can be rejected, that assumes the same population of TFs influence AMP 
genes and housekeeping genes. Consequently, it is concluded that AMP genes and 
housekeeping genes utilize different groups of TFs in a significantly different manner. 
Among the six most utilized TF categories (AD, NHR, IMM, LIV, LUNG, NS) NHR 
was found indicating a potential link of the endocrine and immune response systems 





Table 5.5: Distribution of motifs associated with different tissue/function-specific TF groups among AMP families.  
 
Tissue/function-specific TF groups are AD: adipocyte-related TFs; NHR: nuclear hormone receptor TFs; CC: cell cycle-
related TFs; IMM: immune cell-specific TFs; LIV: liver cell-specific TFs; LUNG: lung cell-specific TFs; MUS: muscle cell-
specific TFs; NS: nervous system-related TFs; PAN: pancreatic B-cell related; PIT: pituitary gland-specific TFs; Eye: eye-
specific TFs; BS: bone-specific TFs. TF groups (AD, NHR etc.) that occur with highest frequency among AMP families are 





specific TF groups AD NHR CC IMM LIV LUNG MUS NS PAN PIT EYE BS Cut-Off (%) 
Total no. of motifs 131 139 97 122 141 122 78 143 77 74 1 12  
17 18 8 14 19 16 4 17 5 5 0 0 25% 
14 12 7 11 14 10 4 15 3 2 0 0 30% 
8 11 3 6 10 5 2 11 2 1 0 0 35% 
No. of AMPcg 
families 
4 7 3 4 3 4 1 9 0 0 0 0 40% 
 
AMPcg Families AD NHR CC IMM LIV LUNG MUS NS PAN PIT EYE BS 
Alphadefensin 6 12 2 6 6 5 3 9 2 1 0 0 
Apoa2 5 5 5 4 5 5 4 6 4 3 0 0 
Betadefensin 6 5 4 6 6 5 2 8 2 3 0 1 
bin1b/spag11 9 9 3 5 10 10 6 10 5 2 0 3 
Bpi 6 7 8 8 8 5 8 7 7 4 0 0 




Cathelicidin 4 8 6 8 5 5 1 6 3 5 0 1 
Dbi 7 8 4 5 7 6 4 6 1 4 0 0 
Slpi 6 7 3 6 6 5 3 8 5 4 0 0 
Granulin 6 5 6 4 6 6 4 5 4 3 0 0 
Hepcidin 10 9 3 7 11 11 3 9 6 7 0 0 
Histone 5 2 3 3 5 4 3 3 4 3 0 0 
Lactoferrin 7 10 3 4 7 6 4 8 3 1 0 0 
Lysozyme 4 2 4 3 4 4 3 3 2 1 0 0 
Mbp 6 7 9 9 7 6 6 7 2 6 0 2 
Melanotropinalpha 9 6 9 7 8 7 4 8 3 4 0 0 
Proenkaphalin 7 7 3 4 7 7 1 8 3 3 0 1 
Secretogranin 1 5 2 6 3 2 4 3 3 3 0 1 
Spyy 5 5 2 5 5 3 1 5 3 5 0 0 
Vip 3 3 3 4 3 2 1 3 3 1 0 1 
Vstn 4 4 3 3 5 4 3 4 1 2 0 0 




5.4.6 Motifs associated with nuclear hormone receptors (NHRs) 
 
NHR proteins function as dimeric molecules in the nucleus to regulate the transcription 
of target genes in a ligand-responsive manner (Nishikawa et al., 1995 and De Vos et al., 
1994). A number of PEs detected in the 22 AMPcg families potentially binds different 
TFs. Among them the most frequent is the family of NHRs that in the case includes 
(Table 5.6) AR (androgen receptor), GR (glucocorticoid receptor), RXR-alpha (retinoid 
X receptor alpha), VDR (vitamin D receptor), T3R-alpha (thyroid hormone receptor) and 
ER-alpha (estrogen receptor alpha), ERRalpha1 (Estrogen-related receptor alpha 1), 
RAR(retinoic acid receptor)-alpha, beta, gamma, LXR (liver X receptor)-alpha, beta, 
PPAR (peroxisome proliferator-activated receptor)-alpha, beta, gamma. GR, RXR-alpha, 





Table 5.6: Distribution of individual TFs among AMP families  
 





AMP family names 
GR 20 alpha defensin, apoa2, betadefensin, bin1b, bpi, calgranulin, cathelicidin, dbi, slpi, granulin, hepcidin, histone,  lactoferrin, lysozyme, mbp, melanotropinalpha, penk1, vip, vasostatin, zap 
RXR-alpha 18 alpha defensin, betadefensin, bpi, calgranulin, cathelicidin, dbi, slpi, granulin, hepcidin, histone,  lactoferrin, mbp, melanotropinalpha, penk1, secretogranin, spyy, vip, zap 
AR 17 alpha defensin, apoa2, betadefensin, bin1b, bpi, calgranulin, cathelicidin, dbI, slpi, granulin, hepcidin, lactoferrin,  mbp, melanotropinalpha, penk1, vasostatin, zap 
Sp1 16 apoa2, bpi, calgranulin, dbi, granulin, hepcidin, histone, lactoferrin, lysozyme, mbp, melanotropinalpha, penk1, secretogranin, spyy, vasostatin, zap 
VDR 16 alpha defensin, apoa2, betadefensin, bpi, calgranulin, cathelicidin, dbi, slpi, granulin, hepcidin, lactoferrin, mbp, secretogranin, spyy, vasostatin, zap 
T3R-alpha 15 alpha defensin, apoa2, betadefensin, bin1b, bpi, calgranulin, cathelicidin, dbi, slpi, hepcidin, mbp, melanotropinalpha, penk1, spyy, zap 
Meis-1a 15 alpha defensin, apoa2, betadefensin, calgranulin, cathelicidin, dbi, slpi, granulin, histone, lactoferrin, lysozyme, mbp, secretogranin, spyy, vip 
Meis-1b 15 alpha defensin, apoa2, betadefensin, bin1b, calgranulin, cathelicidin, dbi, slpi, granulin, histone, lysozyme, mbp, secretogranin, spyy, vip 
RAR-alpha1 14 alpha defensin, apoa2, betadefensin, bpi, calgranulin, cathelicidin, dbi, slpi, hepcidin, mbp, penk1, secretogranin, spyy, zap 
LXR-alpha:RXR-
alpha 13 alpha defensin, apoa2, betadefensin, bpi, calgranulin, cathelicidin, dbi, slpi, lactoferrin, mbp, secretogranin, vip, zap 
NF-1 13 apoa2, bin1b, calgranulin, cathelicidin, dbi, granulin, histone, lactoferrin, lysozyme, mbp, melanotropinalpha, vip, zap 
AP-2alphaA 13 apoa2, bin1b, bpi, cathelicidin, slpi, granulin, hepcidin, lysozyme, mbp, melanotropinalpha, penk1, spyy, vasostatin 
Nkx2-1 12 betadefensin, bin1b, bpi, calgranulin, cathelicidin, dbi, slpi, granulin, lysozyme, spyy, vip, zap 






Table 5.6: Comments  
GR is involved in the regulation of numerous physiological processes including 
lymphocyte e apoptosis, T cell development and inflammatory responses (Reichardt, 
2004). Several of the TFs found in the analysis are known to interact with GR, like AP-1, 
c-Ets-2 etc. AR has also been shown to play a role in the immune response. It appears that 
androgens have an influence on the developmental maturation of T and B lymphocytes 
(Olsen and Kovacs, 2001, Takeuchi et al., 1998). RXR-alpha binds to many other TFs 
forming complexes that can regulate multiple pathways, including immunomodulatory 
pathways. It has been shown that RXR-alpha binds to VDR, forming a heterodimer that 
inhibits NF-AT and plays a role in immunosuppression (Takeuchi et al., 1998). RXR-
alpha also binds to PPAR-gamma and causes an apoptotic signaling cascade in B cells 
through NF-kappaB activation (Schlezinger et al., 2002).  
VDR is the receptor protein for 1,25-dihydroxyvitamin D which is involved in 
regulating cell growth, modulating the immune system and the renin-angiotensin system 
(Holick, 2003). Recently, it has been shown that VDR can mediate the induction of 
antimicrobial peptide gene expression in human like beta-defensin 2 (Wang T.T. et al., 
2004, Wang Y. et al., 2004). The analysis of the beta-defensin family also shows the 
presence of VDR. T3R-alpha is another of the TFs to be found in high occurrence, 
covering 15 of the AMPcg families. It has been shown that T3R-alpha binds to thyroid 
hormone and is involved in the control of B-cell production level (Arpin et al., 2000). 
RAR-alpha1 is a receptor for retinoids and it is constitutively produced in adenoidal T and 




cellular oxysterols and, are transcriptional activators of genes that control sterol and fatty 
acid metabolism/homeostasis (Edwards et al., 2002). In summary, the occurrence of 
different families of NHR as most frequently occurring TFs among AMPcg families 
indicates an intricate regulatory network encompassing the endocrine (i.e. lipid 
metabolism) system and innate immunity system ( Table 5.6).  
NF-1 (nuclear factor 1) is known to be involved in regulation of genes associated 
with adipogenesis and signal transduction pathways induced by steroid hormones like 
vitamin D, thyrotropin Gronostajski, 2000. The AMP member diazepam binding inhibitor 
(Dbi), is known to have an NF-1 site that plays a crucial role in its transcription in the 
lipogenesis pathway (Hansen et al., 1991). 
 
5.4.7 Other TFs and their potential role in AMPs 
 
Several non-NHR TFs that frequently appear in genes of the 22 AMPcg families were 
also found. ( Table 5.6). Sp1 is a ubiquitous TF that is enriched in the numerous GC-rich 
housekeeping gene promoters, but also contributes to tissue-specific transcription. For 
example, it is detected in the promoters and enhancers of numerous erythroid cell-
expressed genes and appear to cooperate with lineage-restricted factors in directing their 
expression (Suico et al., 2004). Meis1a and Meis1b isoforms are homeoproteins related 
to the pre-B cell transformation protein family. Meis1a is implicated in the myelopoesis 
(Calvo et al., 2001) leading to the basophil, neutrophil and eosinophil granulocytes.  
Meis1a and Meis1b binding sites were detected in members of the apoa2, calgranulin, 
slpi, granulin, secretogranin, mbp, vip, lysozyme AMP families, suggesting a 
granulocyte-specific transcriptional control function. Calvo and co-workers (Calvo et al., 




differentiation-specific genes cytochrome b-245 beta, lactoferrin, early growth response-
1, neutrophil gelatinase B, and lipopolysaccharide receptor CD14. The unique C-terminus 
of Meis1a which was shown to specifically mediate protein kinase A and trichostatin 
activation (Huang et al., 2005) provides additional support for the functional differences 
of Meis1a and Meis1b. Meis1a in combination with other neutrophil-specific TFs (i.e. 
STAT1, STAT6 and NF-kappa B) may play an important role in the recruitment and 
activation of neutrophils seen in sepsis and Helicobacter pylori infection-induced iron-
deficiency (Baveye et al., 1999, Choe et al., 2003). Interestingly, hepcidin, which inhibits 
iron absorption from the small intestine during infection-induced inflammation, lacks 
Meis1, suggesting the induction of multiple alternative transcriptional regulation 
mechanisms during microbial pathogenesis. 
 
5.4.8 Suggested future experiments 
 
The analysis has generated a number of hypotheses that are in good concordance with 
some of the existing knowledge in the field. However, the computationally-inferred 
hypotheses can only be validated through experiments. The author proposes the following 
hypotheses which warrants for experimental validation.  
1. NHRs maybe involved as dominant group in regulating AMP genes. NHR 
candidates such as GR, RXR-alpha, AR, T3R-alpha, RAR-alpha, LXR-alpha:RXR-
alpha should be tested for  their presence in the promoter regions of AMP genes.  
2. VDR which is already known to be involved in directly regulating expression of 




listed in Table 5.6. Hence, the presence of VDR binding site should be validated 
experimentally in other AMP genes. 
3. NF-1 and NKX2-1 which have not yet been implicated to be involved 
immunomodulatory pathways have appeared frequently in many AMP genes in 
the analysis. 
4. C-myb transcriptional regulator is known to be invoved in cell proliferation, 
differentiation (Farrar et al., 1989, Ramsay, 2005). It is critical in lymphocyte 
development (Thomas et al., 2005). A hypothesis related to its role in 
neuroectodermal tumors alludes to activation of innate immune pathway due to 
inhibition of c-myb by antisense oligodeoxynucleotides (Pastorino et al., 2004). 
However, there is no consolidated evidence of its involvement in innate 
immunity. 
5. Meis1a as discuseed in the previous section has been implicated in regulation of 
lactoferrin, may also be involved in regulation of other AMPs under certain 
conditions. 
 The author proposes using microarray technology combined with chromatin 
immunoprecipitation (ChIP) profiling (Ren et al., 2000) to identify all the chromosomal 
locations that are occupied by a transcription factor. These experiments are expected to 
clarify which promoters and TFs are specific for certain tissue cells and how many 
AMPcgs are regulated by a TF, TF pair or multiple TFs. Eventually, the combination of 
both computational and experimental should permit us to construct mechanistic models 






The large-scale computational analysis of promoters of 22 families of AMPcgs across 
three mammalian species has allowed us to identify potential key transcription elements 
of these families. Promoter regions (-1000, +200) were analyzed and it is likely that the 
regulatory elements further upstream may have been missed, that might be important in 
the fine-tuning of the regulation of particular families of AMPcg. The results suggest a 
core set of transcription factors (TFs) that regulate the transcription in the mouse, rat and 
human AMPcg families examined. TFs of the liver, nervous system- specific and NHR 
group are significantly over represented. These TF groups consist of transcription 
regulators that are involved in diverse physiological functions, including control of 
embryonic development, cell differentiation and homeostasis, and also in immune 
response. Interestingly, NHRs appear more dominant than immune cell-specific TFs in 
the analyzed AMPcg families. Numerous experimental evidence show the involvement of 
NHRs in various immunomodulatory pathways (Reichardt, 2004, Hayes et al., 2003, Jeay 
et al., 2002, Reichardt et al., 2000). However, little is known about their direct 
involvement in innate immunity. Recently, there has been evidence that VDR plays a 
direct role in the induction of antimicrobial innate immune response (Wang T.T. et al., 
2004). This analysis concurs with this evidence and elucidates other members of the 
NHR family also, that could play a crucial role in antimicrobial innate immunity. Besides 
the NHR, putative binding sites of Sp1, Meis1a, Meis1b, NF-1 were also found to be 
prevalent across different AMPcg families. Three potential TF-binding motifs that are 
enriched in promoters of AMPcgs are novel. Four identified motifs were found to be 




motifs and motif combinations that are common in primates and rodents, and others that 
are species-specific and specific to enteric versus myeloid expression of alpha-defensins. 
  This analysis brings out the advantage of using a computational approach to 
analyze promoter regions, since the author was able to do a comprehensive analysis and 
get a bird’s eye view of the transcriptional regulators involved in multiple AMPcg 
families across different mammalian species.  
 In addition, 102 new motifs were discovered as candidate TFBS with a role in 
antimicrobial innate immunity. The actual experimental confirmation of the AMPcg 
transcription regulatory elements can only be accomplished by targeted research of 
infection or cellular stress models using time-course sampled tissue cell types. 
 After finding potential TFBS motifs for several of the AMP gene groups within 
different AMP families, it intrigues to know which of the TFBS motifs can appear 
together across promoter regions of same AMP gene across different species. It is 
probable that co-occuring TFBS motifs that are conserved across different species for a 
gene or conserved across a gene family have a role to play in transcription regulation and 
hence are not present in the regulatory region by chance. Chapter 6 elucidates this 










Part III: Chapter 6 Identification of transcription factor 
binding site modules 


























In this chapter, the author analyzes in greater detail promoter regions of three AMP gene 
groups (Alpha defensin, Penk, Zap) that appeared in Chapter 5 so as to identify 
transcription factor (TF) binding motifs that are common among AMP genes of 
mammalian species (i.e. namely human, mouse and rat). In the case of alpha-defensins 
and penk, experimentally identified promoter elements were used to assess and interpret 
the predictions. For the zap family, the findings are novel, since no experimental data is 
present. Further, the author has attempted to identify Transcription Factor Binding Site 
modules (TFBS) module(s) or promoter models which are defined as a TF framework 
consisting of more than one motif found within a given distance and orientation (Werner 
et al., 2003).   
Identification of TFs that control the expression of a given gene is the first step to 
towards understanding the transcriptional regulatory network associated with a gene or a 
given class of genes. TFs mediate their effects via their cognate TFBSs. TFs work in 
combinations to bring out special-temporal expression of genes. Thus, a set of TFs that 
modulate a functional response may trigger a set of related genes associated with that 
functional response. Therefore, finding TFBS modules can lead us to predict other genes 
that are responsive to the same set of TFs (Dohr et al., 2005).  
A TFBS module or framework is a model consisting of two or more TFBSs 
found within a certain distance, having a defined order relative to each other and having 
the same strand orientation. It has been shown that TFBS organization in the promoter 
region plays an important role in transcriptional regulation (Fessele et al., 2001). Genes 
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expressed in the same tissue under similar conditions often share a common organization 
of regulatory binding elements. This organization appears to be conserved across 
different species whereas structure and function of a gene product may be more tolerant 
of gene mutations in the coding sequences. The specific arrangement of TFBSs increases 
the potential specificity of the system to affect gene mechanisms as co-regulation 
imposes stringent constraints on the evolution of the gene’s promoters. Thus the 
organization of promoter motifs can give essential clues about the transcriptional 
regulatory mechanisms at work in a specific biologic context and provide information 
about signal and tissue specific control of expression (Werner et al., 2003). It can thus be 
considered as a “footprint” or “signature” of transcriptional regulatory mechanisms at 
work in a specific biologic context (Werner et al., 2003). Figure 6.1 shows an example 
of a TFBS module. 
Dushay et al showed (Dushay et al., 2000) that promoter region of Drosophila 
AMPs, cecropin, diptericin, metchnikowin, attacin A and attacin B have a common TFBS 
module (Werner et al., 2003). The proximity of GATA, R1 and ICRE to kappaB sites 
was shown (Dushay et al., 2000) to be important for gene expression, as removal of these 
sites reduced the expression of cecropin and diptericin, despite the presence of intact 
kappaB sites. Thus, the presence of certain TFBSs in a particular order and position 
indicates a certain way of conservation that could be essential for induction of a particular 
gene. It is not just a random occurrence of these motifs in that region. Moreover, since 
these subregions of conserved positional arrangement of promoter motifs are usually 
sited at various distances from TSS in different species, they cannot be easily detected in 




Prior studies have suggested that promoter modules are pathway-specific or cell- type- 
specific and hence cause the transcriptional response to specific signal transduction 
pathways, cell type-specific expression and events central to developmental regulation. 
A study (Werner et al., 2003) done of RANTES/CCL5 gene set corroborates this 
point. RANTES/CCL5 is a member of the -CC- subfamily of chemotactic cytokines 
which is involved in different stimuli and plays diverse roles in inflammatory processes. 
Analysis of the RANTES promoter in different cells like monocytes, T cells, astrocytes 
and mesangial cells show that there is an underlying group of six functionally 
characterized short regulatory elements forming a hierarchic organization in them. 
However, the combinations of these elements vary in the four different cell types (Werner 
et al., 2003). This sequence feature can be exploited to look for genes that are regulated 
by similar mechanisms.  
To predict TFBS module, gene expression (Segal et al., 2003, Ihmels et al., 2004, 
Kloster et al., 2005, Kloster et al., 2005, Wang et al., 2005) or DNAseI hypersensitivity 
data (Noble et al., 2005) are taken into account. Most of the methods derive a set of 
TFBS elements from a set of co-regulated genes or a set of genes with similar functions. 
The individual binding elements are then combined into one recognition module/model. 
Another approach is that a set of transcription-factor PWMs that are known to be 
co-occuring are used to identify genomic regions densely populated in putative sites for 
these TFs (Bailey and Noble, 2003, Frith et al., 2003, Johansson et al., 2003, Sinha et al., 
2003, Alkema et al., 2004). 
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To find functional binding sites and modules, the concept of phylogenetic 
footprinting is also used. Phylogenetic footprinting is a comparative genomic approach 
by which non-coding regions of orthologous genes from different species that are 
sufficiently evolutionarily distant (but not too distant) are aligned to detect the conserved 
regulatory elements interspersed between the real non-functional background sequences 
(Zhang and Gerstein, 2003). The major advantage of phylogenetic footprinting compared 
to other techniques is that it is capable of identifying regulatory elements specific even to 
single genes, as long as they are sufficiently conserved across species. This approach 
facilitates finding functional binding sites. However, it is important to note that many of 
the TFBSs that are detected computationally in the promoter region may not be 
functional. They may be false positives, or actually binding sites that are not used in the 
context of the gene studied. By comparing these sequences across species, phylogenetic 
footprinting can help reduce this problem to an extent. Table 6.1 lists the various 
transcription factor module finding programs. 
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Table 6.1: Transcription factor module finding programs 
 
* PMID – Pubmed Unique Identifier 
Program 
name URL Address Reference (PMID)* 
MSCAN http://mscan.cgb.ki.se/cgi-bin/MSCAN 15215379 





CRÈME http://creme.dcode.org/ 12855471 
Module 





star.edu.sg/projects/BayesPromoter/  16613910 
















6.3 Materials and methods 
Figure 6.1: Graphical representation of TFBS module generation 
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Figure 6.1 : (A,B): Orthologous promoter sequences are subjected to DMB motif finding 
program. (C,D): The motifs found by DMB are searched in the TRANSFAC database for 
known TFBSs using Patch program (TRANSFAC program). E: TFBS modules are 
generated by looking for all possible combinations of motifs common across all the input 
sequences which have the same relative order and strand orientation. The different 
colored line connectors (red,green,black) highlight the three different TFBS modules 
found by the program within a given distance cut-off. 
The possible combinations shown here are CREB-ETS-IRF-1, AP-1-ETS,CREB-IRF-1. 
In this study the minimum number of motifs (min.polymer) is set to 3 or more, therefore 
combinations below the min.polymer threshold  will not be shown in the final output by 
the program. PE: promoter element 
 
 
6.3.1 Data selection for generation of promoter models 
 
Alpha-defensins DEFA5, DEFA1, Penk and Zap promoter sequences covering (-1000, 
+200) relative to the estimated transcription start site (TSS) from human, mouse and rat 
were selected. The method of extraction was same as discussed in Chapter 5. Promoters 
of human orthologs were extracted using H-invitational database (Fujii et al., 2004) as 
well as PromoSer (http://biowulf.bu.edu/zlab/PromoSer)  (Halees et al., 2003s). All these 
resources provide estimated TSS locations based on mapping EST and full length cDNAs 
(flcDNA) data to genomic sequences. The TSS location of mouse sequences was 
determined by using the start position of the first exon of the FANTOM cDNA-genome 
mapping data (http://fantom31p.gsc.riken.jp/cage/download/mm5/cage.rep_tag.2004-11-
16.chr_all_gff.tar.gz). Mouse promoter sequences (-1000, +200) were then extracted by 











6.3.2 Prediction of TFBS motifs 
 
The author aligned the (-1000,+200) promoter regions of the orthologs of an AMP family 
and subjected them to Dragon Motif Builder (DMB) (E Huang et al., 2005 ) program for 
prediction of TFBSs. The EM (Expectation Maximization) threshold of the DMB 
program was set to 0.85 for all AMP groups except for DEFA1, where it was set to 0.70 
as 0.85 appeared too stringent. The number of 10-15 nt motif candidates was restricted to 
a maximum of 20 for each of the AMPcg families. The author chose to search for 
maximum of 20 motifs as the optimum number that covers most of the promoter region 
of (-1000, +200) without overlap of motif candidate sequences. After DMB identified the 
sequence motifs, the Patch program (mismatch =0; motif length =6; species =all) 
(Wingender et al., 2000) of the TRANSFAC database ver. 8.4 was used to infer potential 
transcription factors (TFs) that may bind to these motif families. The motifs are reported 
in IUPAC nucleic acid codes format.Figure 6.1 shows the schema for the generation of 
TFBS modules. 
 
6.3.3 Generating the TFBS models 
 
 
The author searched for all possible combinations of motifs that were present in same 
order and same strand orientation for a given set of promoter sequences within a family 
and constrained by a defined range of distances between the motifs. A perl program 
(made by I2R Knowledge Discovery Group) was used that calculated TFBS models from 
the graphic motif representation file generated by DMB and user input of distance 
constraint in percentage and minimum number of motifs. Promoter models that contained 
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experimentally proven TFBSs – if available – for a particular AMP gene group along 
with other motif candidates or TFBSs within the given distance constraint, were selected. 
The minimum number of motifs per model was set to three. The distance constraint was 
tested for the interval of 1%–30% and promoter sequence length of 1200 bp. It was 
observed that promoter models having three or more motifs could be generated with 
distance percentages of 20 or 30. This distance percentage appeared to be optimal for the 
length of 1200 bp. Hence, the distance between two adjacent motifs in a promoter model 
ranges between one to 240bp or up to 300bp from each other. The motif combinations 
that appeared common across all promoters of a given AMP family were chosen as 
candidates for scanning the large promoter data set. 
 
 
6.4 Results  
 
6.4.1 Alpha defensin promoter model  
 
 
Human polymorphonuclear leukocytes (PMNs) or neutrophils express four defensins 
named human neutrophil peptides, HNP1 to HNP4. HNPs are also expressed in immature 
bone marrow cells, in HL-60 and human promyelocytic leukemia cells. Alpha defensin 5 
are enteric defensins expressed mainly in the Paneth cells and are constitutively produced 
(Cunliffe, 2003). Gene duplication events have probably led to both species-specific and 
functionally diverse subsets of alpha-defensins,which should be also reflected in the 
upstream regulatory regions. For example, enteric-expressed defensins are important to 
barrier function of the gut mucosal surface against bacteria, whereas myeloid and 
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neutrophil-specific defensins help macrophages and neutrophils to kill internalized 
bacteria (Patil et al., 2004). 
 The author analyzed HNP-1 (DEFA1) and HNP-3 (DEFA3) from human, which 
are paralogs and alpha-defensin 5 group orthologs (information extracted from Ensembl 
release 40- Aug 2006, http://www.ensembl.org). DEFA1 and DEFA3 have very similar 
promoter regions and are controlled by myeloid-specific regulation, even though they 
have different biochemical properties (Tsutsumi-Ishii et al., 2000).  
 The promoter model of the alpha-defensin 5 group contained four motif 
candidates in the order 15-12-19-5 within the distance threshold of 360 nt (Table 6.2, 
Figure 6.2a). Motif 5 and motif 15 did not correspond to any known TFBS. Motif 12 
represented potential binding sites for TFs namely LF-A1, GATA-1, COUP-TF2, NKX2-
1, NF-E3. GATA-1 is up-regulated by cytokine IL-1B during inflammatory responses 
(Chuen et al., 2004). Recently, it was  reported that human alpha defensin 5 (HD-5) binds 
to the cell membrane of intestinal epithelial cells and induces secretion of the interleukin 
(IL)-8. HD-5 may be playing a role in regulation of the intestinal inflammatory response 
 (de Leeuw et al., 2007). Hence, the presence of putative GATA-1 binding site in 
DEFA5  may indicate binding of GATA-1 to its promoter region and causing up-
regulation of its expression during inflammatory response as a positive feedback loop. 
Motif 19 corresponded to potential binding site for C\EBPalpha. Transcription factor 
C/EBPalpha is known to bind to promoter region of HNPs and regulate myeloid-specific 
genes (Tsutsumi-Ishii et al., 2000).   
The analysis of the promoter regions of DEFA1 and DEFA3 genes returned 
motifs for putative binding sites for CCAAT-binding factor, NF-Y represented by motif 
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10. Zic2 was represented by motif 20. Motif 14 corresponded to binding site for Ets 
transcription factor (c-Ets-2) binding site. Ets is known to bind to HNP1-3 promoter 
region (Tsutsumi-Ishii et al., 2000). Motif 5 represented putative binding sites for HNF-4, 
HNF-4alpha1, C/EBPalpha, C/EBPbeta. As the promoter regions for DEFA1 and DEFA3 
are highly conserved, the original model showed that all the 20 motifs have a conserved 
organization across the two promoter regions. Thus, a subset of consecutively positioned 
motifs was selected and a promoter model created that contained the motifs 10-20-13-5 




Table 6.2: Alpha defensin promoter models  
 




No. Motif Species Start End Putative TFBS 
Distance 
range 
                
alpha defensin 1 10 TTAGCCACAGCCAAT Hs 737 751 
 
CCAAT-binding factor (CTF CTF-1 
CTF-2 CTF-3 NF-1) NF-Y  240 
      Hs 730 744     
  20 AGTTGGTTGCTGCCT Hs 794 808 Zic2   
      Hs 787 801     
  14 CCTTCCCACCAAATT Hs 873 887 c-Ets-2   
      Hs 866 880     
  5 ATGGACCCAACAGAA Hs 919 933 
HNF-4 HNF-4alpha1 C/EBPalpha 
C/EBPbeta   
      Hs 912 926     
alpha defensin 5 15 GAAKMCTGCAR Mm 19 29 unknown 360 
      Hs 582 592     
  12 YMACACMTTGGRYY Mm 223 236 
LF-A1, GATA-1, COUP-TF2, NKX2-1, 
NF-E3   
      Hs 799 812     
  19 RGAGGSATKRA Mm 487 497 unknown   
      Hs 817 827     
  5 YATCCTTGCTG Mm 871 881 C\EBPalpha   








Figure 6.2a: Motif arrangement in promoter region of mouse Defcr3 and its human ortholog (DEFA5) 
 The numbers (i.e. 15) in the boxes refer to different motifs. The grey line represents the (-1000, +200) promoter region 






Figure 6.2b: Motif arrangement in promoter region of human DEFA1 and its human paralog DEFA3 
The numbers (i.e. 10) in the boxes refer to different motifs. The grey line represents the (-1000, +200) promoter region 









Both the alpha defensin promoter models have TFBSs such as C/EBP and Ets that 
have experimentally proven to be present in the regulatory regions of this group of 
AMPs. This corroborates the viability of the strategy that has been implemented in 
this thesis to find TF motifs and promoter models. The other new TF motifs such as 
Zic2, NF-Y etc. could be interesting candidates for experimental validation in alpha 
defensin promoter regions. 
 
6.4.2 Promoter models of penk and zap families  
 
Penk and zap gene groups were chosen for detailed promoter analysis because 
penk1 represents a gene that has several experimentally identified promoter 
elements and this could be used as a benchmark to assess the accuracy of the 
computational analysis. For the zap family, to the best of the author’s knowledge, 
the results presented are completely new.  
 
6.4.3 Penk promoter analysis 
 
Penk1 is a neuropeptide-encoding gene that is known to be expressed primarily in 
mature nervous and neuroendocrine systems. The penk1 gene product is known to 
mimic the effects of opiate drugs. It plays a role in a number of physiologic 
functions, including pain perception and responses to stress. Experimental evidence 
shows that penk family members are also expressed in activated lymphocytes 
(Ovadia et al., 1996). Their expression is induced by bacterial endotoxins (i.e. 




properties ranging from augmenting CTL and NK cell, monocyte chemotaxis to 
being involved in pathophysiology of endotoxic shock (Ovadia et al., 1996, Salzet, 
2001). The penk1 promoter regions contain the experimentally characterized motifs 
for AP-1, CRE, NF-1, AP2, NF-Y, NF-kappaB, MZF-1 and PACH-1 (Le et al., 
2003, Liu et al., 2000). The computational analysis was able to identify all except 
PACH-1 because TRANSFAC 8.4 database lacked the corresponding motif. The 
motifs and corresponding TFBSs associated with the penk family are listed in 
Supplementary Table 6.1.  
In different enkephalin-expressing tumor cell-lines, as well as in adult 
enkephalinergic neurons, the rate of transcription of penk is modulated by several 
ubiquitous factors like NF-kappaB, AP-2, cAMP-response element binding protein, 
etc. (Le et al., 2003), whose DNA binding sites are located immediately upstream 
of TSS of penk (Uhl et al., 1991). This 200 bp DNA stretch is extremely well 
conserved among human (Comb et al., 1992), rat (Joshi and Sabol, 1991) and 
mouse (v Agoston et al., 1998) promoter regions. 
The computational analysis showed that motif 2 corresponds to the TATA 
box. Motif 5 represents a potential binding site for NF-kappaB and AP-2. Motif 9 
contains the putative binding site for NFI/CTF, and NF-Y. Motif 16 represents 
potential binding sites for MZF1, AP2 and NF-kappaB. Motif 3 corresponds to GR 
and AR. It has been found previously that GR is involved in activation of cAMP-
mediated transcription of penk in rats (Jenab and Inturrisi, 1995). Motif 1 appears as 
NHR representing motif. It contains the potential binding site for RXR-alpha, LXR-




(Macian et al., 2001) and is represented by motif 6. Motif 7 represents binding sites 
of c-Ets1, Elk-1, SAP-1a, SAP-1b, PEA3 and ELF-1, all of which belong to the Ets 
family of transcription factors. The expression of penk gene in epididymis is 
regulated by testicular factors that control expression via members of the Ets 
transcription family, (Hinton et al., 1998). Motif 12 represents putative USF family 
of transcription factors USF-1, USF1, USF2, USF2b and USF. These TFs are 
involved in the regulation of activity-dependent gene expression in neurons (Chen 
et al., 2003). They are found along with CREB (cAMP response element binding) 
binding elements in a number of promoters (Cvekl et al., 1994, Durham et al., 
1997, Kingsley-Kallesen et al., 1999) which indicates that the these two factors 
cooperatively activate transcription of calcium-inducible neuronal genes. Moreover, 
the rat penk gene is also known to be regulated by cyclic AMP and calcium 
pathways (Konradi et al., 2003), supporting the observation of USF TFBSs in the 
promoter of proenkephalin genes (Supplementary Table 6.1) 
 
6.4.3.1 Penk family promoter model 
 
The motifs shown in Table 6.3 were analyzed in terms of their orientation, 
positioning and mutual distance common to all three sequences (mouse, human, rat) 
to create promoter models. The arrangements of the motifs are shown in (Table 6.3 
and Figure 6.3). A single model arrangement 3-5-1-13 (representing motifs 3, 5, 1, 
13) common to all the three considered species was generated. The corresponding 
TFs that may bind to the motifs are: GR, AR (motif3), NF-kappaB, AP-2 (motif5). 




ERRalpha1), while Motif13 potentially binds to various TFs including NHR (DSF 




Table 6.3: Motif arrangements in promoter region in mouse (4922504O09), 
human (HIX0007519.2) and rat (NM_017139) of Penk family members.  
 
Species Motif arrangement 
Hs,Rn 3-5-15-18-4-16-8-9-2-10-1-13 
Mm, Hs 7-12-3-5-1-13 
Hs, Rn 3-5-1-13-20 
Mm, Hs, Rn 3-5-1-13 
 
The species abbreviations are Hs: Homo sapiens; Mm: Mus musculus: Rn: Rattus 
norvegicus. 
 




The numbers (i.e. 1) in the boxes refer to different motifs. The grey line represents the 
analyzed (-1000, +200) promoter sequence. This figure is a graphical representation 
of the common motifs across sequences determined by DMB program. It is not drawn 
to scale. The broken arrow indicates the TSS. 
6.4.4  
 
6.4.4 Promoter elements and their organization in the zap family 
 
The AMP CCCH-type zinc finger protein (zap) family acts as an antiviral protein 
against Sindbis virus and retro-viruses like Eco-luc (Gao et al., 2002). Its antiviral 
activity is mediated through the disruption of viral messenger RNAs in the cytoplasm 




mouse zap proteins contain one CCCH-type zinc finger, one PARP catalytic domain 
and one WWE domain. The rat protein contains only the CCCH-type zinc finger and 
WWE domains. It has been shown that different CCCH zinc finger proteins interact 
with the 3' untranslated region of various mRNA (Gao et al., 2002). A similar 
mechanism has been proposed for the zap interaction with viral RNA and subsequent 
exosome recruitment to degrade the mRNA (Gao et al., 2002). The zap gene (known 
as ZC3HAV1 in human and mouse) of human is located at chromosome 7 and is 
flanked by the other genes that are also CCCH-type zinc finger proteins. The mouse 
gene maps to chromosome 6 and is also flanked by CCCH-type zinc finger protein 
genes. The rat gene is located on chromosome 4.  
 The promoter regions of zap genes were analyzed. The zap promoter 
region  (Supplementary Table 6.2) contains a high number of motifs that are 
typically recognized by TFs of NHRs. Motifs 1, 2, 5, 6, 8, 9 and 14 correspond to 
binding sites of NHRs. Also, motifs that are associated with immune related TFs 
were identified. Motif 1 corresponds to E12, E47, c-Ets-2, LyF-1, USF-1. Motif 11 
is associated with NF-1. Motif 19 corresponds to binding sites for NF-AT1, NF-1 
and Ftz. Motif 20 corresponds to TFBSs for MTF-1. MTF-1 is known as metal-
regulatory transcription factor 1. It is required for the basal transcription of 
metallothionein I and II genes (Heuchel et al., 1994). It binds to metal response 
elements (MREs), which are related to Sp1. Heavy metals, but also oxidative stress 
(H2O2) and hypoxia can lead to increased MTF-1 activity and metallothionein 
expression (Zhang et al., 2003) (Murphy et al., 1999). MTF-1 has also been 




6.4.4.1 Zap family promoter model 
 
A motif arrangement for the zap promoter region that is common to all three 
species was identified (Table 6.4, Figure 6.4). The motif arrangement is in the 
order of 1-11-15-8-10-20 motifs. This arrangement corresponds to the following 
TFs, motif1 (Alfin1, RXR-alpha, VDR, E12, E47, MyoD, myogenin, EMF1, 
EMF2, EMF3, EMF4, Myf-5, c-Myc, USF2, CAN, E2A, DEP2, HEB, Ac, AS-C 
T3, Da, Sc, Sn, CLIM2, GATA-1, Lmo2, Tal-1, USF-1, NeuroD, NEUROD, LVa, 
PR B, AR, GR, c-Ets-2, ESE-1, HELIOS, LyF-1) - motif11 (NF-1, TGGCA-
binding protein) - motif15 (Unknown) - motif8 (LyF-1, RXR-beta, VDR) - motif10 
(Unknown) - motif20 (MTF-1). TFs in square brackets represent different TFs that 
potentially bind the associated motif.  
The positional arrangement shows the presence of the NHR binding sites. 
The presence of NF-1 TFBS in both penk and zap families, suggests that transcripts 
of these families might be induced by steroid hormones that interact with NF-1 
(Gronostajski, 2000). Zap protein is found in the liver and kidney at high levels. 
The presence of putative binding site for MTF-1, which is also localized in liver and 
kidney, suggests possible involvement of zap genes in metal regulation pathway or 
stress-related pathways like hypoxia.  
Table 6.4: Motif arrangements in promoter region in mouse (F420004O17), 
human (HIX0007129.3) and rat (NM_173045) of zap family members 
The species abbreviations are Hs: Homo sapiens; Mm: Mus musculus: Rn: Rattus 
norvegicus. 
 
Species Motif arrangement 
Mm, Hs 5-7-9-16-4-13-2-1-11-15-8-19-10-17-20-6
Mm, Hs 1-11-15-8-10-20 
Hs, Rn 1-11-15-8-10-20-18 









The numbers (i.e. 1) in the boxes refer to different motifs. The grey line represents 
the analyzed (-1000, +200) promoter sequence. This figure is a graphical 
representation of the common motifs across sequences determined by the DMB 




The author has shown that using ab-intio approach of finding significant motifs in 
promoters it is possible to generate models out of the motifs that could identify 
potentially co-regulated genes in a large data set. This approach does not require 
prior knowledge of the TFBSs that are present in the promoter regions. It is purely 
based on finding statistical over-representation of motifs across a set of sequences. 
The TFBS modules have been created from promoter regions of genes of orthologs, 
but the concept of phylogenetic footprinting has not been applied. The reason is that 
though phylogenetic footprinting may help in detecting functional binding sites, it 
restricts the region of motif search to only the conserved regions. In this study, 
motifs detected in the promoter regions were spread across the entire promoter 
region and not restricted to only the conserved regions between the orthologs. It 
was observed that with ab-initio search- known TFBSs motifs were also detected in 
non-conserved region of the promoters of AMP genes thus allaying the need for 




  Some putative motifs in defa1, defa5, penk and zap promoter models are 
good candidates for experimental validation.  For example, motif 12 of DEFA5 
promoter model represents a potential binding site for LF-A1, GATA-1, COUP-
TF2, NKX2-1, NF-E3. Motif 10 of DEFA1 represents putative binding sites for 
CCAAT-binding factor, NF-Y represented by motif 10. Motif 20 of DEFA1 
represents Zic2. Many of the new motifs are located in the proximity to 
transcriptional start sites, suggesting that they have a role in mediating the binding 




The author was able to find a set of TFBS motifs that were present across all 
orthologous genes of the three AMP gene groups (alpha defensin, penk, zap). 
Promoter models on orthologs of three AMP gene groups were created. Both alpha 
defensin and penk had known TFBS and new TFBS motifs in their promoter 
models. Alpha defensin models contained known TFBS motifs like C/EBPalpha 
and some new motifs. Examples of new motifs are Zic2 (motif 20 of DEFA1), LF-
A1, GATA-1, COUP-TF2, NKX2-1, NF-E3 (motif 12 of DEFA5). Penk promoter 
model had known TFBS motifs like motif 3 (GR), motif5 (AP-2) and new motifs 
such as motif 1 (RXR-alpha, LXR-alpha, ERRalpha1) and motif 13 (DSF, GCN4, 
COUP-TF1, RAR-beta, RXR-alpha, RAR-alpha1, TLX, Pax-2.1).  
Zap promoter model indicates a linkage of zap, with NHRs and metal regulatory 
transcriptional control of innate immunity and oxidative stress. As stated in section 




responsive to the same set of TFs. Chapter 7 exemplifies this hypothesis using the 







































Part III: Chapter 7:  Implicated gene regulatory networks 
in AMPcg activities 
 










In lower organisms, AMPs function merely as antibiotics by permeabilizing the cell 
membranes and lysing the invading microbes. However, during evolution these peptides 
have become multi-functional molecules acting in complex gene networks of higher 
organisms with additional properties like playing role as a mitogen or, taking part in 
adaptive immune responses (Kamysz et al., 2003). Hence, it is likely that AMP genes are 
a part of more than one transcriptional co-regulation network. In support of this 
statement, experiments have revealed that TFBSs like USF2 and (Nicolas et al., 2001), 
NKX2.2 (Wei et al., 20051) are present in the promoter regions of some of the AMPcgs, 
are also involved in regulating the expression of non-immune gene pathways. The 
objective of this study has been to identify for the two different alpha defensin gene 
groups, candidate co-regulated genes that could be part of the same transcription 
regulation networks or otherwise be members of common activation phenomenon. 
From the previous chapter (Chapter 6), two gene groups of alpha-defensins (alpha 
defensin 1 and alpha defensin 5) were selected that represent different cell origin. Alpha 
defensin 1 genes are expressed in the neutrophils whereas alpha defensin 5 genes are 
specific for paneth cells. For alpha defensin 5, human and mouse ortholog sequences 
were taken for the study. For alpha defensin 1, only human paralogs (defa1, defa3) were 
considered for promoter modeling. Defensins of neutrophil origin in human do not have 
corresponding mouse orthologs originating from neutrophils, thus alpha defensin 1 gene 
group was restricted to human sequences only. Using the shared TFBS organization 
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modules the human promoter dataset was scanned in search for genes that have a similar 
modular organization of elements in their promoters as that of the parent set of AMP 
genes. The predicted gene hits were then checked against co-expressed genes with the 
parent AMP genes that were extracted out of gene expression data.  
7.2 Background  
 
7.2.1 Gene regulatory networks (GRNs) 
 
One gene can affect the expression of another gene by binding the gene product (protein 
such as TF) of one gene to the promoter region of another gene. Looking at more than 
two genes, regulatory networks can be referred as the regulatory interactions between the 
genes. Central to the computation of gene regulatory network (GRN) are DNA 
recognition sequences (TFBSs) with which TFs associate. When active transcription 
factors associate with the promoter region of target genes, they can function to 
specifically repress (down-regulate) or induce (up-regulate or activate) synthesis of the 
corresponding RNA. The immediate molecular output of a GRN is the constellation of 
RNAs and proteins encoded by network target genes. The resulting cellular outputs are 
changes in the structure, metabolic capacity, or behavior of the cell mediated by new 
expression of up-regulated proteins and elimination of down-regulated proteins. When 
creating a GRN, genes can be viewed as nodes in the network, with input being proteins 
such as TFs and outputs being the level of gene expression (Veiga et al., 2006). The node 
itself can also be viewed as a function, which can be obtained by combining basic 
functions upon the inputs.   
Mathematical models of GRNs have been developed to allow predictions of the 
models to be tested. Various modeling techniques have been used, including boolean 
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networks (Klamt et al., 2006, Chaves et al., 2005), Petri net (Matsuno et al., 2000), 
Bayesian networks (Werhli et al., 2006) and sets of differential equations (Chen et al., 
2005). Conversely, techniques have been proposed for generating models of GRNs that 
best explain a set of co-expressed genes (Dohr et al., 2005 ).  
The key yet unsolved problem with GRNs is identification of genes that form a particular 
network. This chapter approaches the generation of GRNs based on the later technique as 
discussed in the previous paragraph in the context of specific alpha defensins gene groups 
in human. The author shows a plausible approach to find genes that are part of the same 
GRN on the assumption that they a) share the same promoter model and b) are also co-
expressed with the alpha-defensin 1 and 5 genes. TFs that bind motifs in the common 
promoter model are likely to be among the key drivers of co-expression of genes in the 
network.  
 
7.2.2 Examples of known gene regulatory networks in AMPs (defensins) 
 
 
Alpha defensins originating from the paneth cells exhibit numerous non-antimicrobial 
functions such as regulation of cell volume, chemotaxis, mitogenicity, and inhibition of 
natural killer cell activity (Ouellette, 1997). Mouse cryptidins 2 and 3 when administered 
apically can reversibly stimulate human T-84 intestinal epithelial cells to secrete chloride 
ion. This indicates that alpha defensins of paneth cells not only are components of the 
immune network of the crypt lumen but also influence the environment of the lumen by 
influencing other functional networks.(Ouellette, 1997). 
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 Toll receptor (TLR) -mediated activation of AMPs specifically defensins is the 
most well-studied pathway (Froy, 2005). Many of the TLRs are involved in activation of 
defensin sythesis such as TLR2, TLR3, TLR4, TLR5, TLR6 and TLR9  
(Froy, 2005). TLR mediated activation of alpha defensins takes place in natural killer 
(NK cells) (Chalifour et al., 2004). CD56+CD3– NK cells and some CD56+CD3+ T 
lymphocytes constitutively express alpha defensins (HNP-1, HNP-2 and HNP-3). NK 
cells CD56+CD3– and CD56+CD3+ are stimulated by the outer membrane protein A 
from Klebsiella pneumoniae and flagellin, that are the ligands of TLR2 and TLR5, 
respectively (Froy, 2005). This results in intracellular up regulation and secretion of alpha 
defensins. This phenomenon is different from the synthesis of alpha defensins in 

























7.3 Materials and Methods 
 
Figure 7.1 Workflow of generation of promoter models, scan across promoter 
dataset and analysis of gene hits  





7.3.1 Preparation of the promoter dataset 
 
Preparation of the human target promoter data set to be scanned by the promoter models 
was done using cDNA data from H-invitational database, as well as Tag cluster groups 
from Fantom3 collection 
(ftp://fantom.gsc.riken.jp/FANTOM3/boundary_set/end5_clusters.txt.gz). cDNAs from 
H-invitational dataset were compared using the BLAT program against the human 
genome HG17 that was downloaded from UCSC 
(http://hgdownload.cse.ucsc.edu/goldenPath/hg17/chromosomes/). Only those cDNAs 
that satisfied  95% identity and 90% of the sequence length mapped to the human 
genome were chosen. The regions covering (-3000, +3000) inclusive of the gene were 
then extracted. Using information from the Tag cluster (TC) data, cDNAs were chosen 
based on their chromosome, strand, TSS location and number of tags. To chose the most 
accurate TSS position the following approach was implemented.  
If the first 5' nucleotide of the CAGE tag or 5’ ditag 
(http://fantom31p.gsc.riken.jp/cage_analysis/export) coincided with the first 5′ nucleotide 
of the full-length cDNA (http://fantom.gsc.riken.go.jp/download.html), the TSS 
determined by this tag was selected. In cases when this condition did not hold, we 
selected TSSs where it we had information of a representative TSS location from a tag 
cluster that has at least ten tags, the representative TSS is supported by at least six tags, 
and there is at least one other piece of transcriptional evidence associated with this tag 
cluster (expressed sequence tag, full-length cDNA, or long SAGE; 
http://fantom.gsc.riken.go.jp/download.html). The resultant dataset had in total 10,255 
sequences of human.  
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7.3.2 Quality assessment of the promoter models 
 
In order to decide on the quality of the models, the sensitivity and specificity of the 
models were calculated. The models were validated using “leave-one-out-cross validation 
method (Nason, 1996). To determine sensitivity of the models the following procedure 
was applied. The DEFA1 training set had three promoter sequences, which consisted of 
DEFA1 (human), DEFA3 (human) and MNP1A (monkey). Two of the promoter 
sequences were used to generate the promoter model and the third sequence excluded. 
Then the promoter model was tested on the excluded sequence. This was done with each 
of the sequence in the training set. The sensitivity of each test was calculated. The 
average sensitivity of the model has been reported in (SupplementaryTable 7.1). Similar 
validation was done for DEFA5 model. The training set had 3 sequences that included the 
DEFA5 human, defcr3 mouse and defcr2 mouse (ortholog of DEFA5 human). The 
average sensitivity of DEFA5 model emerged as 100% (Supplementary Table 7.1). The 
cross validation was done with a small number of sequences in the training set as only 
orthologous genes having quality promoter sequence were chosen. 
 Specificity of the models was determined with a slightly different approach. All 
the three promoter sequences of DEFA1 training set were used to create a model. This 
model was applied to a test set of 18 AMP promoter sequences from different families. 
The model was able to pull out all the true positives ie. orthologs of DEFA1, DEFA3 in 
the test set and also some false positives.  
Thus, the specificity of this model with three sequences was 45%. The results are 
shown in (Supplementary Table 7.1). To make the model more specific, only two 
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sequences DEFA1, DEFA3 were taken into consideration. DEFA5 model pulled out only 
the DEFA5 related sequences from the test set. DEFA5 model showed 100% specificity. 
7.3.3 Scanning the promoter data 
When a suitable model could be generated that fulfilled the criterion as discussed in 
Chapter 6, (Section 6.2), it was chosen to scan the promoter data set for human. Position 
weight matrices (PWM) for each of the motifs (generated in the DMB results) contained 
in an AMP promoter model were used to scan the target human promoter data set of 
length 3000 upstream and 3000 downstream. The length of 3000 downstream was taken 
as many genes have multiple TSSs, which are spread across adjacently over a region 
(Bajic et al., 2006). Not all TSSs in the region are functional and it is the functional TSS, 
which helps to determine the actual starting point of the promoter region. To take into 
account the entire TSS region, the length of 3000 downstream was considered.  
The initial scanning of the promoter dataset was done based on a threshold which 
was the same as the threshold set to search motif using DMB (see section 2). If the 
threshold returned too few hits (less than 4 hits) then it was lowered to allow matching of 
the matrix model to ~250–300 genes, that would be a manageable number of genes to do 
further analysis. Only those promoters of the human target data set emerged as hits if the 
matched model contained all the motifs present in the same order as within the promoter 





7.3.4 Comparison with expression data 
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To validate the model matches and assess if the predicted genes are likely to be part of 
the co-regulation network, hits were compared to co-expressed genes extracted from 
microarray expression data. The sources of microarray data were UCSC Expression 
(GNF Atlas 1) http://genome.ucsc.edu/cgi-bin/hgNear, NCBI GEO 
(http://www.ncbi.nlm.nih.gov/geo/) and Standford microarray database (http://genome-
www5.stanford.edu/). From UCSC genome browser and Stanford microarray database 
data of co-expressed genes was obtained for the parent AMP genes (DEFA1, DEFA5). 
From GEO, normal human tissue expression profile (HG-U95A), GDS422 consisting of 
12 different tissue types were chosen and GDS260 representing data derived from 
pathogen exposure (Leishmania major, Leishmania donovani, Toxoplasma gondii, 
Mycobacterium tuberculosis, Brugia malyi) and immune response was taken. Using 
Pearson correlation coefficient, the genes that had similar gene expression profiles to the 
DEFA1, DEFA3, DEFA5 genes were selected. The cutoff of the correlation coefficient 
was above 60%. The selected genes comprised the co-expression data that was compared 
with promoter model predicted genes. The sample points with detection call = absent 
were not considered. 
Collection of gene expression data from various experiments yielded a set of 
genes, which are co-expressed with the parent AMP genes. These set of genes were 
compared to the predicted list of genes produced by the scan and the common genes 





7.3.5 Statistical significance of predicted genes from the scan  
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All the predicted genes from a single model were matched to co-expressed genes as 
described in section 5 (section 7.3.4). The p-value was calculated for the enrichment in 
genes that are potentially co-regulated with each of the parent AMP gene (DEFA1, 
DEFA5). The p-value was determined using the hypergeometric distribution and the 
right-side Fisher’s exact test (Fisher, 1922) and was corrected by the Bonferroni method 
(Supplementary Table 7.2). 
 
7.3.6 Analysis based on Gene Ontology 
 
To classify the promoter model hits according to function GO terms were extracted based 
on biological process and molecular function. FATIGO (http://www.fatigo.org/) (Al-
Shahrour et al., 2004) facilitated extraction and clustering of genes based on GO terms 
and pathways. The GO terms of the co-expressed genes were compared to GO terms of 
the model matches* to identify groups of genes, which have common GO categories. 
This is an indirect comparison approach that indicates that possibly the predicted gene set 
has genes which have same function as the genes from microarray data set and hence are 
probably co-regulated with the AMP genes of interest. The significance of this 
comparison of the GO terms in the two sets (predicted versus experimentally found co-
expressed genes) has been statistically computed using Fisher’s exact test and the p-
values are corrected for multiple testing (Al-Shahrour et al., 2004). 
Figure 7.1 shows the schema for the promoter model scan and the post scan analysis 
 
* model matches are the genes that emerged from promoter model scanning of the promoter dataset and has 
been use interchangeably with the word gene hits in this thesis 
 
 
7.3.7 Finding common co-regulators and targets for the candidate network genes  
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The author identified common regulators and targets of gene hits through literature 
search. This was done to in order to decipher whether these genes are already known to 
be component of common pathways. 
 
7.4 Results and Discussion 
 
Using promoter models from different alpha-defensin groups and scanning 10,255 human 
promoters, the author identified sets of human genes that are likely to be co-regulated 
with parent alpha defensin groups. To validate the gene hits as plausible co-regulated 
gene candidates for a particular AMP gene, the following functional and regulatory based 
comparisons were done: 
a. The gene hits were compared to co-expressed genes of AMPs to identify 
genes that are present in both datasets, 
b. Functional comparison based on GO terms was undertaken between the 
co-expressed gene group and the predicted gene hits to observe 
similarities, 
c. Gene hits that could not be identified in co-expressed gene data were 
grouped as unmatched gene hits which are possibly novel co-regulated 
genes, 
d. The novel genes were compared and grouped alongwith the parent AMP 
gene based on the functions (GO based) 
e. The novel genes were also compared with respect to function with the 
gene hits that emerged in the co-expressed gene data (matched gene hits) 
and, 
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f. Common regulators, transcription factors and downstream targets were 
looked at to deduce underlying common factors between the gene hits 
which potentially causes them to be co-regulated. 
The following sections demonstrate the above points in details. 
 
7.4.1 Alpha defensins 
 
Alpha defensin (HNP1-4) also known as neutrophil defensins are synthesized 
constitutively by the bone marrow precursors of neutrophils (Selsted and Ouellette, 
2005). The neutrophil defensins are then packaged in azurophil granules of neutrophils 
and comprise 30–50% of azurophil granule protein (Ganz et al., 1985, Ganz, 1987, Rice 
et al., 1987). The azurophil granules then fuse with phagocytes where they kill 
endocytosed microbes. Alpha defensins are thus only secreted when the neutrophils are 
stimulated. Alpha defensin 5 is an enteric defensin expressed mainly in the paneth cells 
and are constitutively produced (Cunliffe, 2003). Paneth cell alpha defensins are released 
when the cells are stimulated by cholinergic agonists and prokaryotic microbial antigens. 
HNP-1 (DEFA1 gene product) has been also been found to be expressed in by NK and T 
cells (Yang D. et al., 2000 ). They are present in blood, bone marrow, plasma, spleen and 
thymus. Alpha defensin 1 is an antimicrobial peptide that is chemotactic for T cells and 
inhibits classical complement pathway (van den Berg et al., 1998). It inhibits adenoviral 
infection and may play a role in tumor cell proliferation (Bastian and Schafer, 2001,  
Muller et al., 2002 ,  Aarbiou et al., 2002). Alpha defensin 5 is an antimicrobial and 
antifungal agent that is associated with, nasal polyps (Frye et al., 2000), inflammatory 
bowel disease (Schmid et al., 2004) and Crohn’s disease (Wehkamp et al., 2005). It is 
 161 
found in colon, female reproductive tract, ileum, intestine, jejunum, small intestine, 
stomach and urogenital tract.  
The specific regulatory elements and pathways that regulate alpha defensin 
synthesis and release in different tissues have not been well characterized. It was 
observed that promoter regions of pairs of defensin genes from the same site of 
expression, for example HNP1 and HNP4, and HD5 and HD6 (paneth cell specific) 
reveal marked similarities even in cases where the peptide sequence is highly divergent  
(Mallow et al., 1996). Currently, existing knowledge about the promoter regions of 
human alpha defensins implies that they have binding sites for myeloid transcription 
factors that are essential for their transcription in HL-60 myeloid cell line (Ma et al., 
1998), but otherwise no detailed study of alpha defensin promoter structure has been 
published. This study provides the first more detailed analysis of these promoters. To 
date, no TFBS module or cis-regulatory module has been published for alpha defensins. 
 
7.3.1 Scanned gene hits with alpha defensin models 
 
 
The promoter model for alpha defensin 5 identified 240 unique promoters in the human 
promoter data set with a threshold of 0.77 (Supplementary Table 7.3a, Supplementary 
Table 7.3b). Out of 240, 177 gene hits matched experimentally found co-expressed data 
(73.75%). The co-expressed gene data set with DEFA5 consisted of 729 genes collected 
from various experiments (see section 7.3.4). However, out of 729, only 226 genes had 
their promoters in the human promoter data set. To determine the significance of match 
of the 177 gene hits with co-expressed data, statistical test was done (section 7.3.5). This 
yielded a Bonferroni corrected p-value of 1.765e-071 (Supplementary Table 7.2), which 
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indicated that predictions of genes that are co-expressed by DEFA5 based on promoter 
model is very good.  
For alpha defensin 1 scanning the human promoter dataset with a threshold setting 
of 0.65, yielded 104 hits (Supplementary Table 7.4a, Supplementary Table 7.4b). The 
collection of co-expressed genes for alpha defensin 1 and alpha defensin 3 was 472. 
Promoters for 51 genes were found in the human promoter dataset. Out of 51 promoters, 
17 hits emerged in the prediction list. Hence, 17 genes coincided with experimentally 
found co-expressed genes with DEFA1 and DEFA3 genes. Similar statiscal test was 
carried out in this case. The p-value of these predicted genes (17 genes) was 3.72E-18. 
It was observed that the number of genes that emerged as hits using the promoter 
model for DEFA1-3 was less, although a lower threshold was used for scanning as 
compared to DEFA5 genes. DEFA1 and DEFA3 promoter regions are highly similar. 
Hence, the promoter model generated consisted of most of the 20 motifs in the same 
order in both the promoter regions of DEFA1 and DEFA3. However, having several 
motifs in a model makes the model highly restrictive. Hence, a optimal number (3–4) 
motifs should be used to have a promoter model. For DEFA1, DEFA3, there were several 
combinations that could be used. The author chose the model that had more number of 
motifs that corresponded to known TFBSs found in the promoter region of DEFA1-3. It 
is likely that although two of the motifs are known to occur in alpha defensin promoters, 
the combination of all the four motifs in the promoter model may have not been found in 
many promoters of the human data set and in DEFA1-3 co-expressing genes.  
 
7.3.2 Some interesting gene hits from DEFA1and DEFA5 promoter model scan 
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Alpha defensins are known to be involved in adaptive immune pathways other than their 
main role as antimicrobial peptides of innate immunity. Some of the scanned gene hits 
for DEFA1, DEFA3 and DEFA5 have direct or indirect association with immune 
pathways. These gene hits have been discussed in the following paragraphs.  
CX3CL1 was one of the gene hits that emerged from both DEFA1, DEFA5 promoter 
model scan. It is a membrane-expressed protein promoting cell-cell adhesion, which also 
is a soluble molecule inducing chemotaxis. It is known that besides having chemotactic 
property, some chemokines like CXCL4, CXCL9, CXCL10, CXC11, CTAP3, RANTES 
also have antimicrobial activity (Krijgsveld et al., 2000  Durr and Peschel, 2002). 
CX3CL1 did not appear in the co-expressed data for either DEFA1 or DEFA5. However, 
its functional property of being associated with the immune pathway, and having 
common promoter elements makes it a probable co-expressed gene with DEFA1-3 and 
DEFA5.  
DEFA1 gene hit, FKBP12 is an immunophilin, which plays a role in immuno-regulation 
and basic cellular processes involving protein folding and trafficking. It complexes with 
immunosuppressor protein FK506 and inhibits calcineurin which is involved in activation 
of NF-kappaB (Odom et al., 1997). Inhibition of calcineurin in fungal pathogen 
Cryptococcus neoformans adversely effects virulence (Odom et al., 19975). It also 
interacts with several other intracellular signal transduction proteins including type I 
TGF-beta receptor. Model match for DEFA1, VSIG2 is a member of the immunoglobulin 
domain cell adhesion molecule (cam). Another gene hit of DEFA1 scan, PSMB8 is 
involved in the process of antigen presentation (Schwarz et al., 2000). Model hits CPNE6 
and CPNE4 belong to the C2 domain family which are Ca2+-dependent membrane-
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targeting module found in many cellular proteins involved in signal transduction or 
membrane trafficking. C2 domains are unique among membrane targeting domains in 
that they show a wide range of lipid selectivity for the major components of cell 
membranes, including phosphatidylserine and phosphatidylcholine. CCND2, which is a 
G1/S phase specific cyclin was one of the hits that coincided with expression data for 
DEFA1, DEFA3 genes. CCND2 and alpha defensins are over-expressed in colon cancer 
when induced by a carcinogen, PhIP (Fujiwara et al., 2004). The model matches with 
DEFA1 promoter model are reported in (Supplementary Table 7.4a) and (Supplementary 
Table 7.4b). INS (insulin) emerged as another gene hit that is implicated to be expressed 
in thymus and induces tolerance in CD8+ T cells (Ma et al., 2000). Insulin is involved in 
alpha-beta T-cell activation (Ma et al., 2000). 
DEFA5 scan result yielded seven gene hits were grouped under immune response namely 
HLA-DMA, ILF2, G10P1, TTF, IFI30, AIF1, DHLAG. HLA-DMA, AIF1, DHLAG. 
TTF, DHLAG are involved in lymphocyte differentiation (Table 7.1). CKLFSF6 is 
another gene hit that belongs to the chemokine-like factor gene superfamily, which is a 
novel gene family and has properties that indicate that it has chemokine and chemotaxis 
activity (Han et al., 2003).   
 
Table 7.1 is a summary of DEFA1 and DEFA5 gene hits that have been discussed in the 
previous paragraphs. Figure 2a and Figure 2b show the regulatory networks for the 
genes listed in Table 7.1. The networks were created using Ingenuity system software 
(www.ingenuity.com).  
In the DEFA1 regulatory network (Figure 2a), TNF and IL-15 are the key 
regulators. TNF controls expression of INS and is also regulated by INS (Hostens et al., 
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1999, Iida et al., 2001). Other genes such as CCND2, CX3CL1, PSMB8 are regulated by 
TNF (Banno et al., 2004, Li et al., 2002), Banno et al., 2004). IL-15 regulates PSMB8, 
DEFA1 (Tourkova et al., 2005, Liu et al., 2002). DEFA1 is known to bind to SERPING1 
and inhibit the classical complement pathway (van den Berg et al., 1998). SERPING1 
decreases the mRNA expression of TNF-alpha in mouse (Liu et al., 2003). Whether the 
DEFA1, SERPING1 interaction has any direct effect on TNF-alpha expression is 
unknown. 
For the DEFA5 network (Figure 7.2b), IFNG (interferron, gamma), PTEN 
(phophatase and tensin homolog) and ILF3 (inteleukin enhancer binding factor, 3) are at 
the core of the network. IFNG indirectly regulates many of the genes that have been 
listed in Table 7.1 for DEFA5, such as CX3CL1 (Ludwig et al., 2002), AIF1 (Autieri et 
al., 2000), IFIT1 (Okumura et al., 2003), HLA-DMA (Muczynski et al., 1998), CD74 
(DHLAG) (Cao et al., 2000). It appears that PTEN indirectly acts as a negative regulator 
for DEFA5 expression. It decreases binding of DNA and a protein-protein complex 
consisting of human beta catenin (ctnnb1) and of human Tcf (Persad et al., 2001) that 
activate DEFA5 expression (Schwartz et al., 2003). PTEN negatively regulates IFI30 
(Matsushima-Nishiu et al., 2001). 
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Table 7.1 Selected gene hits of DEFA1 and DEFA5 
H-inv ID: Ids from the H-Invitational database 
H-inv ID Gene symbol Gene Description Pathway Tissue origin 
     
HIT00003749
0 CX3CL1 
chemokine (C-X3-C motif) ligand 1; 
small inducible 
 Cytokine-cytokine 









Immunoglobulin subtype domain 
containing protein, 
 complete cds.   Colon,adenocarcinoma 
HIT00003014
5 Y2,PSMB8 
Similar to Proteasome subunit beta type 8 
precursor  
(EC 3.4.25.1)   Skin,melanoticmelanoma.
HIT00003823
5 CPNE6 
Copine VI (Neuronal-copine) (N-copine), 
partial cds.   Brain,hypothalamus 
HIT00003667
3 CPNE4 Copine IV, complete cds   Brain,neuroblastoma 
HIT00003514
6 CCND2 G1/S-specific cyclin D2, partial cds. 







5 INS Insulin precursor, complete cds. 
 Regulation of actin 











molecules (CAMs)  Skeletal Muscle 
HIT00002957
1 ILF2 NF45protein,completecds.   










inducedproteinwithtetratricopeptide   






bindingproteinTTF),   





machain(HLA-DR   









inducibleprotein30preproprotein;   
 Skin, melanotic 








































The dotted lines indicate indirect relationships and the other lines indicate direct 
relationship. The grey shaded circles and boxes are the genes of interest found by the 
promoter model scan. Rhombuses: enzymes, rectangle: ligand dependent nuclear 
receptor, oval horizontal circles: transcription regulator, oval vertical circles: 




















The dotted lines indicate indirect relationships and the other lines indicate direct 
relationship. The grey shaded circles and boxes are the genes of interest found by the 
promoter model scan. Rhombuses: enzymes, rectangle: ligand dependent nuclear 














7.4.4 Comparison of gene hits with co-expressed genes for DEFA1, DEFA3 
The author compared the predicted gene hits with co-expressed gene data for human 
DEFA1 and DEFA3 and found eleven genes (CCND2, ABHD2, TMED9, ARB2, 
FKBP12, MARS, MEA1, CNOT2, PIAS2, CASP5, RSU) that overlapped with the co-
expressed gene data sets of DEFA1 and DEFA3. Another set of model matches 
(UGT2B11, DDX23, MARCH5, ZNF33A, VSIG2, PSMB8) had similar protein domains 
and GO functions to the co-expressed genes of DEFA1 and DEFA3 (UGT2B15, DDX27, 
MARCH3, ZNF167, VSIG4, PSMB4) respectively (Supplementary Table 7.4a). The 
gene hits that did not overlap with the co-expressed data set were grouped as “unmatched 
gene hits”. These unmatched gene hits that had GO terms were compared with DEFA1, 
DEFA3 GO terms of co-expressed gene group to determine if they could be categorized 
under similar GO categories. Several GO categories were common and significant in both 
the unmatched gene group and the co-expressed gene group (Supplementary Figure 
7.1). The common GO categories that came up were regulation of cellular physiological 
process, defense response, regulation of metabolism, signal transduction, primary, 
cellular and macromolecule metabolism, biosynthesis. 
Next, all the gene hits from DEFA1, DEFA3 model with GO terms were 
compared with GO terms for entire co-expressed gene dataset for DEFA1, DEFA3. The 
results showed that biological processes like regulation of cellular and physiological 
process, cell communication, and response to stimulus had significantly comparable 
percentage of genes represented in both data sets. The significance of this comparison 
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was determined by p-values as shown in Supplementary Figure 7.2. The null hypothesis 
in this comparison was that the genes from the two groups (predicted versus co-
expressed) fall under similar GO categories. This hypothesis was supported by the 
corrected p-values as shown in column 4 of Supplementary Figure 7.2. The high p-
values indicated that the gene groups were not significantly different, therefore, the null 
hypothesis was true. Therefore, many of the predicted genes for DEFA1, DEFA3 appear 
to have similar functions to the experimentally derived co-expressed genes for DEAF1, 
DEFA3. 
 Comparison was also performed at molecular function level. The results 
indicated that, protein binding, nucleic acid binding, ion binding, oxido-reductase 
activity, ion transporter activity, hydrolase activity and transferase activity had significant 
number of genes represented from both data sets for these categories (Supplementary 
Figure 7.3).  
 
7.4.5 Gene ontology based clustering for DEFA1 gene hits 
 
For alpha defensin 1 group, gene hits were clustered based on GO biological process and 
molecular function. Clustering based on GO biological process showed 13 hits 
categorized under cellular metabolism and primary metabolism. MIP, FTL, ATP5S, 
CPNE6, SRPR, SEC5L1 are involved in the process of transport. Six genes (TAF11, 
MYST2, CCND2, CHD2, CNOT2, CCNI) came under regulation of cellular 
physiological process. APBB1IP, CX3CL1, FMOD, INS are involved in signal 
transduction processes. Three genes UGT2B11, MIP, CX3CL1 were categorized under 
the GO category response to external stimulus (Supplementary Table 7.5a). Analysis of 
all gene hits at GO molecular function level showed nucleic acid binding function as the 
 171 
most significant function covering 10 hits. Next was function category of hydrolase 
activity with CHD1L, CHD2, DDX23, and SRPR under its category (Supplementary 
Table 7.5b).  
7.4.6 Alpha defensin 5 gene hits 
 
 
Alpha defensin 5 promoter model yielded 240 unique gene hits. The predicted gene list 
was divided into two groups as previously done with DEFA1 gene hits One group 
consisted of those genes that matched expression data (co-expressed gene data for 
DEFA5 human) and the other section had those that did not match (Supplementary 
Tables 7.3a, and 7.3b). GO based analysis of matched gene group with respect to 
biological process showed that the largest number of gene hits came under cellular, 
primary and macromolecular metabolism (Supplementary Table 7.6a). The next two 
categories that had many genes clustered under them were regulation of cellular 
physiological process, localization and transport. Seven hits, HLA-DMA, ILF2, G10P1, 
TTF, IFI30, AIF1, DHLAG were grouped under immune response. 
GO based clustering in the unmatched group also had cellular, primary and 
macromolecular metabolism categories having the highest number of genes 
(Supplementary Table 7.6b). 
GO biological functions like immune response, signal transduction, transport, 
cellular, primary and macromolecular metabolism, cell cycle, localization and a few other 
categories showed comparable number of genes between the matched group and 
unmatched group of predicted genes (Supplementary Figure 7.4). The significance of 
the comparison is depicted by the corrected p-values in (Supplementary Figure 7.4). 
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This perhaps indicates that although the genes in the unmatched category do not coincide 
with experimentally found co-expressed genes for DEFA5, they have similar functions to 
the co-expressed genes for DEFA5. Another observation was that many of the genes in 
both the matched and unmatched groups for alpha defensins came under non-immune 
categories like metabolism, transport and localization. These findings support the 
multifunctionality of defensins and their involvement in pathways other then innate 
immunity. In fact, some of these functions may be attributed to the tissue cell ontogeny 
and evolutionary adaptations. Table 7.2 lists the significant GO categories for the 












Table 7.2: The GO terms having the maximum number of novel (predicted gene hits 
not in the co-expressed gene data) gene hits from DEFA1 and DEFA5 
 
DEFA1    
GO biological function DEFA1_umatched gene hits No. of genes 
primary metabolism 
 
FARS1 DPM1 CHD1L MTMR5 HRMT1L1 PECI 
KIAA0065 MYST2 H1F0 ALDR1 TMPRSS1 LSM6 GUK1 
FKBP1A KIAA0929 KIAA0935 CPNE6 CHD2 MIZ1 




FARS1 DPM1 CHD1L MTMR5 HRMT1L1 PECI 
KIAA0065 MYST2 H1F0 NDUFS5 TMPRSS1 LSM6 
GUK1 FKBP1A KIAA0929 KIAA0935 CHD2 MIZ1 




FARS1 DPM1 CHD1L MTMR5 HRMT1L1 MYST2 H1F0 
ALDR1 TMPRSS1 LSM6 FKBP1A KIAA0935 CHD2 
PDCD9 NCL PFD4 KIAA0060 ARAF INS 19 
establishment of localization 
 
NTT73 ATP5S BGP1 CX3CL1 FTL NDUFS5 CPNE6 
SEC5L1 INS 9 
signal transduction 
 
BGP1 HRMT1L1 CX3CL1 FKBP1A KIAA0929 FMOD 
APBB1IP ARAF INS 9 
regulation of metabolism KIAA0065 MYST2 KIAA0929 CHD2 MIZ1 TAF11 INS 7 
biosynthesis FARS1 DPM1 GUK1 PDCD9 KBL RODH INS 7 
transport NTT73 ATP5S FTL NDUFS5 CPNE6 SEC5L1 INS 7 
regulation of cellular physiological process KIAA0065 MYST2 KIAA0929 CHD2 MIZ1 TAF11 CCNI 7 
cell organization and biogenesis MYST2 H1F0 PEX11G CHD2 4 
nitrogen compound metabolism FARS1 KBL KIAA0060 INS 4 
catabolism RODH KIAA0060 INS 3 
cell cycle MIZ1 CCNI DCTN3 3 
regulation of organismal physiological process CX3CL1 INS 2 
cell-cell adhesion BGP1 CX3CL1 2 
positive regulation of cellular process CX3CL1 FKBP1A 2 
immune response CX3CL1 INS 2 
defense response CX3CL1 INS 2 
cell-cell signaling CPNE6 INS 2 
regulation of signal transduction FKBP1A 1 
 
DEFA5    
GO biological function DEFA5_unmatched_genes No. of genes 
cellular metabolism 
 
PCCX1 NPD002 VPS11 TRIM9 EFCBP1 ELE1 RPS27L 
RBM3 PSMA7 MXD3 H2AFX EPM2A USP39 13 
primary metabolism 
 
PCCX1 VPS11 TRIM9 ELE1 RPS27L RBM3 PSMA7 
MXD3 H2AFX EPM2A USP39 11 
macromolecule metabolism 
 
VPS11 TRIM9 RPS27L RBM3 PSMA7 H2AFX EPM2A 
USP39 8 
establishment of localization NPD002 VPS11 CX3CL1 VIM TFIP11 KCNMA1 6 
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transport NPD002 VPS11 VIM TFIP11 KCNMA1 5 
regulation of cellular physiological process PCCX1 YWHAG ELE1 MXD3 EPM2A 5 
signal transduction YWHAG TENC1 CX3CL1 ELE1 PDZK2 5 
 
Table 7.2 continued    
regulation of metabolism PCCX1 ELE1 MXD3 EPM2A 4 
biosynthesis EFCBP1 RPS27L EPM2A 3 
positive regulation of cellular process CX3CL1 ELE1 2 
catabolism PSMA7 USP39 2 
cell organization and biogenesis YWHAG H2AFX 2 
cell-cell signaling YWHAG KCNMA1 2 
cell cycle YWHAG H2AFX 2 
 
 
7.4.7 Common regulators and targets of the predicted gene hits  
Common transcriptional regulators and common targets for the gene hits for each of the 
gene groups (DEFA1, DEFA5) were looked at to understand the commonalities in 
transcription regulation of the predicted gene hits. These links between the gene hits and 
the common regulators and targets is substantiated by literature evidence. 
For DEFA1 gene hits, ADP is involved in regulation of DEFA1, H1F0 (h1 
histone family, member 0) and INS (insulin) (Paone et al., 2002, Adamietz et al., 1978, 
Petit et al., 1989).  
Model matches of DEFA1, INS (insulin), MARS (methionine-tRNA synthetase), 
H1F0 (h1 histone family, member 0), AKR1B1 (aldose reductase) are involved in cell 
differentiation function (Table 7.3), a function that is common with DEFA1, DEFA3. 
HNP1-3 (DEFA1, DEFA3) is known to be involved in mucin cell differentiation 
(Aarbiou et al., 2004). The neutrophil defensins have mitogenic properties as 
demonstrated on epithelial cells and fibroblast (Murphy et al., 1993). DEFA1 gene hits, 
INS, CCND2, CEACAM1, FKBP1A, TNPO1, NCL, SBF1, H1F0, CCNI also appear to 
be involved in various mitogenic functions (Table 7.3). Moreover, INS is known to 
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synergistically act with the defensins in the mitogenic process (Murphy et al., 1993. 
Many of the DEFA1 gene hits such as NCL, MIP, INS, CEACAM1, PDCD4, CCND2, 
ARAF1, AKR1B1, H1F0 are regulated by protein kinase C. Interestingly, DEFA1 
inhibits protein kinase C (PKC) activity in CD4+T cells (Chang et al., 2005) causing 
inhibition of HIV-1 replication. 
Model hits INS, H1F0 are reglated by various hormones like glucocoticoid, 
progesterone and thyroid stimulating hormone. 
For the alpha defensin 5gene hits, GFAP, BGN, TXNRD1, CLG4A, NAALAD1, 
MMP2, FOLH1 and F3 have TNF (tumor necrosis factor) involved in their regulation. 
TNF-alpha expression is up-regulated by alpha defensins (Chaly et al., 2000). A common 
regulator of some of the DEFA5 gene hits is interleukin 1-beta (IL1B). It is involved in 
regulation of FABP1, MMP2, F3 and AIF1. IL1B has been observed to stimulate MMP2 
in cultured rat astrocytes. IL1B positively regulates F3, AIF1, IFI30 and negatively 
effects FABP1. DEFA5 gene hits CX3CL1, YWHAG, VIM and PSMA7 come under 
cytokine regulation.  
Some of the DEFA5 gene hits have known regulatory effects on other gene hits. 
For example, the gene Claudin-2 is also involved in the formation of intestinal epithelial 
barrier and its gene expression is up-regulated when stimulated with interleukins 
(Kinugasa et al., 2000). Claudin-2 (CLDN2) and Discoidin domain receptor 2 (DDR2) 
indirectly increase the protein activity of another DEFA5 gene hit, MMP2. Likewise, 
HSPA14 increases the protein secretion of CCL4. MLL binds to the promoter of HOXA9 
and increases its mRNA abundance.  





Transcription factors (TFs) that regulate many of these genes were also looked at. 
Supplementary Table 7.7 gives a list of the common TFs found across the predicted 
gene hits. These TFs were found across various genes by implementing FATIGO plus 
analysis module for finding transcription factors (Al-Shahrour et al., 2006). Some of the 
TFs found across several of these genes are immune system regulatory factors. HNF-1, 
CDX, Nkx2-5, GATA-4, LXR, PXR, CAR, COUP, RAR, Oct-1, and NF-kappaB are the 
commonly found TFs across both the matched and unmatched gene sets for DEFA5. NF-
kappaB is a key regulatory transcription factor for genes involved in response to 
infection, inflammation, stress (Baeuerle and Henkel, 1994) , (Sica et al., 1997) , 
(Quinlan et al., 1999) , (Hiroi and Ohmori, 2003). GATA-4 is also known to be involved 
in regulation of immune system (Su et al., 2004). Nkx2-5, GATA-4, HNF-1, CDX are the 
common TFs found in both the matched and unmatched predicted gene hits for DEFA1. 
HNF-3alpha, Evi-1 were the two other TFs that were found in genes that matched 
experimental co-expressed data set for DEFA1. Both Defa1 and DEFA5 gene hits have 







Table 7.3 Common regulators and common targets of DEFA1 and DEFA5 predicted 
genes 
 
(*PMID: Pubmed unique identifier). --->  indicates regulation, ---+> positive regulation, 
 -----| negative regulation 
 
Defa1       
Type Nodes Effect References (PMID)* 
Regulators       
ProtModification ADP ---> DEFA1   12060767 
ProtModification ADP ---> H1F0   729572 
MolTransport ADP ---> INS   2686791 
Regulation glucocorticoid --+> INS positive 11121405 
Regulation thyroid stimulating hormone --+> INS positive 11473059 
Regulation progesterone --+> H1F0 positive 8187766 
Regulation PKCINS negative 11246878 
ProtModification PKC->H1F0   3028404 
Regulation PKC->MIP   2541249 
ProtModification PKC ---> NCL   10811822 
ProtModification PKC ---> CEACAM1   10754323 
Regulation PKC --+> PDCD4 positive 2752524 
Expression PKC --+> CCND2 positive 11120786 
Regulation PKC --+> ARAF1 positive 8621729 
Regulation PKC --+> AKR1B1 positive 12527382 
Targets       
Regulation INS differentiation 11872678, 10385414 
Regulation DEFA1 differentiation 9352884 
Regulation MARS differentiation 4331137 
Regulation H1F0 differentiation 1988682 
Regulation AKR1B1 differentiation 151810922 
Regulation DEFA3 differentiation 12871849 
Regulation INS mitogenesis 10706096, 12183434 
Regulation CCND2 mitogenesis 11691826 
Regulation CEACAM1 mitogenesis 11694516 
Regulation FKBP1A mitogenesis 11226255 
Regulation TNPO1 mitogenesis 9388191 
Regulation NCL mitogenesis 12506112, 10811822 
Regulation SBF1 mitogenesis 12704202 
Regulation H1F0 mitogenesis 15694489 
Regulation CCNI mitogenesis 11054536 
Defa5       
Expression TNF ---> GFAP   8622125 
Regulation TNF ---> BGN   11322893 
Regulation TNF --+> TXNRD1 Positive 14584040 
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Regulation TNF --+>CLG4A Positive 10233890 
Regulation TNF --+> NAALAD1 Positive 12744776 
MolSynthesis TNF --+> F3 Positive 9002957 
Regulation IL1B ---| FABP1 Negative 10477831 
Regulation IL1B ---> MMP2   8945720 
Regulation IL1B --+> F3 Positive 12429585 
Regulation IL1B --+> AIF1 Positive 10894811 
Regulation IFNG --+> IFI30 Positive 12215441 
 
7.4.8 Commonality and differences between DEFA1 and DEFA5 gene hits 
DEFA1 and DEFA5 genes belong to the same AMP family and hence it is expected that 
they would have similar functions and perhaps be involved in similar gene networks. 
Interestingly, the gene hits that emerged from both the models did not have a significant 
overlap. This instigates the curiosity to compare the gene hits of DEFA1 and DEFA5 and 
observe the commonalities and differences between them. 
DEFA1 and DEFA5 gene hits (104, 240 respectively) were compared based on 
their GO terms and pathways. It was observed that metabolic activity, signal 
transduction, localization, biosynthesis, transport, cell death, neuro-physiological process, 
cell activation and immune response were the common GO function categories between 
DEFA1 and DEFA5 gene hits (Figure 7.3, Supplementary Table 7.8). However, some 
GO functions were exclusive to either group of gene hits as discussed later in this section. 
DEFA5 gene hits had involvement in more varied functions than DEFA1 gene hits. This 
could be due to the unequal number of gene hits emerging from the different model 
scans. DEFA5 gene hits appeared to be more involved in cell differentiation, organ 
development and cell growth functions compared to DEFA1 gene hits (Figure 7.4, 
Figure 7.5, Supplementary Table 7.8). 
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In terms of pathway level comparison, both DEFA1 and DEFA5 gene hits were 
involved in metabolic pathways such as prostaglandin and leukotriene, fructose and 
mannose, starch and sucrose, tyrosine, purine, galactose metabolism etc. Other pathways 
that had gene hits from both groups comprised of the WNT signaling pathway, MAPK 
signaling, insulin signaling and cell cycle. The GO comparison shows that genes from 
both alpha defensin groups are involved in signal transduction. Since GO function terms 
and pathways of a gene are interdependent, it is not surprising to see these signaling 
pathways emerge in the analysis of AMP co-regulated genes. MAPK signaling pathway 
is involved in innate immune responses as it is involved in activation of macrophages 
(Schorey and Cooper, 2003). WNT-signaling pathway has a important role to play in 
organ development, and dysregulated WNT signaling causes tumors. Recently its role has 
been implicated at several stages of lymphocyte development and in the self-renewal of 
haematopoietic stem cells (Staal and Clevers, 2005). The GO analysis of DEFA1 and 
DEFA5 gene hits show that many of them are involved in organ development (Figure 
7.4, Figure 7.5, Supplementary Table 7.8). Insulin signaling pathway is indirectly 
involved in the regulation of the immune system (McKenzie et al., 2006). Pathways that 
affect innate immunity have not been studied as well as that of adaptive immunity. An 
analysis of this kind indicates that many known pathways that in the current knowledge 
have no link to immune related mechanisms may perhaps be involved in direct or indirect 
ways in regulation of the latter. 
Within the data analyzed, some pathways appeared to be exclusive to a single 
gene group such as the Jak-Stat signaling pathway that involved gene hits of the DEFA1 
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group only. DEFA5 gene hits were involved in calcium signaling pathway. Table 7.4 
shows the comparison of DEFA5 and DEFA1 gene hits with respect to pathways.  
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Table 7.4: Comparison of DEFA1 and DEFA5 gene hits based on pathways 
The p-values are calculated by Fisher’s exact test  and multiple corrections have been done using the FDR procedure 
(Benjamini, 1995)  
Common pathways between DEFA1 and DEFA5             
Pathways DEFA1 genes No. of genes DEFA5 genes No of genes Unadjusted pvalue Adjusted pvalueFDR 
Focal adhesion CAV2 CCND2 2 PARVA 1 5.55E-01 1 
Cell cycle CCND2 1 YWHAG CCNB 2 1 1 
Prostaglandin and leukotriene metabolism CBR1 1 KIAA0106 1 1 1 
Wnt signaling pathway CCND2 1 NMP238 1 1 1 
Fructose and mannose metabolism ALDR1 1 PFKL 1 1 1 
Insulin signaling pathway INS 1 PFKL MNK1 2 1 1 
Starch and sucrose metabolism DDX23 1 UGP2 NUDT5 2 1 1 
Folate biosynthesis DDX23 1 NUDT5 1 1 1 
Purine metabolism GUK1 1 PRIM1 NUDT5 2 1 1 
Tyrosine metabolism HRMT1L1 1 AOC1 1 1 1 
Galactose metabolism ALDR1 1 PFKL UGP2 2 1 1 
Pentose and glucuronate interconversions ALDR1 1 UGP2 1 1 1 
Histidine metabolism HRMT1L1 1 AOC1 1 1 1 
Tryptophan metabolism HRMT1L1 1 MID1 AOC1 2 1 1 
MAPK signaling pathway ARRB2 CASP5 2 MAP2K1IP1 MNK1 2 1 1 
Glycine, serine and threonine metabolism KBL 1 AOC1 1 1 1 
DEFA1_specific pathway             
Pathways DEFA1 genes No.of genes DEFA5 genes No. of  genes Unadjusted pvalue Adjusted pvalueFDR 
Selenoamino acid metabolism HRMT1L1 MARS 2 No genes 0 1.55E-01 1 
Jak-STAT signaling pathway PIAS2 CCND2 2 No genes 0 1.55E-01 1 
Regulation of actin cytoskeleton INS 1 No genes 0 4.00E-01 1 
Methionine metabolism MARS 1 No genes 0 4.00E-01 1 
Dentatorubropallidoluysian atrophy (DRPLA) INS 1 No genes 0 4.00E-01 1 
N-Glycan biosynthesis DPM1 1 No genes 0 4.00E-01 1 
Pyruvate metabolism ALDR1 1 No genes 0 4.00E-01 1 
Oxidative phosphorylation NDUFS5 1 No genes 0 4.00E-01 1 
N-Glycan degradation KIAA0935 1 No genes 0 4.00E-01 1 
Nitrobenzene degradation HRMT1L1 1 No genes 0 4.00E-01 1 
Aminoacyl-tRNA synthetases MARS 1 No genes 0 4.00E-01 1 
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Glycerolipid metabolism ALDR1 1 No genes 0 4.00E-01 1 
Aminosugars metabolism KIAA0060 1 No genes 0 4.00E-01 1 
Aminophosphonate metabolism HRMT1L1 1 No genes 0 4.00E-01 1 
Androgen and estrogen metabolism HRMT1L1 1 No genes 0 4.00E-01 1 
Fatty acid metabolism PECI 1 No genes 0 4.00E-01 1 
DEFA5_specific pathway             
Pathways DEFA1 genes No. of genes DEFA5 genes No. of genes Unadjusted pvalue Adjusted pvalueFDR 
Alkaloid biosynthesis II No genes 0 AOC1 KIAA0106 2 5.09E-01 1 
Pyrimidine metabolism No genes 0 TXNRD1 PRIM1 2 5.09E-01 1 
Cell adhesion molecules (CAMs) No genes 0 HLA-DMA CLDN2 2 5.09E-01 1 
Adherens junction No genes 0 SNAI1 SLUG 2 5.09E-01 1 
Phenylalanine metabolism No genes 0 AOC1 KIAA0106 2 5.09E-01 1 
Calcium signaling pathway No genes 0 HER3 CCNB 2 5.09E-01 1 
Prion disease No genes 0 GFAP 1 1 1 
Neurodegenerative Disorders No genes 0 GFAP 1 1 1 
Proteasome No genes 0 PSMA7 1 1 1 
Methane metabolism No genes 0 KIAA0106 1 1 1 
Glycolysis / Gluconeogenesis No genes 0 PFKL 1 1 1 
Bile acid biosynthesis No genes 0 NPD002 1 1 1 
Stilbene, coumarine and lignin biosynthesis No genes 0 KIAA0106 1 1 1 
Nucleotide sugars metabolism No genes 0 UGP2 1 1 1 
1- and 2-Methylnaphthalene degradation No genes 0 NPD002 1 1 1 
Glycosylphosphatidylinositol(GPI)-anchor biosynthe No genes 0 PIGT 1 1 1 
2,4-Dichlorobenzoate degradation No genes 0 KIAA0106 1 1 1 
Valine, leucine and isoleucine degradation No genes 0 AUH 1 1 1 
Ribosome No genes 0 RPS27L 1 1 1 
DNA polymerase No genes 0 PRIM1 1 1 1 
beta-Alanine metabolism No genes 0 AOC1 1 1 1 
Tight junction No genes 0 CLDN2 1 1 1 
Pentose phosphate pathway No genes 0 PFKL 1 1 1 
Protein export No genes 0 SPC18 1 1 1 
Butanoate metabolism No genes 0 KIAA0106 1 1 1 
O-Glycan biosynthesis No genes 0 WBSCR17 1 1 1 
Arginine and proline metabolism No genes 0 AOC1 1 1 1 
  




Using promoter models of alpha defensin, the human promoter dataset was scanned. 
Several of the predicted model hits matched with experimental co-expressed gene data.  
 
The selection of genes from the promoter data set by the promoter models is dependent 
on the specificity of the motifs that are contained in the promoter model and the threshold 
that is used to scan the data set  
The caveats of this work is that it had limited gene expression data to analyze 
which cover the various stimuli for studying co-expressed genes for parent AMP genes. 
Secondly, the promoter data set was limited since it did not cover promoter regions for 
the entire human genome. This is because the choice of TSS position was determined 
using strict rules (section 7.3.1), which greatly decreased the possibility of false TSSs, 
but the number of promoter sequences extracted was also decreased.  
CX3CL1 is one of the predicted genes that came up for both the DEFA1 and 
DEFA5 model scan. CX3CL1 is one of the chemotaxins that stimulate NK cells (Morris 
and Ley, 2004). NK cells are known to produce alpha defensins and are directly involved 
in protection against microorganisms (Chalifour et al., 2004). CKLFSF6 is another 
interesting gene hit that emerged from DEFA5 scan. This recently discovered gene that 
belongs to a novel gene family also indicates that chemotaxins are probably co-regulated 
along with genes of innate immunity.  
The author found immune defense related genes for both DEFA1 and DEFA5 
scans. DEFA1 hits were FKBP12, PSMB8, and DEFA5 hits were HLA-DMA, ILF2, 
G10P1, TTF, IFI30, AIF1, DHLAG. These genes are known to be co-expressed with 
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DEFA1, DEFA5 respectively. These findings corroborate the strategy that the author has 
used to find co-regulated genes for the AMP genes of interest. 
The author compared the gene hits of DEFA1 and DEFA5 and found that both 
groups have a significant number of genes involved in metabolic pathways, signal 
transduction, biosynthesis, transport, cell death besides immune response. This supports 
the hypothesis that AMPs are involved in other pathways besides immune related ones. 
This analysis also indicated that though DEFA1 and DEFA5 belong to the same AMP 
family and have similarities in their transcription regulatory pathways, they still have 
some differences in terms of the different pathways they maybe involved in. However 
this statement may not be conclusive as the analysis was done based on GO terms and 
pathways which limits the number of genes that are taken consideration from the original 
pool of gene hits due to lack of annotation. 
This analysis elucidate novel gene which are potentially co-regulated with the 
alpha defensins. This claim is backed up by the fact that these gene hits share the same 
promoter model with the alpha defensin genes. Furthermore, the gene hits have been 
subjected to different types of analyses based on GO term classification, expression data 
comparison, common transcription factors and regulators.  
Though these results are just a drop in the sea of latent knowledge of 
transcriptional regulatory pathways for AMPs, it gives a glimpse of the complex interplay 
of different pathways and genes that could possibly be involved in influencing innate 




The objective of this study was to find co-regulated genes for the two different 
alpha defensin genes, which have different sites of expression. To do this, the regulatory 
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elements in the promoter regions of the alpha defensin genes were searched and TFBS 
modules were found. These modules were then used to scan human promoter dataset to 
find potentially co-regulated genes. Promoter regions were analyzed for alpha defensin 
1/alpha-defensin 3 and alpha-defensin 5 genes in human and mouse orthologs using ab-
initio motif searching algorithm. 
Seventeen predicted hits from alpha-defensin 1 promoter model scan and 177 
predicted hits from alpha-defensin 5 coincided with experimentally found co-expressed 
genes with DEFA1, DEFA3 and DEFA5 genes. 
The scan results reported gene hits CX3CL1 (chemokine (C-X3-C motif) ligand 
1), an immunophilin FKBP12 (FK506-binding protein 1A), VSIG2 which is a member of 
the immunoglobulin domain cell adhesion molecule (cam), INS (insulin), PSMB8 which 
is involved in the process of antigen presentation to promoter model of DEFA1. Gene 
hits from DEFA5 promoter model HLA-DMA, ILF2, G10P1, TTF, IFI30, AIF1, 
DHLAG are immune genes. CX3CL1 comes up in scan for both DEFA1 and DEFA5 
promoter model. CKLFSF6 is a gene that belongs to a novel superfamily of chemokine-
like factor that emerged as a DEFA5 gene hit. 
All the gene hits for DEFA1, DEFA5 emerged due to complete match of all 
motifs that made the promoter modules. However, not all gene hits matched 
experimentally found co-expressed genes. Comparison of functions of gene hits and the 
co-expressed genes showed significant similarity. This could probably indicate that these 


















Part IV: Chapter 8  Discussion and Conclusion 














Computational biology appeared as a specialized discipline in the last quarter of the 20th 
century, and it is revolutionizing how biological research is conducted. Researchers are 
increasingly conducting searches in public databases for characterized sequences that 
match theirs before doing experiments to determine their function. Bioinformatics 
narrows down the number of essential experiments needed and thus expedites the 
discovery process. Technological innovations in biology have made possible the genome 
sequencing of various organisms, which has generated a tremendous amount of sequence 
data deposited in the databases. Inferring knowledge from these data has become a 
priority. Computational biology facilitates extraction of knowledge by high throughput 
analysis of vast chunks of data, which is not otherwise possible simply by experiments. 
This thesis exemplifies this statement by showing the usage of various computational 
methods to derive new knowledge from the antimicrobial peptide dataset. The main 
emphasis of this study has been to analyze the promoter region of AMPs and deduce 
promoter elements. However, in due course of the study many other interesting and novel 
results have been generated at both peptide and genomic level of AMPs. 
The following paragraphs summarize the results of this thesis and discuss the 
implications of the findings. 
8.1 Database of antimicrobial peptides 
 
Databases serve as valuable resource for exploration of antimicrobial peptides, allowing 
users to query complex biological questions that may usually involve searching multiple 
sources. . In this thesis, the author created a publicly accessible database of antimicrobial 
peptides called ‘ANTIMIC’. ANTIMIC contains 1788 entries from both eukaryotic and 




collection, curation and cleaning that has been documented in Chapter 3 and can be 
reproduced if needed to update and enrich the database further. During the process of 
data collection and cleaning the public database records, some errors in the data were 
identified and corrected. Examples of errors include high redundancy due to maintenance 
of the same sequence in different public databases, discrepancies in primary sequences 
and conflicting annotation. Data checking and correction are thus critical for the 
improvement of data quality. Interpretation of unclean data is normally inaccurate and 
errors will be propagated in subsequent analysis where high data quality is important for 
accurate predictions. The creation of the ANTIMIC database was the first step towards a 
systematic sequence analysis of antimicrobial peptides. It helped in collating and 
systematizing the scattered information of antimicrobial peptides in one place and in easy 
access of information, which would help in the analysis process.  
Data classification usually is the next step computational step applied to the data 
that facilitates better understanding of the data and sets ground for prediction work. There 
are two principal approaches taken for data classification, manual and automatic. Manual 
classifications are based on human expertise, facilitated by bioinformatic analyses, to 
cluster data into particular groups that share common properties defined by domain 
experts. Examples include the manually curated Swiss-Prot and PROSITE databases. The 
other approach is automatic classifications that depend on algorithms or models. 
Examples of automatic classification algorithms include self-organized maps, artificial 
neural network, and support vector machines which belong to the fields of artificial 
intelligence and machine learning ProDom (Kapetanovic et al., 2004), and DOMO 




with automated processes that classify entire protein sequence databases. The advantage 
of manual classification is the high quality of clustering but the final classification result 
may be irreproducible because of differences in the experts’ knowledge. In contrast, 
automation is fully reproducible because of fixed rules written in computer programs and 
scalable to large data set, but implies caveat that the same threshold is used in the process 
and this may not be the optimal choice, thus potentially opening a way for the 
propagation of errors caused in this manner. 
Multiple alignments of protein sequences are an effective way of classifying and 
also identifying conserved amino acids that provide clues to functional relationships 
among proteins. The patterns of amino acid variability in multiple sequence alignments 
reveal evolutionary pressure, mutation, recombination and genetic drift that spans 
millions of years Valdar, 2002. Conserved residues could be critical to the structure and 
function of a peptide. However, multiple alignments alone can go as far as aligning 
multiple sequences and indicating the conserved residues. To be able to increase the 
applicability of multiple alignments, HMMs are introduced. HMM approach models 
expectations of what unknown members of a protein family could be through the use of 
probabilities calculated from multiple alignments and assuming independence (except 
within consecutive deletions and insertions) among amino acids of a protein. Thus, each 
position is modeled separately; the concatenation of these amino acid probabilistic 
models is the protein model (Amitai, 1998). The author, implemented the HMM based 
machine learning approach to create a score based method of classification of AMPs  that 
can be used to query for new AMPs and also predict the classification of new AMPs into 




based on prior knowledge of the AMP families. These profiles also proved to be useful in 
tagging of conserved residues that could potentially be important for the antimicrobial 
function for a particular family of AMP. The HMM based software was integrated into 
the ANTIMIC database as the ANTIMIC profile module.  
 
8.2 Comparative genomic analysis of AMPs to find transcriptional regulatory 
 elements 
 
Understanding regulation of a gene or gene family at transcription level in recent years 
has gained momentum due to high-throughput genome sequencing of whole genomes and 
experimental techniques that have made it possible to explore non-coding regions. This 
understanding can be expedited through computational methods. Comparative genomics 
has long held the promise for the identification of response elements in eukaryotic 
genomes (Hardison et al., 1997).  Initially, searches for regulatory elements were 
conducted with consensus sequences and positional weight matrices and were confined to 
the detection of known elements. Now, ab-initio approaches show great potential for the 
identification of response elements in eukaryotic organisms (Lawrence et al., 1993, Roth 
et al., 1998). Ab-initio approach on regulatory region of multiple species and validation 
with co-expression information from DNA expression analysis experiments brings a 
powerful way to determine new regulatory elements. This approach allows for 
elucidation of new promoter elements (TFB motifs) which are previously unknown. This 
work shows implementation of this approach in understanding antimicrobial peptides and 
the author was able to find new insights into the transcriptional regulation of AMPs. 
In order to collate the promoter sequences of various AMP genes, the author 




orthologous human or rat sequences. TBLASTN search was done on the FANTOM3 
dataset using the ANTIMIC sequences and some additional AMP sequences from 
GenBank. The author was able to find 103 mouse AMP members that were new in 
FANTOM3. The sequences belonged to 28 families (alpha-defensin, alpha2casein, 
apoa2, beta-defensin, spag11, bpi, calgranulin, cathelicidin, cathepsinG, dbi, slpi, 
enhancer of rudimentary homolog, granulin, hepcidin, histone2a, IFN-inducible antiviral 
protein Mx, lactoferrin, lysozyme, mbp, melanotropin alpha, ovotransferrin, 
proenkephalin 1, sap2, secretogranin, skiv2l, spyy, vasostatin, vip and zap).  
The extraction of promoter sequences of AMPs involved a systematic collection 
from various sources. Mouse promoter sequence extraction involved sequential steps of 
finding the TSS location that was determined by using the start position of the first exon 
of the FANTOM cDNA-genome mapping data. Upstream region of 1000 base pairs and 
downstream region of 200 base pairs were then extracted by mapping the TSS location to 
the mouse genome data from UCSC. 
The promoter analysis was done on genes from 22 AMP families. The promoter 
regions of AMPcgs in the three species (human, mouse and rat) were screened for motifs 
by an ab-initio motif finding method and analyzed for promoter characteristics (TFBS 
motifs). Many of the motifs that were detected are known from previous experimental 
studies to be involved in control of AMPs (Chapter 5). This corroborates the 
computational method used to detect TFBS motifs. The analysis showed that the key 
transcriptional regulators are likely to be TFs of the liver-, nervous system-specific and 
NHR group. Nuclear hormone receptors (NHRs) were prominent among the core TF 




the frequently occurring NHR, some of which are implicated in immune responses. Non-
NHR TFs such as Meis1a and Meis1b, Sp1, NF-1, AP-2 and c-Myb were the other TFs 
found in various AMP families. These TF groups consist of transcription regulators that 
are involved in diverse physiological functions, including control of embryonic 
development, cell differentiation and homeostasis, but also in immune response. This 
reiterates that AMPs are involved in  pathways other than innate immunity.  
The analyses of the promoter regions of AMPs lead to several other interesting 
observations. Analysis of alpha defensin promoter regions showed that the conservation 
of the motifs across different species correlated to the phylogenetic groupings that have 
been studied previously by other groups for alpha defensins (Chapter 5). It was observed 
that the motif combinations that are shared between myeloid and enteric specific alpha 
defensins largely differ between rodents and primates. The rat Defa and enteric-expressed 
mouse defcr2 promoter regions share the motifs 20 (AR PXR-1: RXR-alpha) –7 
(POU1F1a, POU2F1) – 4 (RAR-alpha1, RXR-alpha) (20-7-4) arrangement (Chapter 6). 
In contrast, the primate myeloid–expressed (Hosa_DEFA4, Patr_DEFA4, Hosa_DEFA3) 
and enteric-expressed (Hosa_DEFA5 and Patr_DEFA5) alpha defensins share the motif 
organization (20-10-11-19) (Chapter 5). This small study acts as an example of 
investigating phylogeny with respect to regulatory content analysis. It initiates a new 
perspective into the study of evolution of various AMP gene families to find out about 
their common ancestry and divergence and intrigues further investigation on whether a 





Three potential TF-binding motifs that were enriched in promoters of AMPcgs are 
novel. This sets precedence for experimental validation of these cis-elements. (Chapter 
5). Another four motifs were found to be species-specific or lineage-specfic in the context 
of regulation of individual AMPcg families. (Chapter 5). 
 
The next step was to look at cohorts of putative TFBS motifs and deduce a 
common framework or model of TFBS. The author generated promoter models for 
PENK, DEFA5, DEFA1 and ZAP AMP genes (Chapter 6). Most of these models 
consisted of known and novel TFBSs. This has been the first attempt to generate 
promoter models for AMP families. 
The significance of these models was in their usage to be able to extract co-
regulated genes that share the same promoter models. This was demonstrated with the 
alpha defensin promoter models (DEFA1, DEFA5). The promoter models (alpha 
defensins) were used to scan the human promoter dataset (Chapter 7). The scanned hits 
found using the promoter models coincided with known co-expressed genes of the parent 
AMPs (Chapter 7) and this vindicates the computational approach used.  Many novel 
gene hits emerged in the promoter model scan that had similar GO based categorization 
as the experimentally known co-expressed gene group (Chapter 7) indicating the 
possibility that these genes can also be co-expressed under different conditions with 
AMPs. CX3CL1 is one of the predicted genes that came up for both the DEFA1 and 
DEFA5 model scan which is not known to be experimentally co-expressed with alpha 
defensins. However, its function as a chemotaxin and involvement in adaptive immune 




show that the scanned gene hits for alpha defensins are also regulated by immune 
pathway related TFs such as NF-kappaB, GATA-4 and Evi-1 (Chapter 7). From the 
comparison of DEFA1 and DEFA5 gene hits it can be extrapolated that though there are 
many common pathways such as cell cycle, MAPK signaling pathway, insulin signaling 
pathway, etc.) in which both gene groups are involved, there are also different pathways 
which appear exclusive to only one gene group (either DEFA1 or DEFA5) such as 
methionine metabolism, androgen and estrogen metabolism, selenoamino acid 
metabolism which showed up only for DEFA1 gene hits. etc. (Chapter 7). Glycolysis, 
pyrimidine metabolism, alkaloid biosynthesis II etc were some pathways that were 
observed only for the DEFA5 genes. Therefore, this is perhaps an indication that though 
DEFA1 and DEFA5 belong to the same AMP family, they are involved in different gene 
networks. The methodology of promoter element analysis is applicable to any multigene 
families with diverse functions (i.e. cytokines and chemokine ligands and receptors) and 
more importantly for establishing basic functional assignments for transcripts with 
unknown functions.  
In summary, this analysis shows that AMPs from different families have multiple 
roles in cells, which implies that they are likely to be regulated in such a manner that they 
can fulfill their roles. This means that we should expect great variability in their 
promoters. However, since they also have some common roles in immune response, we 






A great part of the author’s computational findings fit into the current knowledge 
about regulation of AMPs and also generate new hypotheses that await experimental 
validation. This study acts as a paradigm for the use of computational tools such as DMB 
, module generation program etc. to understand parts of  regulatory regions for any set of 
genes and collation of the data to fit a bigger network of the underlying workings of the 
transcriptional regulation.  
This thesis unveils opputunities for development and expansion of research in the 
area of transcriptional regulation of AMPs and also other gene families. 
Two principal directions for the development of bioinformatics in the field of 
antimicrobial peptides and transcriptional regulation, are namely the development of 
databases and computational analysis. The development of database includes data update 
on top of data integration, data cleaning and integration of bioinformatic tools. Data 
update focuses on adding new antimicrobial peptide sequences identified and new 3D- 
structures solved. The author suggests that the ANTIMIC database can be enriched 
further with additional annotation to make it a comprehensive and composite repository. 
It can contain in addition to the current version additional information of the known gene 
structures, promoter regions, transcription factors that have been published in literature 
for antimicrobial peptides and also computationally found into the data warehouse. The 
new data can help to verify hypotheses made during analyses of initial dataset while new 



















Part IV: Chapter 9: Future work 























9.1 Experimental work 
In recent years, there has been a rapid increase in our knowledge of understanding the 
role of regulatory regions as “switches” of various pathways and onset of diseases. Both 
experimental and computational tools have improved over the years to enable such a 
growth in our understanding. Now it is very much feasible to deduce missing links in  
pathways by application of a combination of experimental and computational techniques. 
For example,  a study reported the use of promoter analysis to identify novel genes 
showing functional relevance in cell proliferation in a colon cancer model. The analysis 
yielded some known proliferation-associated genes, such as HERG1 and MCM7, and a 
number of genes not previously implicated in cell proliferation in cancer, such as 
TSPAN3, Necdin and APLP2. Suppression of TSPAN3 and APLP2 by siRNA was 
performed and confirmed by RT-PCR. It was seen that inhibition of these genes 
significantly inhibited cell proliferation in colon cancer cell line (Moss AC, 2007). 
In another example, promoter modeling was applied to link disease-associated 
genes to potential regulatory networks. This approach was applied to a Maturity Onset 
Diabetes of the Young (MODY)-associated gene list, which yielded two models 
connecting functionally interacting genes within MODY-related insulin/glucose signaling 
pathways (Dohr et al., 2005). 
Another group has identified some novel potential transcriptional regulators and 
pathways involved at different stages of spermatogenesis based on bioinformatic and 
promoter analysis. The analysis was done on SAGE data on the transcriptome of mouse 
type A spermatogonia (Spga), pachytene spermatocytes (Spcy), and round spermatids 




In this thesis as well,  a number of hypotheses has been generated that have good 
concordance with some of the existing knowledge in the field of AMPs and innate 
immunity. However, the computationally inferred hypotheses can only be tested in 
experiments. This section  discusses the novel findings obtained from the analyses and 
the experimental approaches to validate them. 
1. Several of the NHR group TFs such as RXR-alpha, AR, T3R-alpha, RAR-
alpha, LXR-alpha:RXR-alpha appear as the frequently occurring  candidates in 
AMPS. Their presence in the promoter regions requires validation.   
2. VDR and GR have been reported in scientific literature to be regulating 
expression of some AMP genes such as beta defensins. Our analysis 
indicates their presence in many other AMP genes. 
3. NF-1 and NKX2-1 which have not yet been implicated to be involved 
immunomodulatory pathways have appeared frequently in many AMP 
genes in the analysis.  
4. Transcriptional regulator c-myb is involved in lymphocyte development. 
Experimental validation of its functional binding site in atleast an AMP 
gene can indicate its direct involvement in innate immunity. 
The author suggests genome-scale location analysis (Ren et al., 2000) followed by 
chromatin immunoprecipitation (ChIP) can identify promoters bound by the 




clarify which promoters and TFs are specific for certain tissue cells and how many 
AMPcgs are regulated by a TF, TF pair or multiple TFs.  
This study has also elucidated genes that are novel candidates for co-regulation with 
AMPs such as CX3CL1. Microarray experiments that are pathway specific or ligand 
specific stimulated such as LPS and TNF can be carried out to validate co-expression of 
the candidate genes with certain AMP genes.  
Another experimental approach could be knocking out of a particular AMP gene and 
checking for the effects of the deletion on a pathway of interest from the suggested 
pathways in this study. This can facilitate validation of a involvement of a particular 
AMP gene in regulation of the pathway. Eventually, the combination of both 
computational and experimental will facilitate construction of mechanistic models of 
AMPcg regulatory transcription networks. 
 
9.2 Computational work 
 
Expression arrays yield high dimensional data that facilitates the deduction of temporal 
and special activation of groups of genes. Through this technology it has been possible to 
find the differential gene expression patterns in normal and diseased tissues as well as the 
response of tissues to the application of therapeutic reagents.  
Computational analysis on gene expression data such as application of clustering 
algorithms facilitate elucidation of co-regulated set of genes. Information about 
underlying transcriptional regulatory networks responsible for the observed expression 




Regulation of expression is determined to a large extent by the promoter sequences of the 
individual genes (and/or enhancers). The availability of the complete human genome 
sequence now provides the molecular basis for the identification of many regulatory 
regions. Promoter sequences for specific cDNAs can be obtained reliably from genomic 
sequences by exon mapping or by mapping full length cDNAs. A sufficient pool of  
promoter sequences can allow deduction to candidates in a network solely on  
bioinformatic analysis as has been demonstrated in this thesis. Generation of promoter 
models based on comparative promoter analysis of co-regulated genes and groups of 
genes leads the way to understanding regulatory networks. Such modules represent the 
molecular mechanisms through which regulatory networks influence gene expression. 
This approach also provides a powerful alternative for elucidating the functional features 
of genes with no detectable sequence similarity, by linking them to other genes on the 
basis of their common promoter structures. 
As a part of future work, the author thus proposes promoter model scanning 
across whole genomes (for eg. human, mouse) to find putatively new AMP related 
sequences that can not be extracted by BLAST or other sequence similarity tools due to 
short length of the exon or low similarity.  
Another possibility is for generation of promoter models for other AMP families 
that have not been addressed in this thesis for example beta-defensins and promoter scan 
with the models generated. This will enable expansion of our knowledge in the realm of 




 It would also be interesting to do the scan across other available promoter 
datasets like mouse and rat and do a comparative genomic study of the gene hits for a 
particular AMP model to find how similarities and differences among them.   
In this thesis, the author restricted the findings of regulatory elements in the promoter 
region. The same computational approach can be extended to find the regulatory 
elements in intergenic regions and 3’UTR region. This would lead to novel findings in 
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We are all inventors, each sailing out on a voyage of discovery, guided each by a 
private chart, of which there is no duplicate. The world is all gates, all opportunities. 


















Supplementary Tables and Figures for Chapter 5 
 
Supplementary Table 5.1 AMPcg families and representative members in 
mouse, rat and human 
Mm: Mus musculus; Hs: Homo sapiens; Rn: Rattus norvegicus: TUID: transcriptional 
unit ID; CTSS: transcription start site (TSS) information based on CAGE tags. 
 
AMP Family Gene symbol Species Representative 
CloneID/Accession 
TUID CTSS
Alpha defensin 2010016B13Rik Mm 2010016B13 
175722
No 
  2010016F14Rik Mm 2010016F14 
168136
No 
  defa5 Hs NM_021010 - - 
  defa6 Hs NM_001926 - - 
  defa4 Hs NM_001925 - - 
  defa3 Hs NM_005217 - - 
Apoa2 (apolipoprotein A-II) Apoa2 Mm I530003A11 
83109
No 
  APOA2 Hs HIT000032344.2 - - 
  Apoa2 Rn NM_013112 - - 
Beta defensin 9230107O10Rik Mm 9230107O10 
103672
No 
  DEFB28 Hs AF525930 - - 
  Defb1 Mm D630029A12 169116 Yes 
  DEFB1  Hs BC033298 - - 
  Defb1 Rn NM_031810 -  - 
  Defb23 Mm 1700012K18 121132 Yes 
  DEFB123 Hs NM_153324 - - 
  Defb4 Mm 2310001F05 168175 No 
  DEFB4 Hs NM_004942 - - 
  Defb36 Mm 1700011J22 168985 Yes 
  DEFB105a Hs NM_152250 - - 
  Defb12 Mm 9230103N16 77756 No 







9230105K17Rik Mm 9230105K17 
112251
No 
  BPI Hs BC040955 - - 
Bin1b/SPAG11 Spag11 Mm 9230111C08 168760 No 
  SPAG11 Hs NM_016512 -  - 
  Spag11 Rn NM_145087 - -  
Cathelicidin Camp Mm F930015N03 112000 Yes 
  CAMP Hs NM_004345 - -  
  cramp Rn AF484553 - -  
Calgranulin S100a9 Mm F430201H11 83114 Yes 
  S100a9 Hs NM_002965 - - 
  S100a9  Rn NM_053587 - - 
DBI (Acyl-CoA-binding 
protein family) 
Dbi  Mm 6720460E16 102356 Yes 
  DBI  Hs NM_020548 - -  
Slpi (skin-derived 
antileukoproteinase) 
Slpi Mm 2310075E18 
75903 
No 
  SLPI Hs HIT000038907.2 - - 
  Slpi Rn NM_053372 - -  
Granulin Grn Mm 0610012H06 104193 Yes 
  GRN Hs BC000324 - - 
  Grn Rn NM_017113 - - 
Hepcidin 1810073K19Rik Mm 2210420P15 
168118
Yes 
  LEAP2 Hs NM_052971 - - 
Histone 2A derived defense 
peptide 
Hist1h2ac Mm 9030420B16 112273 No 
  HIST1H2AC Hs NM_003512 - -  
  Hist1h2ae Mm 1190022L06 112736 No 
  HIST1H2AE Hs NM_021052 - -  
Lactoferrin Ltf Mm 9830118D19 173811 No 




Lysozyme 9530003J23Rik Mm 9530003J23 
106239
No 
  Lyzs Mm I420013M05 111075 Yes 
  LYZS Hs AF099029 - - 
  Lyzs Rn NM_012771 - - 
MBP (Myelin Basic Protein) Prg2 Mm 2510004C07 
112877
No 
  PRG2 Hs HIX0009634.2 - - 
  prg2 Rn NM_031619 - - 
Melanotropin alpha (Pro-
opiomelanocortin family) 
Pomc1 Mm 5730403F20 151196 No 
  POMC1 Hs NM_000939 -  - 
  Pomc1 Rn NM_139326 -  - 
PENK (Proenkaphalin) 
(opioid neuropeptide family) 
Penk1 Mm 4922504O09 
179452
Yes 
  PENK Hs HIX0007519.2 - - 




Chgb Mm 5730420J08 
177050
Yes 
  CHGB Hs HIX0015625.2 - - 
  Chgb Rn NM_012526 - - 
SPYY (Skin peptide 
tyrosine-tyrosine) (NPY 
family) 
Npy Mm 0710005A05 
72959 
Yes 
  Pyy Mm C820007C10 111251 Yes 
  NPY Hs HIX0006525.2 - - 








Chga Mm G630083O06 
83089 
Yes 
  CHGA Hs HIX0011909.2 - - 
  Chga Rn NM_021655 - - 
VIP (Vasoactive intestinal 
peptide) (Glucagon family) 
Vip Mm 9130007F05 
112113
No 
  VIP Hs HIX0006306.2 - - 
ZAP (CCCH type, antiviral 
1) 
Zc3hav1 Mm F420004O17 
99218 
Yes 
  ZC3HAV1 Hs HIX0007129.3 - - 

































Supplementary Table 5.2 FANTOM3 dataset-derived AMP transcripts which 
were new to mouse and absent in human 
 


































Supplementary Table 5.3 TFs associated with ab initio-predicted TFBSs that coincided with experimental data.  
 
References are cited at the end of Supplementary material section 
 
AMP family Experimentally determined TFs References  Predicted TFs matching 
experimental confirmed 
TFs 
Alpha defensin CAAT, PEBP2/CBF (Yamamoto et al., 2004) PEBP2/CBF 
Beta defensin NF-KAPPAB, AP-1, NF-IL6, MEF, VDR 
(Harder et al., 2000),(Vora et al., 
2004),(Lu et al., 2004), (Wang T.T. et al., 
2004) AP-1,MEF(C-ETS1),VDR 
BPI AML-1, PU.1, SP3/SP1,C/EBP,USF, NF-KB, C-REL (Lennartsson et al., 2003 ) SP3/SP1,AML-1,NF-KB 
Cathelicidin VDR, NF-IL6, RAR,IL-6RE 
(Wang T.T. et al., 2004), (Frohm Nilsson 
et al., 1999), (Wu et al., 2000 ) VDR, RAR, IL-6 RE 
DBI 
SREBP, SP1, PPAR-ALPHA,AP-1, C/EBP, HNF-3, RXR-ALPHA, 
NF-1/CTF , AP-2 




Hepcidin C/EBP-ALPHA (Courselaud et al., 2002 ) C/EBPALPHA 
Histone 2A TBP,OCT-1,CAAT box, 
(Oswald et al., 1996 ), (Albig et al., 1999 
), (Trappe et al., 1999 ) Oct-1, CAAT 
Lactoferrin SP1, C/EBP 
(Teng, 2002 ), (Khanna-Gupta et al., 
2000 ) SP1, C/EBP 
Lysozyme SP1,MEF,C/EBP (Suico et al., 2004 ) MEF (C-ETS1),SP-1 
MBP NKX2.2,SP1,SOX10,PAX3, NF-KB 
(Wei et al., 2005), (Wei et al., 2004 ), 
(Wei et al., 2003), (Slutsky et al., 2003 ), 
(Huang et al., 2002 ) SP1 
Melanotropin-alpha SRE,AP-1, AP-2 LIKE, CAAT BOX (Deen et al., 1991 ) AP-1, AP-2 LIKE 
Proenkaphalin1 
TATA, AP-2, NF-KAPPAB,MZF-1,MYC PACH1,CREB,CRE, 
NF1,AP-1 
(Liu et al., 2000 ), (Kobierski et al., 1999 
), (Fu et al., 1997) (Le et al., 2003) 
AP-1, NF1, TATA,AP2,NF-
KB,MZF-1,NF-Y, 
Secretogranin I SP-1, CRE, TATA (Pohl et al., 1990), (Mahata et al., 2002) SP-1, TATA 
Vasostatin OLF/EBF, SP1,CREB,GR 
(Persson et al., 2004), (Mahapatra et al., 
2003), (Hocker et al., 1998), (Rozansky 
et al., 1994) GR,SP-1 





Slpi GR,PR, IRF-1 
(Hayashi et al., 2004), (King et al., 2003), 
(Nguyen et al., 1999) GR, PR 
Apoa2 NA NA NA 
Calgranulin NA NA NA 
Granulin NA NA NA 
SPYY NA NA NA 
ZAP NA NA NA 






























Supplementary Table 5.4 Total number of motifs found for each AMP family  
 
Unknown: motif does not match any of the TRANSFAC-listed TF binding sites 
 
AMP family new TFs Unknown motifs total 
Alpha-defensin 73 3 77 
Apoa2 36 6 42 
BPI 113 4 120 
Beta-defensin 78 8 89 
Bin1b/SPAG11 75 3 78 
Calgranulin 162 4 166 
Cathelicidin 75 3 81 
DBI 53 1 59 
Granulin 67 3 70 
Hepcidin 59 3 63 
Histone 2A 83 12 97 
Lactoferrin 46 4 52 
Lysozyme 30 9 41 
MBP 67 2 70 
Melanotropin alpha 81 1 84 
Proenkaphalin1 54 3 85 
SPYY 58 5 63 
Secretogranin I 31 6 39 
Slpi 94 5 101 
VIP 54 3 60 
Vasostatin 19 9 30 




Supplementary Table 5.5. Ranking of TF groups according to their frequency of appearance in different AMP families.  
For example, under rank 1, AD is the the most frequently occurring TF group in five of the AMP families that are listed in Table 5.5. 
Underlined numbers indicate the TF groups that are high-ranking such as liver-specific, nervous system-related, adipocyte-related, 
nuclear hormone-related, immune cell-specific and lung-specific TFs. 
 
Tissue/Function-specific TF groups 
Rank AD NHR CC IMM LIV LUNG MUS NS PAN PIT EYE BS 
1 5 6 5 6 9 5 1 7 0 1 0 0 
2 6 6 2 2 6 3 0 4 1 0 0 0 
3 4 1 1 2 5 1 1 3 1 0 0 0 
4 3 2 0 0 1 1 0 3 1 1 0 0 
5 0 3 2 4 1 4 3 5 2 2 0 0 
6 1 0 1 5 0 3 4 0 1 2 0 0 
7 0 1 4 3 0 2 4 0 5 2 0 0 
8 2 1 3 0 0 2 1 0 5 4 0 0 
9 0 1 4 0 0 1 4 0 2 3 0 2 
10 1 1 0 0 0 0 4 0 4 6 0 4 
11 0 0 0 0 0 0 0 0 0 1 14 16 
12 0 0 0 0 0 0 0 0 0 0 8 0 
Avg. 
k









Supplementary Table 5.6: Ranksum test of AMPcg families versus house keeping genes 
Unadjusted p-value is p-value from the ranksum test for each AMP family vs. house keeping gene set. Adjusted p-value: p-value corrected for 
multiplicity testing for 6 TF groups that are being tested: namely, AD, NHR, IMM, LIV, LUNG, NS, these are the most frequently present TF 
groups across all AMP families. Seven AMP families have corrected P-value less than 0.05 and thus the null hypothesis that the two distributions 
are the same can be rejected. This means the distirbution of these families of TFs and those in the testes AMP families are different. 





Alphadefensin 6 12 2 6 6 5 3 9 2 1 0 0 0.5591 1 
Apoa2 5 5 5 4 5 5 4 6 4 3 0 0 0.0074 0.0444 
Betadefensin 6 5 4 6 6 5 2 8 2 3 0 1 0.124 0.744 
bin1b/spag11 9 9 3 5 10 10 6 10 5 2 0 3 0.7614 1 
Bpi 6 7 8 8 8 5 8 7 7 4 0 0 0.3293 1 
Calgranulin 8 5 6 9 9 6 7 11 7 5 1 2 0.8165 1 
Cathelicidin 4 8 6 8 5 5 1 6 3 5 0 1 0.1503 0.9018 
Dbi 7 8 4 5 7 6 4 6 1 4 0 0 0.2576 1 
Slpi 6 7 3 6 6 5 3 8 5 4 0 0 0.2199 1 
Granulin 6 5 6 4 6 6 4 5 4 3 0 0 0.0269 0.1614 
Hepcidin 10 9 3 7 11 11 3 9 6 7 0 0 0.4387 1 
Histone 5 2 3 3 5 4 3 3 4 3 0 0 0.0004 0.0024 
Lactoferrin 7 10 3 4 7 6 4 8 3 1 0 0 0.3922 1 
Lysozyme 4 2 4 3 4 4 3 3 2 1 0 0 0 0 
Mbp 6 7 9 9 7 6 6 7 2 6 0 2 0.3562 1 
Melanotropinalpha 9 6 9 7 8 7 4 8 3 4 0 0 0.5525 1 
Proenkaphalin 7 7 3 4 7 7 1 8 3 3 0 1 0.2883 1 
Secretogranin 1 5 2 6 3 2 4 3 3 3 0 1 0.0013 0.0078 
Spyy 5 5 2 5 5 3 1 5 3 5 0 0 0.002 0.012 
Vip 3 3 3 4 3 2 1 3 3 1 0 1 0 0 
Vstn 4 4 3 3 5 4 3 4 1 2 0 0 0.0001 0.0006 
Zap 7 8 6 6 8 8 3 6 4 4 0 0 0.4358 1 
Control set                           





Supplementary Table 5.7 P-value table of motif groups.  
 
The row with bold-face values indicates the boundary of eleven AMP families that were significantly enriched in predicted 
NHR-binding motifs relative to the whole AMP family set. 
 

































137 420 139 440 440 0.023154572 1 21
135 400 139 440 440 0.000884858 0.389337708 20
132 380 139 440 440 0.000128334 0.056466838 19
128 360 139 440 440 5.62042E-05 0.024729858 18
123 340 139 440 440 5.99005E-05 0.026356217 17
118 320 139 440 440 4.74915E-05 0.020896267 16
113 300 139 440 440 3.08239E-05 0.013562527 15
108 280 139 440 440 1.69494E-05 0.00745775 14
103 260 139 440 440 7.94636E-06 0.0034964 13
98 240 139 440 440 3.14129E-06 0.001382167 12
92 220 139 440 440 2.81167E-06 0.001237134 11
85 200 139 440 440 5.55134E-06 0.002442591 10
78 180 139 440 440 9.01694E-06 0.003967454 9
71 160 139 440 440 1.22648E-05 0.005396502 8
64 140 139 440 440 1.39428E-05 0.006134828 7
56 120 139 440 440 3.3908E-05 0.014919519 6
48 100 139 440 440 6.8438E-05 0.030112705 5
40 80 139 440 440 0.000112308 0.049415705 4
31 60 139 440 440 0.000399135 0.175619353 3
22 40 139 440 440 0.001106333 0.486786677 2







Figures for Chapter 5 
 
Supplementary Figure 5.1. UPGMA tree for alpha-defensin promoter regions analyzed in this study  
The tree topology coincides with the exception of rat Defcr4 with the previously reported enteric (i.e. intestine) and 
myeloid/neutrophil cell expression of rat, mouse and human alpha-defensins. The cluster comprising Hosa-defa3, -defa4, Patr-defa4 
and Rano-Defa represents myeloid-specific alpha-defensins. Mumu-Defcr20, -Defcr2, Rano-Defcr4, Hosa-defa5 and Patr-defa5 
represent the enteric-expressed group of alpha-defensins. The species abbreviations are Mumu: Mus musculus; Hosa: Homo sapiens; 







Supplementary Tables and Figures for Chapter 6  
Supplementary Table 6.1 TFs that correspond to ab-initio predicted motifs derived from Penk family promoter regions.  
 
All motifs were detected in mouse, rat and human sequences. The underlined TF binding sites are known to bind TFs in the 
proenkephalin promoter region (Liu et al., 2000, Kobierski et al., 1999, Fu et al., 1997, Le et al., 2003). The species abbreviations are 
Hs: Homo sapiens; Mm: Mus musculus: Rn: Rattus norvegicus. Unknown: motif does not match any of the TRANSFAC-listed TF 






Species Motif TF name 
1 3 Mm,Hs,Rn CCAGTAACCTGCG FXR:RXR-alpha LXR-alpha:RXR-alpha LXR-beta:RXR-alpha ERRalpha1 
2 3 Mm,Hs,Rn TATAAAGTGGCTGT TFIID TBP 
3 3 Mm,Hs,Rn GATCTAAAGAAGAAA AR GR 
4 3 Mm,Hs,Rn CCAAGTCCGTC SF-1 GR 
5 3 Mm,Hs,Rn TTAAGATCCCCA NF-kappaB1 NF-kappaB2 NF-kappaB2 precursor AP-2alpha AP-2alphaA 
6 3 Mm,Hs,Rn GTGATDCAGGA AP-1 c-Fos c-Jun JunD  
7 3 Mm,Hs,Rn TCCAGVAAGDH c-Ets-1 Elk-1 SAP-1a SAP-1b SRF PEA3 ELF-1 
8 3 Mm,Hs,Rn CAGGCGTCGGCGCG DREB1A ZF5 E2F 
9 3 Mm,Hs,Rn CGATTGGGGCGCGC NFI/CTF CTF NF-Y  
10 3 Mm,Hs,Rn CCAGAVAGGCAG UBP-1 GATA-1 GATA-3 Meis-1a Meis-1b GATA-4 RXR-beta VDR MOT3 
11 3 Mm,Hs,Rn CCGGGTCCTA Unknown 
12 3 Mm,Hs,Rn AGCCCGTGBC USF-1 USF1 USF2 USF2b USF HMBP EmBP-1a 
13 3 Mm,Hs,Rn GTGACTTTGCCCCA 
DSF GCN4 COUP-TF1 RAR-beta RXR-alpha RAR-alpha1 TLX Pax-2.1  
Pax-2.2 IRF-4 IRF-8 AP-2alpha AP-2alphaA C/EBPgamma PPAR-gamma:RXR-alpha 
VDR LXR-alpha:RXR-alpha 
14 3 Mm,Hs,Rn GATCTGTBTT Sox2 Meis-1a Meis-1b GR 
15 3 Mm,Hs,Rn TGAAATTTGG Unknown 
16 3 Mm,Hs,Rn GCTGTGGGGACGTCC 
AML1 AML1a AML1c MZF1 MIG1 MZF-1 AP-2alpha AP-2alphaA MBP-1 (1) NF-
kappaB1 NF-kappaB2 NF-kappaB2 precursor 
17 3 Mm,Hs,Rn BHHCAAGAGGA Unknown 
18 3 Mm,Hs,Rn GGAAGGGGCAG VDR LXR-alpha:RXR-alpha CAC-binding protein NF-E2 PPAR-gamma:RXR-alpha Sp1 
19 3 Mm,Hs,Rn AHGCCCCAACC 
Sp1 PPAR-gamma:RXR-alpha VDR LXR-alpha:RXR-alpha AP-2alphaA ADR1 
C/EBPalpha C/EBPbeta 





Supplementary Table 6.2   TF binding sites that correspond to ab-initio-predicted motifs derived from Zap family promoter 
regions.  
 
The species abbreviations are Hs: Homo sapiens, Mm: Mus musculus, Rn: Rattus norvegicus. Unknown: motif does not match any of 





Species Motif TF binding sites 
 





2 3 Mm,Hs, Rn TCACCGCACT ER-alpha,ABI4,AML1a 
3 3 Mm,Hs, Rn CTGGGGGGCCC MIG1,Sp1,ZAC-1a 
4 3 Mm,Hs, Rn AAGCAGTTGGT c-Myb,c-Myc,E47,NeuroD,NEUROD,E12,MyoD,MyoD:E12,myogenin,Myogenin:E12,Dec-02,c-Myb:HES-1 





6 3 Mm,Hs, Rn CATGACCCTGGAG RXR-gamma,CAR:RXR-alpha,Nkx2-1 
7 3 Mm,Hs, Rn ACTCTAAGGTAT Unknown 
8 3 Mm,Hs, Rn ATTCGCTCTCCC LyF-1,RXR-beta,VDR 
9 3 Mm,Hs, Rn GGTTTACCTT CAR:RXR-alpha,LXR-alpha:RXR-alpha,SXR,RAR-beta,RAR-gamma,RXR-alpha,RAR-alpha1,ER-alpha 
10 3 Mm,Hs, Rn GAGCGGCACC Unknown 
11 3 Mm,Hs, Rn AATATCCAAG NF-1,TGGCA-binding protein 
12 3 Mm,Hs, Rn AGCAGCATCA Unknown 
13 3 Mm,Hs, Rn GAGAGTAACAA GATA-6,GCN4,PR B 
14 3 Mm,Hs, Rn AATAGGACTT GR 
15 3 Mm,Hs, Rn CGGATTTGAGGACGC Unknown 
16 3 Mm,Hs, Rn AAAATCATCTT Otx2,GATA-3 
17 3 Mm, Rn TAAGTTTCGATTCT Unknown 
18 3 Mm,Hs, Rn GGAGTCTGGAGG Nkx2-1 
19 3 Mm, Rn GAGTTGGAAAGCGA NF-AT1,NF-1,Ftz 






Supplementary Tables and Figures for Chapter 7  
 
 




names Refseq Id Species Sensitivity Specificity 
            
alpha defensin 1 DEFA1 NM_004084 Hs 100 
  DEFA3 NM_005217 Hs 100 
  MNP1A NM_001032862 Mmu 100 
          
5/5+6 
  
        Average(100%) 45.4% 
            
alpha defensin 5 DEFA5 NM_021010 Hs 100 
  Defcr2 U03028 Mm 100 
  Defcr3 NM_007850 Mm 100 3/3+0 
            
        Average (100%) 100% 
            
 












Supplementary Table 7.2: Statistical significance of predicted genes from promoter model scan  
 
The null hypothesis tested is that proportions A=k/n and B=K/N of genes are the same. The Bonferroni corrected p-value indicates 
that these two proportions are very different and implies that predictions of genes that are co-expressed by DEFA5 based on promoter 
model is very good (A >> B). 
 
    AMP model     
DEFA1 Parameters Values 
Total no. of promoters scanned N 10255 
Total no. genes predicted K 104 
Total no. of coexpressed genes that are present in the 
promoter dataset n 51 
Total no. of genes that matched coexpressed genes k 17 
  bonferroni correction factor 10255 
   
P_value = 3.62347894569854e-022,  
corrected P_value = 3.71587765881385e-018 
      
DEFA5     
Total no. of promoters scanned N 10255 
Total no. genes predicted K 240 
Total no. of coexpressed genes that are present in the 
promoter dataset n 226 
Total no. of genes that matched coexpressed genes k 177 
  bonferroni correction factor 10255 
   













Supplementary Table 7.3a: DEFA5 predicted genes that matched co-expression data 
     
H-inv Ids: Unique gene identifier from H-Invitational  database 
 
 
H-inv IDs Gene Names Gene Description Tissue Pathway 
HIT000036029 SNAI1 SimilartoEscargot/snail protein homolog(Fragment),partial cds.  Testis, embryonal carcinoma Adherens junction 
HIT000036885 SLUG SimilartoSlugprotein,complete cds.  Uterus, leiomyosarcoma Adherens junction 
HIT000039321 TAF11 TBP-associatedfactor11;TAF11 RNApolymeraseII,TATAbox  Lung, small cell carcinoma Basal transcription factors 
HIT000031115 HER3 SimilartoReceptorprotein-tyrosinekinaseerbB-3 precursor(EC  Placenta, choriocarcinoma Calcium signaling pathway 
HIT000032887 CCNB G2/mitotic-specificcyclinB1,partial cds.  Placenta, choriocarcinoma 
Calcium signaling pathway,Cell 
cycle 
HIT000036690 CLDN2 PMP-22/EMP/MP20andclaudinfamilyprotein, complete cds.  Colon, adenocarcinoma 




Phosphatidylinositolglycan class T precursor (Homosapiens) 
 
  Skin, melanotic melanoma. 
Glycosylphosphatidylinositol(G
PI)-anchor biosynthesis 














Mitogen-activated protein kinase kinase1i nteracting protein1; 
  bone marrow MAPK signaling pathway 
HIT000011725 WBSCR17 Similar to Williams-Beurensyndromecritical region gene17,  Brain O-Glycan biosynthesis 
HIT000036299 GFAP Glialfibrillary acidic protein(Homosapiens),completecds. 










X6 Peroxiredoxin 6;antioxidantprotein2;non-seleniumglutathione  Brain 









HIT000036745 SPC18 Microsomal signalpeptidase 18kDasubunit   Colon, adenocarcinoma Protein export 
HIT000038280 TXNRD1 Similar to thioredoxinreductase1; KM-102-derivedreductase-like  Lung, large cell carcinoma Pyrimidine metabolism 
HIT000032334 PRIM1 DNA primases mallsubunit  




HIT000031313 UGP2 SimilartoUTP--glucose-1-phosphateuridylyl transferase2  Lymph, Burkitt lymphoma 





HIT000029290 NUDT5 NudixhydrolaseNUDT5,partial cds.  Placenta, choriocarcinoma 
Starch and sucrose 
metabolism,Purine 
metabolism,Folate biosynthesis
HIT000036950 MID1 Similar to DNA-3-methyladenine glycosylase (EC3.2.2.21)  Pancreas, epithelioid carcinoma Tryptophan metabolism 
HIT000038917 AUH AU-bindingprotein/enoyl-CoAhydratase,complete cds.  Testis, embryonal carcinoma 
Valine, leucine and isoleucine 
degradation 
HIT000031341 NMP238 RuvB-like1 (EC3.6.1.-) (49-kDa TATAbox-binding)  Lung, small cell carcinoma Wnt signaling pathway 
HIT000001945 B5R1 Cytochromeb5reductase1,partial cds.  adrenal gland   
HIT000001890 HSPA14 Similar to Circadian OSCILLATORREGULATOR   adrenal gland   
HIT000002063 BC040106 Conservedhypotheticalprotein,completecds.  Blood   
HIT000042336 
KIAA0198,PLA
GL2 Similar toPLAGL2 (Pleiomorphicadenomagene-like2),partialcds.  bone marrow   
HIT000040748 H3F3A HistoneH3familyprotein,complete cds. 
 Bone marrow, acute myelogenous 
leukemia   




Similar to Tripartitemotifprotein2 (Neuralactivity-related) 
  Brain   
HIT000000363 KIAA0638, Pleckstrin-likedomaincontainingprotein,complete cds.  Brain   
HIT000001102 KIAA1387, EVH1domaincontainingprotein,complete cds.  Brain   






A1745 Semaphorin4Bprecursor,complete cds.  Brain   
HIT000025239 
DKFZp564L023
,UBQLN1 ubiquilin1 isoform1(Homosapiens),completecds.  Brain   
HIT000042245 
KIAA0091,KIA
A0091 Membrane-boundtranscriptionfactorsite-1protease precursor   Brain   
HIT000042312 
KIAA0175,PK3
8 Similar to Proteinkinase PK38(Maternal embryonic leucinezipper)  Brain   
HIT000011833 LOC148137 Conserved hypothetical protein,partialcds.  Brain   
HIT000011902 BX647638 Zn-finger,C2H2 type domain containing protein,partial cds.  Brain   
HIT000012048 AF454939 Conserved hypothetica lprotein,complete cds.  Brain   
HIT000015894 FLJ33708 Hypothetical protein,complete cds.  Brain   
HIT000021463 KBTBD6 BTB/POZ domaincontainingprotein,partial cds.  Brain   
HIT000021509 RCBTB1 Regulatorofchromosomecondensation,RCC1 family protein,  Brain   
HIT000040515 RDH1 11-cis retinoldehydrogenase(EC1.1.1.105)(11-cisRDH),complete 
 Brain, anaplastic oligodendroglioma 
with 1p/19q loss   
HIT000035181 MGC17330 Kringledomaincontainingprotein,complete cds. 
 Brain, anaplastic oligodendroglioma 
with 1p/19q loss   
HIT000041611 GALT4 Beta-1,3-galactosyltransferase4 (EC2.4.1.62)(Beta-1,3-GalTase  Brain, fetal, whole pooled   
HIT000037657 TMSB10 thymosin, beta10(Homosapiens),completecds.  Brain, glioblastoma   
HIT000039547 LAG1 Similar to Longevity assurance homolog1(UOG-1protein)(LAG1)  Brain, hypothalamus   
HIT000041220 CDH14 Cadherin-18 precursor (Cadherin-14),complete cds.  Brain, hypothalamus   
HIT000039784 MKI67IP Nucleolar protein interacting with the FHAdomain of pKi-67  Brain, hypothalamus   
HIT000030877 BGN Biglycan precursor (Bone/cartilageproteoglycanI)(PG-S1),  Brain, neuroblastoma   
HIT000031004 CLG4A 72kDa typeIV collagenase precursor(EC3.4.24.24)  Brain, neuroblastoma   
HIT000033725 SPIN1 General substrate ransporter family protein,partial cds.  Brain, neuroblastoma   
HIT000033832 ATPAF1 ATP synthasemitochondrialF1complexassemblyfactor1;homolog  Brain, primitive neuroectodermal   
HIT000038173 RPP40 ribonucleaseP1;ribonucleaseP(40kD);ribonucleaseP,40kD  Brain, primitive neuroectodermal   
HIT000031528 TRX1 Thioredoxin(ATL-derivedfactor)(ADF)(Surfaceassociated  Cervix, carcinoma   
HIT000033663 BK215D111 RNA-bindingproteinregulatorysubunit,completecds.  Cervix, carcinoma   
HIT000034876 GT197 Beclin1(Coiled-coilmyosin-likeBCL2-interactingprotein)  Cervix, carcinoma   
HIT000038327 UCC1 Mammalianependyminrelatedprotein-1precursor(MERP-1)(UCC1  Cervix, carcinoma   
HIT000035576 FLJ20605 MOSCN-terminalbetabarreldomaincontainingprotein,complete  Cervix, carcinoma   
HIT000040926 7h3 RhoGAPdomaincontainingprotein,completecds.  Cervix, carcinoma   




HIT000008584 FLJ21657 Conservedhypotheticalprotein,completecds.  Colon   
HIT000032907 HOX1G HomeoboxproteinHox-A9(Hox-1G),partialcds.  Colon, adenocarcinoma   
HIT000037949 APOL1 apolipoproteinL1isoformaprecursor;apolipoproteinL;  Colon, adenocarcinoma   
HIT000039048 SLC17A5 solutecarrierfamily17(anion/sugartransporter),member5;  Colon, adenocarcinoma   
HIT000041727 FABPL Fattyacid-bindingprotein,liver(L-FABP),partialcds. 
 Colon, Kidney, Stomach, adult, whole 
pooled   
HIT000020679 C9orf150 Conservedhypotheticalprotein,completecds.  Heart   
HIT000027595 AL832683 Hypotheticalprotein,completecds.  human adipose   
HIT000027097 AL832185 Questionabletranscript,completesequence.  human cervix   
HIT000028510 DTX1 SimilartoDELTEX1,completecds.  human endometrium carcinoma cell line   
HIT000028526 SPATS2 Conservedhypotheticalprotein,completecds.  human endometrium carcinoma cell line   
HIT000009540 AK026266 C2domaincontainingprotein,partialcds.  human small intestine   
HIT000010243 HRPT2 RNApolIIaccessoryfactor,Cdc73familyprotein,partialcds.  human small intestine   
HIT000010276 DDX31 SimilartoRNAhelicase(Fragment),partialcds.  human small intestine   
HIT000002335 ARP11 Actin-relatedprotein10(hARP11),completecds.  Hypothalamus   
HIT000002429 CR612307 Conservedhypotheticalprotein,completecds.  Hypothalamus   
HIT000003106 PAK1IP1 PAK1interactingprotein1;PAK1-interactingprotein;  ileal mucosa   
HIT000002946 AK000471 Hypotheticalprotein,completecds.  ileal mucosa   
HIT000012430 PODXL podocalyxin-likeprecursor;podocalyxin(Homosapiens),partial  Kidney   
HIT000016815 LTB4DH 
SimilartoNADP-dependentleukotrieneB412-
hydroxydehydrogenase  Kidney   
HIT000025305 
DKFZp566N20
24,NESH NESHprotein;newmoleculeincludingSH3(Homosapiens),partial  Kidney   
HIT000035749 MAP17 17kDamembraneassociatedprotein(DD96protein),completecds.  Kidney, hypernephroma   
HIT000037427 MRPS36 Conservedhypotheticalprotein,completecds.  Kidney, hypernephroma   
HIT000032241 ISOT Ubiquitincarboxyl-terminalhydrolase5(EC3.1.2.15)(Ubiquitin  Kidney, renal cell adenocarcinoma   
HIT000038939 HST Alcoholsulfotransferase(EC2.8.2.2)(Hydroxysteroid  Liver   
HIT000020824 HSS N-sulphoglucosaminesulphohydrolaseprecursor(EC3.10.1.1)  Lung   
HIT000020830 TYRO10 Discoidindomainreceptor2precursor(EC2.7.1.112)(Receptor  Lung   
HIT000034497 ATPIF1 MitochondrialATPaseinhibitor,IATPfamilyprotein,completecds.  Lung, large cell carcinoma   
HIT000040234 TRIM38 Zn-finger,RINGdomaincontainingprotein,completecds.  Lung, large cell carcinoma   
HIT000037644 HSPC117 ProteinofunknownfunctionUPF0027familyprotein,completecds.  Lung, mucoepidermoid carcinoma   




HIT000029675 DRG2 DevelopmentallyregulatedGTP-bindingprotein2(DRG2),partial  Lung, small cell carcinoma   
HIT000030859 HO2 Hemeoxygenase2(EC1.14.99.3)(HO-2),completecds.  Lung, small cell carcinoma   
HIT000032455 NEC2 Neuroendocrineconvertase2precursor(EC3.4.21.94)(NEC2)(PC2)  Lung, small cell carcinoma   
HIT000034802 TALDOR Transaldolase(EC2.2.1.2),partialcds.  Lung, small cell carcinoma   
HIT000029571 ILF2 NF45protein,completecds.  Lung, small cell carcinoma   
HIT000031956 BC051849 Conservedhypotheticalprotein,completecds.  Lung, small cell carcinoma   
HIT000033592 MRPS2 RibosomalproteinS2,bacterialandorganelleformfamilyprotein,  Lung, small cell carcinoma   
HIT000037835 FLJ20013 2OG-Fe(II)oxygenasesuperfamilyprotein,completecds.  Lung, small cell carcinoma   
HIT000039948 NAALAD1 GlutamatecarboxypeptidaseII(EC3.4.17.21)(Membraneglutamate  Lung, Spleen, fetal, pooled   
HIT000039962 GRID GRB2-relatedadaptorprotein2(GADSprotein)(Growthfactor  Lung, Spleen, fetal, pooled   
HIT000027727 TMEM30A EukaryoticproteinofunknownfunctionDUF284familyprotein,  lymph node   
HIT000033379 SAP114 Splicingfactor3subunit1(Spliceosomeassociatedprotein114)  Lymph, Burkitt lymphoma   
HIT000036615 RF1 Eukaryoticpeptidechainreleasefactorsubunit1(eRF1)  Lymph, Burkitt lymphoma   
HIT000031846 AY736034 Cyclin-likeF-boxdomaincontainingprotein,completecds.  Lymph, Burkitt lymphoma   
HIT000040146 SATT NeutralaminoacidtransporterA(SATT)(Alanine/serine/cysteine/  Lymph, lymphoma   
HIT000032665 AP2B1 adaptor-relatedproteincomplex2,beta1subunit;adaptin,beta2  Muscle, rhabdomyosarcoma   
HIT000033210 TOMM34 MitochondrialimportreceptorsubunitTOM34(Translocaseofouter  Muscle, rhabdomyosarcoma   
HIT000034687 STX6 Syntaxin6,completecds.  Muscle, rhabdomyosarcoma   
HIT000031771 NAT9 GCN5-relatedN-acetyltransferasedomaincontainingprotein,  Muscle, rhabdomyosarcoma   
HIT000003861 TMEM33 ProteinofunknownfunctionUPF0121familyprotein,completecds.  ovarian cancer   
HIT000003917 RNMTL1 tRNA/rRNAmethyltransferase(SpoU)familyprotein,completecds.  ovarian cancer   
HIT000030149 NIFIE14 SimilartoSeventransmembranedomainprotein,completecds.  Ovary, adenocarcinoma   
HIT000031192 CKLFSF6 chemokine-likefactorsuperfamily6(Homosapiens),completecds.  Ovary, adenocarcinoma   
HIT000034621 MRPL4 mitochondrialribosomalproteinL4isoforma(Homosapiens),  Ovary, adenocarcinoma   
HIT000032704 BRMS1L Conservedhypotheticalprotein,completecds.  Ovary, adenocarcinoma   
HIT000006074 SCAND2 SimilartoSCANdomain-containingprotein2isoform2;SCAN  ovary, tumor tissue   
HIT000010815 MSTP028    ovary, tumor tissue   
HIT000039978 OSR1 odd-skippedrelated1;odz(oddOz/ten-m)related1(Homo  Pancreas, Spleen, adult pooled   
HIT000040025 G10P1 SimilartoInterferon-inducedproteinwithtetratricopeptide  Pancreas, Spleen, adult pooled   
HIT000004408 
2410046H15RI
K SimilartoVitaminDreceptor-interactingproteincomplex  Placenta   
HIT000004626 STAU2 SimilartoDouble-strandedRNA-bindingproteinStaufen2long  Placenta   




HIT000030438 COX4AL NeighborofCOX4,completecds.  Placenta, choriocarcinoma   
HIT000032034 DIA1 NADH-cytochromeb5reductase(EC1.6.2.2)(B5R),partialcds.  Placenta, choriocarcinoma   
HIT000037948 HRBL HIV-1Revbindingprotein-like;Rev/Rexactivationdomainbinding  Placenta, choriocarcinoma   
HIT000038651 TIN2 TERF1-interactingnuclearfactor2(TRF1-interactingnuclear  Placenta, choriocarcinoma   
HIT000038816 CTRP6 Complement-c1qtumornecrosisfactor-relatedprotein6precursor,  Placenta, choriocarcinoma   
HIT000030311 MGC5509 Conservedhypotheticalprotein,completecds.  Placenta, choriocarcinoma   
HIT000036138 C2orf30 Conservedhypotheticalprotein,partialcds.  Placenta, choriocarcinoma   
HIT000036609 TTF Rho-relatedGTP-bindingproteinRhoH(GTP-bindingproteinTTF),  Primary B-Cells from Tonsils   
HIT000038424 DHLAG HLAclassIIhistocompatibilityantigen,gammachain(HLA-DR  Primary B-Cells from Tonsils   
HIT000033818 BAP29 SimilartoB-cellreceptor-associatedprotein29(BCR-associated  Prostate   
HIT000034389 AIF1 SimilartoAllograftinflammatoryfactor-1(AIF-1)(Daintain),  Prostate   
HIT000035173 F3 Tissuefactorprecursor(TF)(CoagulationfactorIII)  Prostate, adenocarcinoma.   
HIT000041853 MBD1 methyl-CpGbindingdomainprotein1isoform3(Homosapiens),  Prostate, carcinoma   
HIT000017568 SAP61 SimilartoSplicingfactor3Asubunit3(Spliceosomeassociated  skeletal muscle   
HIT000033787 C20orf114 Lipid-bindingserumglycoproteinfamilyprotein,completecds.  Skeletal Muscle   
HIT000038179 MRPL46 Conservedhypotheticalprotein,completecds.  Skeletal Muscle   
HIT000035898 MOV34L 26Sproteasomenon-ATPaseregulatorysubunit7(26Sproteasome  Skin, melanotic melanoma, high MDR.   
HIT000039106 IFI30 interferon,gamma-inducibleprotein30preproprotein;  Skin, melanotic melanoma, high MDR.   
HIT000031594 TGT Ubiquitincarboxyl-terminalhydrolase14(EC3.1.2.15)(Ubiquitin  Skin, melanotic melanoma.   
HIT000031679 LGALS4 Galectin-4(Lactose-bindinglectin4)(L-36lactosebinding  Skin, melanotic melanoma.   
HIT000032173 TSSC3 tumorsuppressingsubtransferablecandidate3;imprintedin  Skin, melanotic melanoma.   
HIT000034611 ARFL3 ADP-ribosylationfactor-likeprotein3,partialcds.  Skin, melanotic melanoma.   
HIT000034822 D17WSU104E SimilartoDNAsegment,Chr17,WaynestateUniversity104,  Skin, melanotic melanoma.   
HIT000035389 COL9A3 Collagenalpha3(IX)chainprecursor,partialcds.  Skin, melanotic melanoma.   
HIT000036085 RPMS13 
28SribosomalproteinS26,mitochondrialprecursor(MRP-
S26)(MRP-  Skin, melanotic melanoma.   
HIT000031571 TBC1D17 RabGAP/TBCdomaincontainingprotein,completecds.  Skin, melanotic melanoma.   
HIT000021780 AK096925 Questionabletranscript.  small intestine   
HIT000021855 MTMR11 Conservedhypotheticalprotein,partialcds.  small intestine   
HIT000015332 
FLJ00386,CTG7
A Positivecofactor2glutamine/Q-rich-associatedprotein(PC2  Spleen   
HIT000028634 MSZF13 SimilartoMszf13(Fragment),completecds.  Stomach   




HIT000018125 SOC socius(Homosapiens),completecds.  Testis   
HIT000025493 
DKFZp434E248
, GTP-bindingprotein,HSR1-relatedfamilyprotein,completecds.  Testis   
HIT000026715 
DKFZp434C212
0,KIAA1667 Hermansky-Pudlaksyndrome4protein(Light-earproteinhomolog),  Testis   
HIT000038574 LABH2 Abhydrolasedomaincontainingprotein2(ProteinPHPS1-2),  Testis   
HIT000040591 BC093018 Conservedhypotheticalprotein,partialcds.  Testis   
HIT000035842 HDHD1A Haloaciddehalogenase-likehydrolasefamilyprotein,partialcds.  Testis, embryonal carcinoma   
HIT000038990 CCDC12 Conservedhypotheticalprotein,completecds.  Testis, embryonal carcinoma   
HIT000013018 FLJ31842 
TRAM,LAG1andCLN8homologydomaincontainingprotein,compl
ete  Tongue   
HIT000002015 LOC51255 SimilartoGenomicDNA,chromosome3,P1clone MSJ3,  umbilical cord blood   
HIT000031071 CEV14 SimilartoThyroidreceptorinteractingprotein11(TRIP-11)  Uterus, endometrium adenocarcinoma   
HIT000031086 DDX49 DEAD/DEAHboxhelicasedomaincontainingprotein,partialcds.  Uterus, endometrium adenocarcinoma   
HIT000031778 RNUT1 SNURPORTIN1(RNA,Utransporter1),completecds.  Uterus, endometrium adenocarcinoma   
HIT000035511 LOC113444 Conservedhypotheticalprotein,completecds.  Uterus, endometrium adenocarcinoma   
HIT000034247 GM2A GangliosideGM2activatorprecursor(GM2-AP)(Cerebrosidesulfate  Uterus, leiomyosarcoma   
HIT000034834 SCAM1 SimilartoVinexin(SH3-containingadaptormolecule-1)(SCAM-1),  Uterus, leiomyosarcoma   
HIT000037450 TCF3G Hepatocytenuclearfactor3-gamma(HNF-3G)(Forkheadboxprotein  Uterus, leiomyosarcoma   
HIT000038271 PIM2 Serine/threonine-proteinkinasePim-2(EC2.7.1.37)(Pim-2h),  Uterus, leiomyosarcoma   
HIT000033497 DENR Density-regulatedproteinDRP1familyprotein,completecds.  Uterus, leiomyosarcoma   
HIT000035667 CBX6 Chromodomaincontainingprotein,completecds.  Uterus, leiomyosarcoma   
HIT000010634 D-UBP-64E SimilartoUbiquitincarboxyl-terminalhydrolase64E(EC3.1.2.15)  whole embryo, mainly body   
HIT000007420 TMEM35 Conservedhypotheticalprotein,completecds.  whole embryo, mainly body   
HIT000003470 DERP7 Dermalpapilladerivedprotein7,completecds.  whole embryo, mainly head   













Supplementary Table 7.3b: DEFA5 predicted genes that did not match co-expression data 
  
H-inv IDs Gene Names Gene Description Tissue Pathway 
HIT000002506 FAM45A Conservedhypotheticalprotein,completecds.  adipose tissue   
HIT000001878 C9orf32 
EukaryoticproteinofunknownfunctionDUF858familyprotein
,  adrenal gland   
HIT000036637 MRPL20 RibosomalproteinL20familyprotein,completecds.  Bone marrow, acute myelogenous leukemia   
HIT000033794 TM4SF1 
transmembrane4superfamilymember1;membranecomponen
t,  Bone marrow, chronic myelogenous leukemia   





3B;  Brain   
HIT000021327 TENC1 Hypotheticalprotein,completecds.  Brain   
HIT000040002 FLJ10560 
Cyclase-
associatedproteindomaincontainingprotein,completecds.  Brain, adult, 6 pooled whole brains   
HIT000035185 LRRN6A Cysteine-richflankingregion,N-terminaldomaincontaining 
 Brain, anaplastic oligodendroglioma with 
1p/19q loss   




HIT000036260 TRIM9 Zn-finger,RINGdomaincontainingprotein,completecds.  Brain, neuroblastoma   
HIT000038709 
CG13951/CG88
03 SimilartoLethal(2)k10201protein(WunenregionBprotein),  Cervix, carcinoma   
HIT000007959 SCD5 SimilartoAcyl-CoA-desaturase,partialcds.  Colon   
HIT000040664 PDZK2 
natrium-phosphatecotransporterIIaC-terminal-
associatedprotein  Colon, Kidney, Stomach, adult, whole pooled   
HIT000019739 RASSF4 SimilartoRasandRabinteractor2(Rasinteraction/interference  corpus callosum   
HIT000021028   Conservedhypotheticalprotein,completecds.  Esophagus   
HIT000008909 SPBC15D416 SimilartoCellcyclecontrolproteincwf22,partialcds.  human small intestine   
HIT000002750 KIAA1125 ProteinkinaseCbindingprotein1(Rack7)(CutaneousT-cell  ileal mucosa   
HIT000002981 ZMYND13 
SimilartoAnkyrinrepeatandMYNDdomaincontainingprotein




HIT000002897   Non-protein-codingtranscript,completesequence.  ileal mucosa   
HIT000002952   Hypotheticalprotein,completecds.  ileal mucosa   
HIT000032347 EPM2A 
Similartoepilepsy,progressivemyoclonustype2A,Laforadise
ase  Kidney, hypernephroma   
HIT000029867 NANH Sialidase1precursor(EC3.2.1.18)(Lysosomalsialidase)  Kidney, renal cell adenocarcinoma   
HIT000036261 H2AFX H2Ahistonefamily,memberX;H2AXhistone(Homosapiens),  Lung, small cell carcinoma   








nit  Lung, small cell carcinoma Proteasome 
HIT000005469 FAM26B Conservedhypotheticalprotein,completecds.  Mammary gland   
HIT000001825   Ubiquitouslyexpressedtranscriptfamilyprotein,completecds.  normal pituitary   




622L5.3 novel protein, similar to AASL548  Ovary, adenocarcinoma   
HIT000035989 TREB5 
Xboxbindingprotein-1(XBP-
1)(TREB5protein),completecds.  Ovary, adenocarcinoma   
HIT000006270 ACTR8 Actin-relatedprotein8,completecds.  ovary, tumor tissue   
HIT000005768 RAB3GAP1 Conservedhypotheticalprotein,partialcds.  ovary, tumor tissue   
HIT000006553 VPS11 Vacuolarproteinsorting11(hVPS11)(PP3476),completecds.  ovary, tumor tissue   
HIT000010702 ZDHHC12 
Zn-
finger,DHHCtypedomaincontainingprotein,completecds.  ovary, tumor tissue   
HIT000006231 ZNF447 Zn-finger,C2H2typedomaincontainingprotein,completecds.  ovary, tumor tissue   
HIT000001936 ARBP SimilartoBrainprotein44-likeprotein(Apoptosis-regulating  Pituitary   
HIT000001783 RPS27L ribosomalproteinS27-likeprotein;40SribosomalproteinS27  Pituitary Ribosome 
HIT000017381 AOC1 
Amiloride-sensitiveamineoxidase(copper-






















HIT000013380 VIM SimilartoVimentin,partialcds.  Placenta   
HIT000017327   Non-protein-codingtranscript,completesequence.  Placenta   
HIT000030493 ELE1 
Nuclearreceptorcoactivator4(NCoA-
4)(70kDaandrogenreceptor  Placenta, choriocarcinoma   
HIT000032951 RBM3 RNA-bindingregionRNP-1(RNArecognitionmotif)domain  Placenta, choriocarcinoma   
HIT000029861 SERS 
Seryl-tRNAsynthetase(EC6.1.1.11)(Serine--
tRNAligase)(SerRS),  Placenta, choriocarcinoma   
HIT000032280 ALEX3 ALEX3protein;armproteinlostinepithelialcancers,X  Skin, melanotic melanoma, high MDR.   
HIT000036559 ADPRHL2 ADP-ribosylglycohydrolasefamilyprotein,completecds.  Skin, melanotic melanoma.   
HIT000032646 
OBFC2B,MGC2
731 Conservedhypotheticalprotein,completecds.  Skin, melanotic melanoma.   
HIT000036906 PCCX1 
CpGbindingprotein(ProteincontainingPHDfingerandCXXC
domain  Skin, melanotic melanoma.   
HIT000035319 TFIP11 tuftelininteractingprotein11(Homosapiens),completecds.  Skin, melanotic melanoma.   
HIT000013648 MXD3 
SimilartoMAXdimerizationprotein3(Homosapiens),complet
ecds.  small intestine   
HIT000014896 
FLJ00187,MSZF
13 SimilartoMszf13(Fragment),completecds.  Spleen   
HIT000014696   G-proteinbetaWD-40repeatcontainingprotein,partialcds.  Testis   
HIT000022539   Hypotheticalprotein,completecds.  Testis   
HIT000007189 DAK Dakkinasedomaincontainingprotein,completecds.  thyroid gland   
HIT000012628 NDEL1 nudEnucleardistributiongeneEhomologlike1(A.nidulans);  Tongue   
HIT000012948 USP39 
SimilartoU4/U6.U5tri-snRNP-




HIT000012839   Ankyrinrepeatcontainingprotein,completecds.  Tongue   
HIT000017137   Conservedhypotheticalprotein,partialcds.  Tongue   





e  Uterus, leiomyosarcoma   
HIT000039050 YWHAG 14-3-3proteingamma(ProteinkinaseCinhibitorprotein-1)  Uterus, leiomyosarcoma Cell cycle 
HIT000004823   Hypotheticalprotein,completecds.  whole embryo, mainly head   





























Supplementary Table 7.4a DEFA1 predicted genes that matched co-expression data 
 
H-inv ID Gene symbol Gene Description Pathway Tissue origin 
HIT000035146 CCND2 
G1/S-specific cyclin D2, 
partial cds. 
hsa04110 Cell cycle, hsa04310 
Wnt signaling pathway, hsa04510 
Focal adhesion,hsa04630 Jak 






Similar to Mszf68 
(Fragment), partial cds. 
   Brain 
HIT000037044 MIZ1, PIAS2 
 
Protein inhibitor of 
activated STAT X isoform 
alpha  







hsa00271 Methionine metabolism,  
hsa00450 Selenoamino acid 
metabolism,  
hsa00970 Aminoacyl-tRNA 





protein, complete cds. 
   Colon ,adenocarcinoma 
HIT000030627 MEA1, MEA 
 
Male-enhanced antigen-1 
(Mea-1), complete cds. 




complex, subunit 2; 
NOT2 (negative) 











hsa00040 Pentose and glucuronate 
interconversions 
hsa00150 Androgen and estrogen 
metabolism,  
hsa00500 Starch and sucrose 
metabolism, hsa00860 Porphyrin 




containing protein, partial 
hsa00500 Starch and sucrose 
metabolism,  
hsa00790 Folate biosynthesis Lung,smallcellcarcinoma 
HIT000033214 ARB2, ARRB2 
Beta-arrestin 2 (Arrestin, 
beta 2), partial cds. MAPK signalling Muscle,rhabdomyosarcoma 
HIT000032247 FKBP12, FKBP1A 
FK506-binding protein 
1A (EC 5.2.1.8)  mTOR signalling pathway Placenta,choriocarcinoma 
HIT000030153 TMED9 
Emp24/gp25L/p24 family 
protein, complete cds.   Skin,melanoticmelanoma. 
HIT000030145 Y2, PSMB8 
Similar to Proteasome 
subunit beta type 8 
precursor (EC 3.4.25.1)   Skin,melanoticmelanoma. 
HIT000030885   
Caspase-1 precursor, p45 
family protein, complete 
cds.   Skin,melanoticmelanoma. 
HIT000038574 LABH2, ABHD2 
Abhydrolase domain 
containing protein 2 
(Protein PHPS1-2),   Testis 
HIT000037134 MARCH5 
Zn-finger, RING domain 
containing protein, 
complete cds.   Uterus,leiomyosarcoma 
HIT000032576 RSU 
Ras protein 1 (Rsu-1) 













Supplementary Table 7.4b: Gene hits from DEFA1 promoter model scan that did not match co-expressed gene data for  
    DEFA1, DEFA3 
 
H-inv ID Gene name Gene Description Pathway 1..1.1.1.2 Tissue 
HIT000014970 SSB3 
SPRY domain-containing SOCS box protein 
SSB-3 (Homo sapiens)   adiposetissue 
HIT000041181 NA 
Pleckstrin putative G-protein interacting domain 





HECW1 NEDD4-like ubiquitin ligase 1, complete cds.   brain 
HIT000000210 KIAA0494, 
Calcium-binding EF-hand domain containing 
protein, complete cds.   brain 
HIT000000384 KIAA0659, C11orf11 Lipase, class 3 family protein, partial cds.   brain 
HIT000025067 DKFZp564C047, STAM2 






HIT000040216 NA Chaperonin Cpn60   Brain, hippocampus 
HIT000029388 NICE-3, C1orf43 NICE-3 protein (Homo sapiens), complete cds.   Cervix, carcinoma 
HIT000008039 PSARL 
Rhomboid-like protein family protein, complete 
cds.   colon 
HIT000030636 CASM,LSM1 
U6 snRNA-associated Sm-like protein LSm1 
(Small nuclear   Eye,retinoblastoma 
DKFZp686K0367, Kaiso (Homo sapiens), complete cds.   




Prolyl 4-hydroxylase, alpha subunit family 
protein, complete cds.   humansmallintestine 

























CTD-binding SR-like protein RA4 (Fragment). 
Splice isoform 2,   
HIT000029034 SFRS15   melanoma(MeWocellline) 
HIT000003713 RBM28 
RNA-binding region RNP-1 (RNA recognition 
motif) domain   ovariancancer 
HIT000004151 NA 
Amino acid/polyamine transporter, family II 
protein, complete cds.   ovariancancer 
HIT000004194 FLJ10858,NEIL3 
DNA glycosylase hFPG2 (Homo sapiens), 
complete cds.   ovariancancer 
HIT000037144 EDF1,NA 
endothelial differentiation-related factor 1 
isoform alpha;   Pancreas,epithelioidcarcinoma 
HIT000004532 LARP6 
RNA-binding protein Lupus Lal domain 
containing protein, complete   placenta 
HIT000030445 MDHA,MDH1 
Malate dehydrogenase, cytoplasmic (EC 
1.1.1.37), partial cds.   Placenta,choriocarcinoma 
HIT000034068 ECHS1,ECHS1 
Enoyl-CoA hydratase, mitochondrial precursor 
(EC 4.2.1.17) (Short   Placenta,choriocarcinoma 
HIT000038819 ZNF183 
Zn-finger, C-x8-C-x5-C-x3-H type domain 
containing protein,   Placenta,choriocarcinoma 
HIT000035139 GPIP4,PIP 
Prolactin-inducible protein precursor (Secretory 
actin-binding   Prostate 
HIT000039309 TCF5,CEBPB 
CCAAT/enhancer binding protein beta (C/EBP 







Histidine-rich membrane protein Ke4, partial 
cds.   Skin,melanoticmelanoma. 
HIT000014971 ZNF414  
Zn-finger, C2H2 type domain containing 
protein, complete cds.     
HIT000000974 KIAA1258,GDA 
Guanine deaminase (EC 3.5.4.3) (Guanase) 
(Guanine aminase)   adiposetissue 








Farnesyl pyrophosphate synthetase (FPP 




DEFINITION: Rho guanine nucleotide 
exchange factor 7 (PAK-interacting exchange   
HIT000042279 ARHGEF7   brain 
HIT000041526 ATP6V0A1  
V-type ATPase, 116 kDa subunit family 
protein, complete cds.   brain 
HIT000035869 MRPS10,MRPS10 
Mitochondrial 28S ribosomal protein S10 
(MRP-S10) (MSTP040),   Brain,adult,6pooledwholebrains 
HIT000041711 OPTN,OPTN,NRP 
optineurin; tumor necrosis factor alpha-
inducible cellular protein   Brain,primitiveneuroectodermal 
HIT000015206 UBAP1,NA 
ubiquitin associated protein (Homo sapiens), 
complete cds.   Cervix,carcinoma 
HIT000038183 VAMP5,NA 
vesicle-associated membrane protein 5 
(myobrevin) (Homo sapiens),   humanlung 
HIT000035479 NA PPR repeat containing protein, complete cds.   Lung 
HIT000030704 HIG2, NA Hypoxia-inducible protein 2, complete cds.   Lung,smallcellcarcinoma 
HIT000030303 YIF1 Hrf1 family protein, complete cds.   Lung,smallcellcarcinoma 
HIT000032951 RBM3 
RNA-binding region RNP-1 (RNA recognition 
motif) domain   Placenta,choriocarcinoma 
HIT000017533 STEAP2  
NADP oxidoreductase, coenzyme F420-
dependent family protein,   Placenta,choriocarcinoma 
HIT000039707 ORF1-FL49  
Molluscan rhodopsin C-terminal tail family 
protein, complete cds.   prostate 




DEFINITION: PDZ/DHR/GLGF domain 





Acidic leucine-rich nuclear phosphoprotein 32 
family member B   spleen 
Model hits which 
are hypothetical 
protein        Testis,embryonalcarcinoma 
HIT000029004 DKFZp547B1713,  Conserved hypothetical protein, complete cds.     
HIT000039620 NA Conserved hypothetical protein, complete cds.   brain 
HIT000028000 DKFZp451M2119,  Hypothetical protein, complete cds.   Brain,hippocampus 
HIT000033703 NA Conserved hypothetical protein, complete cds.   humanspinalcord 
HIT000032617 C14orf160 Conserved hypothetical protein, complete cds.   Lung,smallcellcarcinoma 
HIT000020033 NA Hypothetical protein, complete cds.   Placenta,choriocarcinoma 
HIT000013900 PACRG Conserved hypothetical protein, complete cds.   substantianigra 




Supplementary Table 7.5a: Alpha defensin1 predicted genes clustered based on GO 
       biological function  
 
Percentage: The number of genes that have a particular GO term / total number of genes 
that have a GO term 
 
 Clustering based on 
GO level 4        
GO ID GO Biological function Gene name Percentage 
GO:0044237 cellular metabolism 
NDUFS5 MARCH5 TAF11 
DPM1 UGT2B11 MYST2 
CHD2 H1F0 PECI CNOT2 
DDX23 MARS INS  48.15 
GO:0044238 primary metabolism 
MARCH5 TAF11 DPM1 
UGT2B11 MYST2 CHD2 H1F0 
CPNE6 PECI CNOT2 DDX23 
MARS INS  48.15 
GO:0006810 Transport 
MIP FTL ATP5S CPNE6 SRPR 
SEC5L1  22.22 
GO:0051234 establishment of localization 
MIP FTL ATP5S CPNE6 SRPR 
SEC5L1  22.22 
GO:0051244 
regulation of cellular physiological 
process 
TAF11 MYST2 CCND2 CHD2 
CNOT2 CCNI  22.22 
GO:0043170 macromolecule metabolism 
MARCH5 DPM1 H1F0 MARS 
INS  18.52 
GO:0043283 biopolymer metabolism 
MYST2 CHD2 H1F0 DDX23 
MARS  18.52 
GO:0007165 signal transduction APBB1IP CX3CL1 FMOD INS  14.81 
GO:0019222 regulation of metabolism TAF11 MYST2 CHD2 CNOT2  14.81 
GO:0007049 cell cycle DCTN3 CCND2 CCNI  11.11 
GO:0007267 cell-cell signaling MIP CPNE6 INS  11.11 
GO:0009605 response to external stimulus UGT2B11 MIP CX3CL1  11.11 
GO:0007155 cell adhesion TMEM8 CX3CL1  7.41 
GO:0008104 protein localization SRPR SEC5L1  7.41 
GO:0009058 Biosynthesis DPM1 MARS  7.41 
GO:0009887 Organogenesis CPNE6 KRT5  7.41 
GO:0016043 cell organization and biogenesis CHD2 H1F0  7.41 
GO:0045045 secretory pathway SRPR SEC5L1  7.41 
GO:0050877 neurophysiological process MIP CPNE6  7.41 
GO:0051301 cell division DCTN3 CCND2  7.41 
GO:0001775 cell activation CX3CL1  3.7 
GO:0006928 cell motility CX3CL1  3.7 
GO:0006950 response to stress CX3CL1  3.7 

















Supplementary Table 7.5b: Alpha defensin1 predicted genes clustered based on 
molecular function.  
 
Percentage: (The number of genes that have a particular GO term / total number of genes in the 
dataset that have  GO annotation ) 
 
 
GO ID GO molecular function Gene Names Percentage 
GO:0003677 DNA binding 
CHD1L TAF11 MYST2 CHD2 NCL 
H1F0  23.08 
GO:0017076 purine nucleotide binding 
CHD1L CHD2 DDX23 SRPR MARS 
NUBP2  23.08 
GO:0003723 RNA binding NCL DDX23 AKAP1 SRPR MARS  19.23 
GO:0016817 hydrolase activity, acting on acid anhydrides CHD1L CHD2 DDX23 SRPR  15.38 
GO:0043169 cation binding MARCH5 MYST2 FTL CPNE6  15.38 
GO:0046872 metal ion binding MARCH5 MYST2 FTL CPNE6  15.38 





Supplementary Table 7.6a: DEFA5 predicted genes that matched co-expressed genes classified based on GO 
biological function 
 Percentage: The number of genes that have a particular GO term / total number of genes in  the dataset that 
have a GO annotation 




CLG4A KIAA0175 MRPL4 PRIM1 AP2B1 SLUG ATPIF1 ILF2 PRDX2 
TXNRD1 MBD1 TTF DENR TAF11 SCAND2 ISOT HER3 LTB4DH 
TOMM34 TSSC3 HSPA14 CEV14 ATPAF1 KIAA0106 SPC18 APOL1 
KIAA0517 TYRO10 SAP61 MRPS36 PFKL NMP238 MRPS2 NUDT5 
KIAA1667 MKI67IP SAP114 AUH MID1 UGP2 TRIM38 NEC2 MNK1 
PLAGL2 UBQLN1 RPP40 DHLAG GM2A RNMTL1 KIAA0091 TRX1 
CBX6 HOX1G NAALAD1 PIM2 
 55 67.9 
primary metabolism 
 
CLG4A KIAA0175 MRPL4 PRIM1 AP2B1 SLUG ATPIF1 ILF2 MBD1 
TTF DENR TAF11 SCAND2 ISOT HER3 LTB4DH TOMM34 TSSC3 
HSPA14 CEV14 ATPAF1 KIAA0106 SPC18 APOL1 KIAA0517 TYRO10 
SAP61 MRPS36 PFKL NMP238 MRPS2 NUDT5 KIAA1667 MKI67IP 
SAP114 AUH MID1 UGP2 TRIM38 NEC2 MNK1 PLAGL2 UBQLN1 
RPP40 DHLAG GM2A RNMTL1 KIAA0091 TRX1 CBX6 HOX1G 
NAALAD1 PIM2 
 53 65.43 
macromolecule metabolism 
CLG4A KIAA0175 MRPL4 PRIM1 AP2B1 DENR ISOT HER3 TOMM34 
HSPA14 ATPAF1 SPC18 APOL1 KIAA0517 TYRO10 SAP61 MRPS36 
PFKL NMP238 MRPS2 NUDT5 KIAA1667 MKI67IP SAP114 AUH 
MID1 UGP2 TRIM38 NEC2 MNK1 UBQLN1 RPP40 DHLAG RNMTL1 
KIAA0091 TRX1 CBX6 NAALAD1 PIM2 39 48.15 
regulation of cellular physiological process 
SLUG ATPIF1 ILF2 PRDX2 CCNB MBD1 TTF TAF11 SCAND2 
NMP238 MNK1 PLAGL2 AIF1 DHLAG TRX1 CBX6 HOX1G 17 20.99 
establishment of localization 
STX6 AP2B1 TXNRD1 STAU2 TTF TOMM34 APOL1 SATT MSTP028 
BAP29 SLC17A5 KIAA1667 CTRP6 ARFL3 NESH DHLAG COL9A3 17 20.99 
Transport 
STX6 AP2B1 TXNRD1 STAU2 TTF TOMM34 APOL1 SATT MSTP028 
BAP29 SLC17A5 KIAA1667 CTRP6 ARFL3 DHLAG COL9A3 16 19.75 
regulation of metabolism 
SLUG ATPIF1 ILF2 MBD1 TTF TAF11 SCAND2 NMP238 MNK1 
PLAGL2 TRX1 CBX6 HOX1G 13 16.05 
signal transduction 
TXNRD1 TTF HER3 TYRO10 DRG2 ARFL3 TRIM38 MNK1 DHLAG 
PAK1IP1 10 12.35 
immune response HLA-DMA ILF2 G10P1 TTF IFI30 AIF1 DHLAG 7 8.64 
response to pest, pathogen or parasite HLA-DMA AIF1 DHLAG 3 3.7 
 
hemopoietic or lymphoid organ  
development TTF DHLAG TRX1 3 3.7 





Supplementary Table 7.6b: DEFA5 novel predicted genes classified based on GO biological function 
 
Percentage: The number of genes that have a particular GO term / total number of  genes in the dataset 
that have a GO annotation 
 
 





PCCX1 NPD002 VPS11 TRIM9 EFCBP1 ELE1 RPS27L 
RBM3 PSMA7 MXD3 H2AFX EPM2A USP39 
 13 65 
primary metabolism 
 
PCCX1 VPS11 TRIM9 ELE1 RPS27L RBM3 PSMA7 MXD3 
H2AFX EPM2A USP39 
 11 55 
macromolecule metabolism 
 
VPS11 TRIM9 RPS27L RBM3 PSMA7 H2AFX EPM2A 
USP39 
 8 40 
establishment of localization 
 
NPD002 VPS11 CX3CL1 VIM TFIP11 KCNMA1 
 6 30 
Transport 
 
NPD002 VPS11 VIM TFIP11 KCNMA1 
 5 25 
signal transduction 
 
YWHAG TENC1 CX3CL1 ELE1 PDZK2 




 1 5 
response to pest, pathogen or parasite 
 
CX3CL1 










Supplementary Table 7.7: Common regulatory elements found across the predicted set of genes from DEAF1 and 
DEFA5 models.  
 






Matched gene hits 
Genes No. of genes 
HNF-1 
 
STX6 CLG4A HLA-DMA AK000471 KIAA0175 MRPL4 AP2B1 WBSCR17 SLUG ATPIF1 
RDH1 UCC1 ILF2 RPMS13 TMEM30A RCBTB1 PRDX2 HDHD1A G10P1 BC093018 CCNB 
STAU2 MBD1 TTF DENR TAF11 SCAND2 SPATS2 ISOT LGALS4 TIN2 HER3 PIGT LTB4DH 
TOMM34 TSSC3 HSPA14 HRBL CEV14 PODXL ATPAF1 KIAA0106 SPC18 IFI30 APOL1 
SATT KIAA0517 TYRO10 MSTP028 KIAA1745 BAP29 DRG2 SAP61 DDX49 TMSB10 BGN 
MRPS36 COPS7A DERP7 AK096925 PFKL NMP238 KBTBD6 MRPS2 SLC17A5 AF454939 
NUDT5 BRMS1L KIAA1667 MKI67IP MRS1 SAP114 BC051849 CTRP6 DDX31 GFAP AUH 
AK026266 ARFL3 MID1 UGP2 SNAI1 RNUT1 TRIM38 NEC2 MNK1 PLAGL2 UBQLN1 RPP40 
HN1 AIF1 KIAA1624 NESH LABH2 DHLAG TMEM35 MRPL46 CCDC12 TMEM33 RNMTL1 





STX6 HLA-DMA KIAA0175 MRPL4 AP2B1 WBSCR17 SLUG TBC1D17 ATPIF1 RDH1 UCC1 
ILF2 RPMS13 TMEM30A RCBTB1 PRDX2 HDHD1A G10P1 BC093018 CCNB STAU2 MBD1 
TTF DENR TAF11 SCAND2 SPATS2 ISOT LGALS4 TIN2 HER3 PIGT LTB4DH TOMM34 
TSSC3 HSPA14 HRBL CEV14 PODXL ATPAF1 KIAA0106 SPC18 IFI30 APOL1 SATT 
KIAA0517 TYRO10 MSTP028 KIAA1745 BAP29 DRG2 SAP61 DDX49 TMSB10 BGN MRPS36 
COPS7A DERP7 AK096925 NMP238 KBTBD6 MRPS2 SLC17A5 AF454939 NUDT5 BRMS1L 
MKI67IP MRS1 SAP114 BC051849 CTRP6 DDX31 GFAP AUH AK026266 ARFL3 MID1 UGP2 
SNAI1 RNUT1 TRIM38 NEC2 MNK1 PLAGL2 UBQLN1 RPP40 HN1 AIF1 KIAA1624 NESH 
LABH2 DHLAG TMEM35 MRPL46 CCDC12 TMEM33 RNMTL1 CKLFSF6 KIAA0091 TRX1 








RDH1 UCC1 ILF2 RPMS13 TMEM30A RCBTB1 PRDX2 HDHD1A G10P1 BC093018 CCNB 
STAU2 TTF DENR TAF11 SCAND2 SPATS2 ISOT LGALS4 TIN2 HER3 PIGT LTB4DH 
TOMM34 TSSC3 HSPA14 HRBL CEV14 PODXL ATPAF1 KIAA0106 SPC18 IFI30 APOL1 
SATT KIAA0517 TYRO10 MSTP028 KIAA1745 BAP29 DRG2 SAP61 DDX49 TMSB10 
MRPS36 COPS7A DERP7 AK096925 PFKL NMP238 KBTBD6 MRPS2 SLC17A5 AF454939 
NUDT5 BRMS1L KIAA1667 MKI67IP SAP114 BC051849 CTRP6 DDX31 GFAP AUH 
AK026266 ARFL3 MID1 UGP2 SNAI1 RNUT1 TRIM38 NEC2 MNK1 PLAGL2 UBQLN1 RPP40 
HN1 AIF1 KIAA1624 NESH LABH2 DHLAG TMEM35 MRPL46 CCDC12 TMEM33 RNMTL1 




STX6 CLG4A HLA-DMA AK000471 KIAA0175 MRPL4 AP2B1 WBSCR17 SLUG TBC1D17 
ATPIF1 RDH1 UCC1 ILF2 RPMS13 TMEM30A RCBTB1 PRDX2 HDHD1A G10P1 BC093018 
CCNB STAU2 MBD1 TTF DENR TAF11 SCAND2 SPATS2 ISOT LGALS4 HER3 PIGT 
LTB4DH TOMM34 TSSC3 HSPA14 HRBL CEV14 PODXL ATPAF1 KIAA0106 SPC18 APOL1 
SATT KIAA0517 TYRO10 MSTP028 KIAA1745 BAP29 DRG2 SAP61 DDX49 TMSB10 
MRPS36 COPS7A DERP7 AK096925 NMP238 MRPS2 SLC17A5 AF454939 NUDT5 BRMS1L 
KIAA1667 MKI67IP MRS1 SAP114 BC051849 CTRP6 DDX31 GFAP AUH AK026266 ARFL3 
MID1 UGP2 SNAI1 RNUT1 TRIM38 NEC2 MNK1 PLAGL2 UBQLN1 RPP40 HN1 AIF1 
KIAA1624 NESH LABH2 DHLAG TMEM35 MRPL46 CCDC12 TMEM33 RNMTL1 CKLFSF6 
KIAA0091 TRX1 CBX6 MAP2K1IP1 HOX1G CLDN2 NAALAD1 COL9A3 PIM2 PAK1IP1 
KIAA0638 
 108 
LXR, PXR, CAR, 
COUP, RAR 
 
STX6 CLG4A HLA-DMA AK000471 KIAA0175 MRPL4 AP2B1 WBSCR17 TBC1D17 RDH1 
UCC1 ILF2 RPMS13 TMEM30A RCBTB1 PRDX2 HDHD1A G10P1 CCNB STAU2 MBD1 TTF 
DENR TAF11 SCAND2 SPATS2 ISOT LGALS4 TIN2 HER3 PIGT LTB4DH TOMM34 TSSC3 
HSPA14 HRBL CEV14 PODXL ATPAF1 KIAA0106 SPC18 IFI30 APOL1 SATT KIAA0517 
TYRO10 MSTP028 KIAA1745 BAP29 DRG2 SAP61 DDX49 TMSB10 BGN MRPS36 COPS7A 
DERP7 PFKL NMP238 KBTBD6 MRPS2 SLC17A5 AF454939 NUDT5 BRMS1L KIAA1667 
MKI67IP MRS1 SAP114 BC051849 CTRP6 DDX31 GFAP AUH AK026266 ARFL3 UGP2 SNAI1 
RNUT1 TRIM38 MNK1 PLAGL2 UBQLN1 RPP40 HN1 AIF1 KIAA1624 NESH LABH2 DHLAG 
TMEM35 MRPL46 CCDC12 TMEM33 RNMTL1 CKLFSF6 KIAA0091 TRX1 CBX6 HOX1G 




STX6 CLG4A HLA-DMA AK000471 KIAA0175 MRPL4 AP2B1 WBSCR17 SLUG TBC1D17 




DENR TAF11 SCAND2 SPATS2 ISOT TIN2 HER3 PIGT LTB4DH TOMM34 TSSC3 HSPA14 
HRBL CEV14 PODXL ATPAF1 KIAA0106 SPC18 IFI30 APOL1 SATT KIAA0517 TYRO10 
MSTP028 KIAA1745 BAP29 DRG2 SAP61 DDX49 TMSB10 MRPS36 COPS7A DERP7 
AK096925 NMP238 KBTBD6 MRPS2 SLC17A5 AF454939 NUDT5 BRMS1L KIAA1667 
MKI67IP MRS1 SAP114 BC051849 CTRP6 DDX31 GFAP AUH ARFL3 MID1 UGP2 SNAI1 
RNUT1 TRIM38 NEC2 MNK1 PLAGL2 UBQLN1 RPP40 HN1 AIF1 KIAA1624 NESH LABH2 
DHLAG TMEM35 MRPL46 TMEM33 RNMTL1 CKLFSF6 KIAA0091 TRX1 CBX6 MAP2K1IP1 




STX6 CLG4A HLA-DMA AK000471 KIAA0175 AP2B1 WBSCR17 SLUG TBC1D17 ATPIF1 
RDH1 UCC1 RPMS13 TMEM30A RCBTB1 HDHD1A G10P1 BC093018 CCNB STAU2 MBD1 
TTF DENR TAF11 SCAND2 SPATS2 ISOT LGALS4 TIN2 HER3 PIGT LTB4DH TOMM34 
HSPA14 HRBL CEV14 PODXL ATPAF1 KIAA0106 SPC18 IFI30 APOL1 SATT KIAA0517 
TYRO10 MSTP028 KIAA1745 BAP29 DRG2 SAP61 TMSB10 MRPS36 COPS7A DERP7 
AK096925 NMP238 KBTBD6 MRPS2 SLC17A5 AF454939 NUDT5 BRMS1L KIAA1667 
MKI67IP MRS1 BC051849 CTRP6 DDX31 AUH AK026266 ARFL3 MID1 UGP2 SNAI1 RNUT1 
TRIM38 NEC2 MNK1 PLAGL2 UBQLN1 RPP40 HN1 KIAA1624 NESH LABH2 DHLAG 
TMEM35 MRPL46 TMEM33 RNMTL1 CKLFSF6 KIAA0091 TRX1 CBX6 MAP2K1IP1 HOX1G 




STX6 CLG4A HLA-DMA AK000471 KIAA0175 MRPL4 AP2B1 WBSCR17 SLUG TBC1D17 
ATPIF1 RDH1 UCC1 ILF2 RPMS13 TMEM30A RCBTB1 PRDX2 HDHD1A G10P1 BC093018 
CCNB STAU2 MBD1 TTF DENR TAF11 SCAND2 SPATS2 ISOT LGALS4 TIN2 PIGT LTB4DH 
TOMM34 TSSC3 HSPA14 CEV14 PODXL ATPAF1 KIAA0106 IFI30 APOL1 SATT KIAA0517 
MSTP028 KIAA1745 BAP29 DRG2 SAP61 TMSB10 BGN MRPS36 COPS7A DERP7 AK096925 
PFKL NMP238 KBTBD6 MRPS2 SLC17A5 AF454939 BRMS1L KIAA1667 MKI67IP MRS1 
SAP114 BC051849 CTRP6 DDX31 GFAP AUH AK026266 MID1 UGP2 SNAI1 RNUT1 TRIM38 
NEC2 MNK1 UBQLN1 RPP40 HN1 AIF1 KIAA1624 NESH LABH2 DHLAG MRPL46 CCDC12 













LXR, PXR, CAR, 
COUP, RAR 
PCCX1 YWHAG NPD002 VPS11 TENC1 TRIM9 FAM45A CX3CL1 AOC1 EFCBP1 ADPRHL2 
ALEX3 VIM ELE1 PDZK2 ZMYND13 TFIP11 RPS27L RBM3 PSMA7 MXD3 FAM26B ACTR8 
H2AFX DNCLI2 EPM2A USP39 NDEL1 LRRN6A KCNMA1 ZDHHC12 TM4SF1 
 32 
CDX 
PCCX1 YWHAG NPD002 VPS11 TENC1 TRIM9 FAM45A CX3CL1 AOC1 EFCBP1 ADPRHL2 
ALEX3 VIM ELE1 PDZK2 ZMYND13 TFIP11 RPS27L RBM3 PSMA7 MXD3 FAM26B ACTR8 
H2AFX DNCLI2 EPM2A USP39 NDEL1 LRRN6A KCNMA1 ZDHHC12 TM4SF1 
 32 
HNF-1 
PCCX1 YWHAG NPD002 VPS11 TENC1 TRIM9 FAM45A CX3CL1 AOC1 EFCBP1 ADPRHL2 
ALEX3 VIM ELE1 PDZK2 ZMYND13 TFIP11 RPS27L RBM3 PSMA7 MXD3 FAM26B ACTR8 
H2AFX DNCLI2 EPM2A USP39 NDEL1 LRRN6A KCNMA1 ZDHHC12 TM4SF1 32 
Nkx2-5 
PCCX1 YWHAG NPD002 VPS11 TENC1 TRIM9 FAM45A CX3CL1 AOC1 EFCBP1 ADPRHL2 
ALEX3 VIM ELE1 PDZK2 ZMYND13 TFIP11 RPS27L RBM3 MXD3 FAM26B ACTR8 H2AFX 
DNCLI2 EPM2A USP39 NDEL1 LRRN6A KCNMA1 ZDHHC12 TM4SF1 
 31 
GATA-4 
PCCX1 YWHAG NPD002 VPS11 TENC1 TRIM9 FAM45A CX3CL1 AOC1 EFCBP1 ADPRHL2 
ALEX3 VIM ELE1 PDZK2 ZMYND13 TFIP11 RPS27L RBM3 MXD3 FAM26B ACTR8 H2AFX 
DNCLI2 EPM2A USP39 NDEL1 LRRN6A KCNMA1 ZDHHC12 TM4SF1 
 31 
Oct-1 
PCCX1 YWHAG NPD002 VPS11 TENC1 TRIM9 CX3CL1 AOC1 EFCBP1 ADPRHL2 ALEX3 
VIM ELE1 PDZK2 ZMYND13 TFIP11 RPS27L RBM3 PSMA7 MXD3 FAM26B ACTR8 H2AFX 
DNCLI2 EPM2A USP39 NDEL1 LRRN6A KCNMA1 ZDHHC12 TM4SF1 
 31 
NF-kappaB 
PCCX1 NPD002 VPS11 TENC1 TRIM9 FAM45A CX3CL1 AOC1 EFCBP1 ADPRHL2 ALEX3 
VIM ELE1 PDZK2 ZMYND13 TFIP11 RPS27L RBM3 MXD3 FAM26B ACTR8 H2AFX DNCLI2 
EPM2A USP39 NDEL1 LRRN6A KCNMA1 ZDHHC12 TM4SF1 
 30 
DEFA1  
Matched gene hits   
PPAR direct repeat 1 
 
RBM3 ATP6V0A1 STEAP2 LZIC ARHGEF7 SFRS15 PACRG PSARL RBM28 FDPS 10 
Nkx2-5 
 
RBM3 ATP6V0A1 STEAP2 LZIC ARHGEF7 SFRS15 PACRG PSARL RBM28 FDPS 10 
Cdc5 
 
RBM3 ATP6V0A1 STEAP2 LZIC ARHGEF7 SFRS15 PACRG PSARL RBM28 FDPS 10 




RBM3 ATP6V0A1 STEAP2 LZIC ARHGEF7 SFRS15 PACRG PSARL RBM28 FDPS 
CDX 
 
RBM3 ATP6V0A1 STEAP2 LZIC ARHGEF7 SFRS15 PACRG PSARL RBM28 FDPS 10 
HNF-1 
 
RBM3 ATP6V0A1 STEAP2 LZIC ARHGEF7 SFRS15 PACRG PSARL RBM28 FDPS 10 
NF-kappaB 
 
RBM3 ATP6V0A1 STEAP2 LZIC ARHGEF7 SFRS15 PACRG PSARL RBM28 FDPS 10 
Unmatched gene 
hits   
Nkx2-5 CCND2 CNOT2 MARS VSIG2 DDX23 5 
GATA-4 CCND2 CNOT2 MARS VSIG2 DDX23 5 
CDX CCND2 CNOT2 MARS VSIG2 DDX23 5 
TFIIA CCND2 CNOT2 MARS VSIG2 DDX23 5 
HNF-3alpha CCND2 CNOT2 MARS VSIG2 DDX23 5 
Evi-1 CCND2 CNOT2 MARS VSIG2 DDX23 5 
HNF-1 CCND2 CNOT2 MARS VSIG2 DDX23 5 
Oct-1 CCND2 CNOT2 MARS VSIG2 DDX23 5 
LXR, PXR, CAR, 
COUP, RAR CCND2 CNOT2 MARS VSIG2 DDX23 5 
TFII-I CCND2 CNOT2 MARS VSIG2 DDX23 5 
 
Supplementary Table 7.8 Comparison of DEFA1 and DEFA5 gene hits based on GO terms.  
 
This table lists the common and different GO categories for DEFA1 and DEFA5 gene hits 
 
Gene Ontology : biological process. Level: 4 DEFA1_genes No. of genes DEFA5_genes 






COMMON GO categories 
  
 
immune response INS PSMB8 CX3CL1 3 
TTF AIF1 DHLAG HLA-
DMA ILF2 G10P1 IFI30 
CX3CL1 8 7.18E-01 1 
macromolecule metabolism 
DPM1 CHD1L H1F0 
TMPRSS1 CHD2 NCL INS 25 
CLG4A KIAA0175 DENR 




FARS1 MTMR5 HRMT1L1 
ALDR1 PDCD9 KIAA0060 
PSMB8 PIAS2 MARS PFD4 
ARAF DDX23 MYST2 
LSM6 FKBP12 KIAA0935 
MARCH5 CASP5 
SAP61 VPS11 TRIM9 
PFKL NMP238 MKI67IP 
SAP114 RPS27L UGP2 
MID1 NEC2 UBQLN1 
RPP40 DHLAG RNMTL1 
KIAA0091 PIM2 
NAALAD1 MRPL4 
PRIM1 AP2B1 PSMA7 





KIAA1667 AUH RBM3 
TRIM38 MNK1 H2AFX 
TRX1 CBX6 
neurophysiological process ARRB2 CPNE6 2 
RDH1 YWHAG 
CKLFSF6 KCNMA1 
SLUG 5 1 1 
cell activation INS 1 TTF DHLAG 2 1 1 
regulation of cellular physiological process 
CHD2 CCNI CNOT2 
KIAA0065 PIAS2 MYST2 
KIAA0929 MIZ1 CCND2 
CASP5 10 
PCCX1 ATPIF1 PRDX2 
TTF YWHAG NMP238 
MXD3 AIF1 DHLAG 
SLUG ILF2 ELE1 MBD1 
CCNB SCAND2 EPM2A 
MNK1 PLAGL2 TRX1 
CBX6 HOX1G 21 1 1 
catabolism 
RODH INS KIAA0060 
PSMB8 4 
CLG4A PFKL PSMA7 
ISOT USP39 KIAA0106 
NUDT5 AUH GM2A 9 1 1 
regulation of metabolism 
CHD2 INS CNOT2 
KIAA0065 PIAS2 MYST2 
KIAA0929 MIZ1 8 
PCCX1 ATPIF1 TTF 
NMP238 MXD3 SLUG 
ILF2 ELE1 MBD1 
SCAND2 EPM2A MNK1 
PLAGL2 TRX1 CBX6 
HOX1G 16 1 1 
regulation of signal transduction FKBP12 1 
TTF YWHAG TRIM38 
PAK1IP1 4 1 1 
cellular metabolism 
DPM1 CHD1L H1F0 
TMPRSS1 CHD2 NCL 
RODH INS FARS1 CNOT2 
MTMR5 HRMT1L1 
KIAA0065 NDUFS5 PDCD9 
KIAA0060 PSMB8 PIAS2 
GUK1 MARS PFD4 ARAF 
DDX23 PECI MYST2 LSM6 
FKBP12 KIAA0929 
KIAA0935 MARCH5 MIZ1 33 
PCCX1 CLG4A 
KIAA0175 ATPIF1 
PRDX2 TXNRD1 DENR 
TTF HER3 LTB4DH 
TSSC3 ATPAF1 SPC18 
SAP61 VPS11 TRIM9 
PFKL NMP238 MKI67IP 
SAP114 RPS27L UGP2 
MID1 MXD3 NEC2 




CASP5 KBL RNMTL1 KIAA0091 
PIM2 NAALAD1 MRPL4 
PRIM1 AP2B1 SLUG 
ILF2 EFCBP1 ELE1 
MBD1 PSMA7 SCAND2 





MRPS36 MRPS2 NUDT5 
KIAA1667 AUH RBM3 
TRIM38 MNK1 PLAGL2 
H2AFX GM2A TRX1 
CBX6 HOX1G 
nervous system development CPNE6 1 
KIAA1745 YWHAG 
SNAI1 3 1 1 
negative regulation of physiological process INS MIZ1 2 
ATPIF1 YWHAG AIF1 
DHLAG SLUG MBD1 6 1 1 
biosynthesis 
DPM1 RODH INS FARS1 
PDCD9 GUK1 MARS KBL 8 
DENR RPS27L DHLAG 
MRPL4 EFCBP1 EPM2A 
MRPS36 MRPS2 
KIAA1667 MNK1 10 2.88E-01 1 
establishment of localization 
NTT73 SEC5L1 INS BGP1 
NDUFS5 ATP5S FTL 
CPNE6 8 
TXNRD1 TTF MSTP028 
VPS11 CTRP6 DHLAG 
KCNMA1 COL9A3 STX6 
AP2B1 TFIP11 STAU2 
TOMM34 APOL1 SATT 
BAP29 NPD002 SLC17A5 
KIAA1667 VIM ARFL3 
NESH 22 5.16E-01 1 
protein localization SEC5L1 INS 2 
TTF VPS11 DHLAG 
STX6 AP2B1 TOMM34 
BAP29 KIAA1667 ARFL3 9 5.05E-01 1 
cell cycle CCNI DCTN3 MIZ1 CCND2 4 
YWHAG AIF1 PIM2 
CCNB H2AFX 5 4.74E-01 1 
primary metabolism 
DPM1 CHD1L H1F0 
TMPRSS1 CHD2 NCL 
RODH INS FARS1 CNOT2 
MTMR5 HRMT1L1 
KIAA0065 ALDR1 PDCD9 
KIAA0060 PSMB8 PIAS2 
GUK1 MARS PFD4 ARAF 
DDX23 PECI MYST2 LSM6 
FKBP12 KIAA0929 
KIAA0935 CPNE6 
MARCH5 MIZ1 CASP5 
KBL 34 
PCCX1 CLG4A 
KIAA0175 ATPIF1 DENR 
TTF HER3 LTB4DH 
TSSC3 ATPAF1 SPC18 
SAP61 VPS11 TRIM9 
PFKL NMP238 MKI67IP 
SAP114 RPS27L UGP2 
MID1 MXD3 NEC2 
UBQLN1 RPP40 DHLAG 
RNMTL1 KIAA0091 
PIM2 NAALAD1 MRPL4 




ILF2 ELE1 MBD1 
PSMA7 SCAND2 ISOT 




MRPS36 MRPS2 NUDT5 
KIAA1667 AUH RBM3 
TRIM38 MNK1 PLAGL2 
H2AFX GM2A TRX1 
CBX6 HOX1G 
cell organization and biogenesis 
H1F0 CHD2 MYST2 
PEX11G 4 
TIN2 YWHAG TMSB10 
NMP238 MID1 DHLAG 
STX6 AP2B1 TOMM34 
BAP29 KIAA1667 ARFL3 
H2AFX CBX6 14 4.24E-01 1 
transport 
NTT73 SEC5L1 INS 
NDUFS5 ATP5S FTL 
CPNE6 7 
TXNRD1 TTF MSTP028 
VPS11 CTRP6 DHLAG 
KCNMA1 COL9A3 STX6 
AP2B1 TFIP11 STAU2 
TOMM34 APOL1 SATT 
BAP29 NPD002 SLC17A5 
KIAA1667 VIM ARFL3 21 3.79E-01 1 
signal transduction 
APBB1IP INS BGP1 
HRMT1L1 FMOD PIAS2 
ARAF ARRB2 FKBP12 
KIAA0929 10 
PDZK2 TXNRD1 TTF 
HER3 YWHAG DHLAG 
TENC1 ELE1 TYRO10 
DRG2 ARFL3 TRIM38 
MNK1 PAK1IP1 14 3.44E-01 1 
nitrogen compound metabolism 
INS FARS1 KIAA0060 
MARS KBL 5 AUH 1 1.44E-02 1 
cell death INS PDCD9 CASP5 3 
PRDX2 TSSC3 YWHAG 
DHLAG BAP29 5 7.16E-01 1 
positive regulation of physiological process INS PIAS2 2 ILF2 ELE1 2 5.97E-01 1 
cell-cell signaling INS CPNE6 2 YWHAG NEC2 KCNMA1 3 6.62E-01 1 
positive regulation of physiological process INS PIAS2 2 ILF2 ELE1 2 5.97E-01 1 
GO categories exclusive for one AMP gene group 
  
  









ARFL3 7 9.62E-02 1 




vasculature development BGP1 1 No genes 0 3.27E-01 1 
ion homeostasis FTL 1 No genes 0 3.27E-01 1 
ectoderm development KRT5 1 No genes 0 3.27E-01 1 
cell proliferation No genes 0 AIF1 DHLAG PIM2 3 5.51E-01 1 
hemopoietic or lymphoid organ development No genes 0 TTF DHLAG TRX1 3 5.51E-01 1 
cartilage development No genes 0 SNAI1 1 1 1 
skeletal development No genes 0 SNAI1 TFIP11 2 1 1 
male sex differentiation No genes 0 ELE1 1 1 1 
lymphocyte differentiation No genes 0 TTF DHLAG 2 1 1 
cellular morphogenesis No genes 0 NMP238 1 1 1 
regulation of cell growth No genes 0 NMP238 1 1 1 
regulation of developmental pigmentation No genes 0 KIAA1667 1 1 1 
neuron differentiation No genes 0 YWHAG 1 1 1 
response to oxidative stress No genes 0 PRDX2 KIAA0106 2 1 1 
response to wounding No genes 0 AIF1 DHLAG 2 1 1 
embryonic hemopoiesis No genes 0 TRX1 1 1 1 
cell growth No genes 0 NMP238 1 1 1 
positive regulation of development No genes 0 KIAA1667 1 1 1 
mesoderm development No genes 0 SLUG 1 1 1 
development of primary sexual characteristics No genes 0 ELE1 1 1 1 
embryonic organ development No genes 0 TRX1 1 1 1 
taxis No genes 0 CKLFSF6 1 1 1 
regulation of cell differentiation No genes 0 YWHAG 1 1 1 




Figures for Chapter 7 
 
Supplementary Figure 7.1: Alpha defensin 1 unmatched gene hits (did not match 
with co-expressed gene list for DEFA1, DEFA3) compared with co-expressed genes 
of DEFA1,DEFA3 
 
    
c 
Supplementary Figure 7.1: The orange bar indicates the unmatched gene hits and 
the green bar indicates the co-expressed genes for DEFA1, DEFA3. The raw p-




Supplementary Figure 7.2: All alpha defensin 1 predicted genes compared with co- 




Supplementary Figure 7.2: The orange bar represents the co-expressed genes and green bar 




Supplementary Figure 7.3: All alpha defensin 1 predicted genes compared with co-











Supplementary Figure 7.4: DEFA4 novel predicted genes compared with  




Supplementary Figure 7.4: The orange bar is the matched predicted genes and green bar 
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Supplementary Material for Chapter 4 
 






















Figure 4.1: The mellitin profile is tested against a set of 12 sequences which include 
mel_apicc (mature_peptide), melittin analogs: mut5_l6, mut13_l13, mut1_g1, mut6_l7, 
mut10_t11, mut13_p14, melittin hybrid: cecropina(1-8)-melittin(1-18), ca(1-7)m(2-9), 
non-melittin sequences: protegrin (PG3_PIG), acyl-coadehydrogenasefamilymember8 
(ACAD8_HUMAN), mel_apicc(complete peptide) (melittin_complete). The E-value and 
score indicate the statistical significance of similarity of the sequence to the profile. A 
lower E-value score indicates a better match. Analysis of the E-values of different test 
sequences shows that the melittin profile generated by HMM is able to differentiate 























Figure 4.2: The mellitin profiles categorizing decreased hemolytic activity, increased 
hemolytic activity is tested against a set of melittin analogs, K-23, L-16, I-2 and normal 
melittin sequence melittin wild type, mel_apicc (mature_peptide). The profiles could 






















Figure 4.3:  The beta-defensin profile is tested against a set of five sequences co-
adehydrogenase family member 8, Protegrin, bd01_cerpr, bd01_caphi, bd01_ponpy . 
Analysis of the E-values of different test sequences shows that the beta-defensin profile 
generated by HMM is able to differentiate between members of the beta-defensin family 




















Figure 4.4: The melittin profile was queried against the nr database and three sequences 


























Figure 4.5:  The beta-defensin profile was queried against the nr database and 12 






List of parameters of the  Dragon Motif Builder program 
 
Parameter Explanation 
Infile input file 
Outfile output file 
EMSearchOption EM search option 1)EM1 2) EM2 
RandomLimit Random Peak scan coefficient: 10-100 recommented, higher value= long search time 
motiflength User specified motif length 
EMmaxLength Maximun length for motif, ONLY applicable for EM2 
motifNum number of motifs user wants 
IterationThreshod Maximun iteration for one search, program will terminate the search when exceeds the threshold 
ICThreshold Information content threshold, to maintain the result's IC quality. Vary 0 - 2 
EMCriteria 
EM eliminating criteria. 1-> Eliminate the identified motif patterns  
2- >Eliminate the sequences which contain the sequences 
revCompOption 0-> No reverval completement 1-> Reversal completement option 
dirOption 0-> Forward strand search 1-> Inverse strand search 
Selectpos position segment analysis 0- full sequence length analysis 1-> Segment sequences anlysis 
Startpos Segment start position, 
Endpos Segment end position 
EMThreshold EM search threshold, vary 0-1 
bgAnalysis 
background analysis, 0-> no background analysis, 1-> analysis with internal generation background 
sequences,  
2-> user induce background sequences, 3-> user specified the background sequences with the percentage  
4-> user define the background sequence by their own data file 
KeepZero Remove the poor patterns from the group 
nucleatideA percentage of A NN in the background sequences 0-100 
nucleatideC percentage of C NN in the background sequences 0-100 
nucleatideG percentage of G NN in the background sequences 0-100 
nucleatideT 
percentage of T NN in the background sequences 0-100 
 NOTE: nucleatideA+nucleatideC+nucleatideG+nucleatideT = 100 
appearOption pattern appearance option 0-> Single 1-> Pair 2-> Single&Pair 
pairDistance pattern pair distance 
MarkovModelorder Markov Model order, recommented 3rd order 
bgSeqFile background sequence file 
MarkovTable Markov loop-up table 
PlotGraph graph plotting option 0-> No, 1-> Yes 
EValue background pattern appearance threshold 
bgMaxlen  the background length that user specified 
ContrastCoeff  contrast ratio btw the target and background, range from 0-1 
PThreshold  p-value threshold range from 0 -1 
controlOption  0-> no e and p value control, 1-> e value control, 2-> p value control, 3 -> both 
EPIteration  number of iteration for the p & e value control before we relax the threshold condition 
ERatio  number of relaxation coefficient for e value 
 
